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1 Introduction 
1.1 Intestinal parasites 
Nematodes are extremely successful widespread organisms, many of which have evolved a 
parasitic life style, being relevant pathogens of humans and animals. More than two billion 
humans, mostly among the world’s poorest (Awasthi et al 2003; WHO, 2003), are infected by 
nematodes and 3.5 billion are exposed to them (Chan 1994; Hotez 2008). The vast majority of the 
nematode burden of the human population is due to gastro-intestinal nematodes. The total number 
of people with high intensity infection in the world is 152 million for hookworms, 60 million for 
Ascaris lumbricoides and 45 million for Trichuris trichiura (Stephenson et al 2000). These 
infection burdens can be measured in terms of disability-adjusted life-years (DALYs) (Stephenson 
et al 2000; WHO World Health Report 2002). For theses three species of intestinal parasitic 
nematodes, it has been shown that 39 million DALYs are caused per year 
(hookworm 22.1 million; A. lumbricoides 10.5 million; T. trichiura 6.4 million). This is 
comparable to other significant infectious diseases: tuberculosis 46.5 million; malaria 
35.7 million; measles 34.1 million (Stephenson et al 2000). 
On the other hand, substantial evidence from animal models of human disease supports the 
hypothesis that infection with helminths can suppress the development of other maladies. In the 
past, there has been an exponential increase in the incidence of autoimmune and idiopathic 
inflammatory disorders such as inflammatory bowel disease (IBD), diabetes and atopic diseases in 
westernised societies, and a similar pattern is emerging in urbanised areas of developing countries 
(Smits & Yazdanbakhsh 2007). 
This thesis focuses on the identification, isolation and characterisation of potential immune 
modulating molecules to better understand the parasite-host interaction. 
Nematodes of the genus Strongyloides infect a wide variety of terrestrial vertebrate hosts 
(Speare 1987). Strongyloides, containing some 50 species of obligate gastrointestinal parasites, is 
a relatively common infection of wild and domestic animals, but also infects birds, reptiles and 
amphibians. Strongyloides stercoralis (S. stercoralis, threadworm), a species naturally infecting 
humans, is considered the fourth most important intestinal nematode infection, after hookworm, 
A. lumbricoides, and T. trichiura, with an estimate of 100-200 million infected people (Viney 
2006; Viney et al 2007). It is endemic in tropical and subtropical countries, but also in the United 
States of America, Europe and Asia. Due to its low incidence in industrialised countries, 
misdiagnoses and medical errors may occur (Boulware et al 2007). Human infection occurs when 
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infective (filariform) larvae penetrate intact skin. This most commonly happens when the host’s 
bare feet come in direct contact with soil contaminated with infective Strongyloides larvae 
(Figure 1.1). Once infected, the pathology of Strongyloides infection is often not overt (Genta & 
Caymmi Gomes 1989). However, because of the unique ability of S. stercoralis to complete its 
life cycle within the human host, the burden of worms can dramatically increase through a cycle 
of autoinfection. During autoinfection, the rhabditiform larvae become infective filariform larvae, 
which can penetrate either the intestinal mucosa (internal autoinfection) or the skin of the perianal 
area (external autoinfection). Cycles of auto-infection lead to chronic disease that can persist for 
several decades, more than 50 years. In either case, the filariform larvae may follow the route 
described in Figure 1.1, and migrate successively to the lungs, the bronchial tree, the pharynx and 
the small intestine, where they mature into adults, or they may disseminate widely in the body. To 
date, the occurrence of autoinfection in humans with helminthic infections is recognised only in 
S. stercoralis and Capillaria philippinensis infections. In the case of S. stercoralis, autoinfection 
may explain persistent infection in people who have not been in a disease-endemic area for many 
years and hyperinfection in immunodepressed patients. No other human parasitic nematode has 
been associated with such a broad spectrum of manifestations and different clinical syndromes as 
has S. stercoralis. Chronic infection with S. stercoralis often is clinically inapparent or can lead to 
cutaneous, gastrointestinal, or pulmonary symptoms. Gastrointestinal manifestations include 
vomiting, diarrhoea, abdominal discomfort, nausea, and anorexia. In contrast to other soil-
transmitted helminthes (STH), the unique life cycle of S. stercoralis encompasses both obligate 
parasitic (direct, asexual, homogonic) and facultative free-living (indirect, sexual, heterogonic) 
generations (Viney 2006). These multiple peculiarities and singularities of Strongyloides infection 
stress the determining influence of the immune system and its partial protection of the host.  
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Figure 1.1: The life cycle of Strongyloides stercoralis 
In the free-living cycle, the rhabditiform larvae passed in the stool (1) can either moult twice and become infective 
filariform larvae (6) or moult four times and become free-living adult males or females (2) that mate and produce eggs 
(3), from which rhabditiform larvae hatch (4). The rhabditiform larvae (5) in turn can develop into the infective 
filariform larvae (6). The filariform larvae penetrate the human host skin to initiate the parasitic cycle (7). In the 
parasitic cycle, filariform larvae are transported to the lungs, where they penetrate the alveolar spaces. They migrate 
through the bronchial tree to the pharynx, are swallowed and then reach the small intestine. Here, they moult twice and 
become adult female worms (8). The females live in the epithelium of the small intestine and, parthenogenetically, 
produce eggs (9), which yield rhabditiform larvae (1). The rhabditiform larvae (1) can either be passed in the stool or 
cause autoinfection (10). 
 
Immunocompetent persons, when chronically infected with S. stercoralis, can control the 
worm burden at a very low level over decades, sustained by autoinfection. A hyperinfection and 
dissemination, often with fatal outcome, can occur only when the immune control collapses. 
Following immunocomprising conditions, e.g. immunosuppressive drug therapy (glucocorticoids, 
cyclosporine, azathioprine), hematologic malignancies, transplantations, HTLV-1 infection, 
hypogammaglobulinemia, tuberculosis or protein-caloric malnutrition syndrome, hyperinfection 
and dissemination, complete disruption of the mucosal structures or ulcerations have been 
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observed (Genta et al 1989; Fardet et al 2006). Dissemination may involve gut, stomach, lung 
and/or cerebrospinal fluid. Furthermore, larval penetration of the intestinal wall during 
dissemination may result in bacteraemia, due to the introduction of bowel flora. Recent reports 
indicate the underestimation of strongyloidiasis and its hyperinfection syndrome, which was 
evaluated as an emerging infectious disease that has migrated from developing regions to 
industrialised areas (Marcos et al 2008). 
In the developed countries, helminth infections including strongyloidiasis in humans can be 
widely controlled by primary health care programmes and effective public sanitation. In 
developing counties, helminth diseases are still widespread and drug treatment does not protect 
against rapid re-infection (Anthony et al 2007). In general, the options for the treatment of 
helminth infections offer a range of different substances for example benzimidazoles, macrocyclic 
lactones, tetrahydrompyrimidines and emodepsides. The drug of choice for strongyloidiasis is the 
macrocyclic lactone ivermectin (www.dpd.cdc.gov.2008), which is derived from the bacterium 
Streptomyces avermitilis (Li et al 2008). It binds to and activates glutamate-gated chloride 
channels which can be predominantly found in neurons and myocytes of non-vertebrates. This 
leads to an influx of calcium ions causing hyperpolarisation of the cell membrane and ultimately 
death. Albendazole, belonging to the chemical class of benzimidazoles, is the recommended 
alternative (www.dpd.cdc.gov.2008) to ivermectin for treatment. Its proposed way of action is the 
inhibition of tubulin polymerisation in intestinal parasites which leads to metabolic interception 
including the loss of energy metabolism. These pathophysiological alterations lead to parasite 
death. Both drugs can be administered orally in non severe strongyloidiasis, whereas in 
hyperinfection syndrome a combination therapy has been proposed (Lim et al 2004). Most of the 
active substances were introduced into the market many years ago and were widely used in 
humans and animals. The resulting reduced efficacy of common anthelmintic drugs in veterinary 
medicine show the need for the development of new therapeutic agents for the treatment of 
parasitic nematode infections. 
The diagnosis of strongyloidiasis can only be made in a laboratory because the only 
pathognomic clinical sign of a Strongyloides infection is the larva currens which does not 
necessarily occur. Baermann technique, Harada-Mori filter paper technique, Koga agar plate 
method and direct staining of faeces can be performed for the examination of stool samples. A 
single stool examination detects larvae in only 30% of infections, which makes it necessary to 
examine stool probes over several days. Other diagnostic tools include the detection of 
anti-strongyloides antibody, using the enzyme-linked immunosorbent assay (ELISA). However, 
the ELISA test cannot distinguish antibodies produced by past or current infections. A real-time 
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polymerase chain reaction (RT-PCR) targeting the small subunit of the rRNA gene was recently 
developed for the detection of S. stercoralis DNA in faecal sample (Verweij et al 2009). The use 
of this assay could facilitate monitoring the prevalence and intensity of S. stercoralis infections 
during helminth intervention programmes. Moreover, the use of this assay in diagnostic 
laboratories could make the introduction of molecular diagnostics feasible in the routine diagnosis 
of S. stercoralis infections, with a two-fold increase in the detection rate as compared with the 
commonly used Baermann sedimentation method. As an invasive method, endoscopy can reveal 
mucosal erythema and edema in the duodenum, and a probe of duodenal fluid can contain both 
eggs and larvae. 
1.2 Strongyloides ratti  
In comparison to S. stercoralis, the rat-invading parasite Strongyloides ratti (S. ratti) is an 
ideal organism to work with in the laboratory. The human parasite S. stercoralis can be 
maintained in dogs (Lok 2007) and gerbils (Nolan et al 1999). However, the use of these animals 
is costly, and of ethical concern. S. ratti has a parasitic and a non-parasitic phase, thus, in contrast 
to most other nematodes, there is no insect vector needed for the perpetuation of the cycle. The 
absence of an insect vector allows comparing parasitic and non-parasitic stages at the molecular 
level in order to study genes and gene products that might be important in the process of infection 
or in parasite survival within its host. Furthermore, due to the absence of an insect vector, the 
handling is less time consuming. Also, S. ratti has a remarkable life cycle, including both a 
parasitic and a free-living phase (Figure 1.2). The parasitic phase consists solely of adult parasitic 
females, which live embedded in the mucosa of the small intestine of rats. The eggs produced by 
these females are passed with the faeces into the external environment. Two types of development 
can then occur, termed homogonic and heterogonic. In homogonic (or direct) development, larvae 
moult via two larval stages into infective third-stage larvae (iL3s), which infect new hosts by skin 
penetration. The iL3 stage is developmentally arrested and will not develop further until it 
encounters a host. In heterogonic (or indirect development), larvae moult via four larval stages, 
finally maturing as free-living adult males and females. These mate, and the progeny develops, as 
in the homogonic development. Thus, despite being an obligate parasite, a significant part of the 
Strongyloides life cycle occurs outside the host. This has the practical advantage that the free-
living stages can be readily grown and manipulated in faeces from infected animals. This life 
cycle is shared by all Strongyloides spp. However, there are species differences in the number of 
free-living generations that occur. For example, Strongyloides planiceps (a parasite of cats) was 
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found to undergo up to nine, decreasingly fecund, free-living generations (Yamada et al 1991). 
For S. ratti no more than one free-living generation has been observed. 
 
 
Figure 1.2: The life cycle of Strongyloides ratti 
In the free-living cycle, the rhabditiform larvae passed in the stool (1) can either moult twice and become infective 
filariform larvae (6) or moult four times and become free-living adult males or females (2) that mate and produce eggs 
(3), from which rhabditiform larvae hatch (4). The rhabditiform larvae (5) in turn can develop into the infective 
filariform larvae (6). The filariform larvae penetrate the rat host skin to initiate the parasitic cycle (7). In the parasitic 
cycle are transported to the lungs, where they penetrate the alveolar spaces. They migrate through the bronchial tree to 
the pharynx, are swallowed and then reach the small intestine. Here, they moult twice and become adult female worms 
(8). The females live embedded in the epithelium of the small intestine and, parthenogenetically, produce eggs (9), 
which yield rhabditiform larvae (1). The rhabditiform larvae are passed in the stool. 
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1.3 Heat shock proteins 
Heat shock proteins (HSPs) comprise ubiquitous, highly conserved molecular chaperones and 
proteases that are essential for cell viability. Furthermore, HSPs are required by many proteins to 
reach their native conformation (Hartl & Hayer-Hartl 2002). Selected HSPs, also known as 
chaperones, play crucial roles in folding/unfolding of proteins, assembly of multiprotein 
complexes, transport/sorting of proteins into correct subcellular compartments, cell-cycle control 
and signalling, and protection of cells against stress or apoptosis. HSPs have been implicated in 
infectious diseases, being primary targets for the host immune system, and several HSPs have 
been found to be immunogenic (Zugel & Kaufmann 1999b). In particular HSP60 attracted 
attention as a highly immunogenic molecule that activates T cells (Kaufmann 1992) and 
cross-reacts with eukaryotic HSP has been implicated in autoimmune and inflammatory diseases 
(Kiessling et al 1991). Chaperonins belong to the group of chaperones and are divided in two 
groups. Group I chaperonins, such as chaperonin 60 (Hemmingsen et al 1988) also known as 
HSP60 and called groEL in bacteria, require a co-chaperone to carry out the refolding reaction, 
HSP10 also known as GroES in bacteria. The complex structure of HSP60 and HSP10 was 
elucidated at high resolution (Xu et al 1997). The functional unit of the HSP60 species is a 
homotetradecameric complex consisting of two stacked rings with seven subunits each. HSP10 
heptamers form the lid. Group II chaperonins are found in archaea and the eukaryotic cytosol, 
where a single polypeptide, called thermosome or TRiC, respectively, exerts the function of both 
HSP60 and HSP10. Detailed descriptions of the chaperonin-mediated folding cycle have been 
proposed (Bukau & Horwich 1998, Walter & Buchner 2002). It is thought that unfolded 
polypeptides are captured through hydrophobic contacts within the chaperonin barrel and then 
forced to refold in the central cavity. Once the native conformation is reached, the protein is 
released into the cytoplasm. The HSP60/10 complex is believed to be responsible for accelerating 
the folding of polypeptides imported into mitochondria. Furthermore, the complex reactivates 
denaturated proteins, and diminishes aggregation of non-native polypeptides and partially 
unfolded kinetically trapped intermediates. Its potential to smooth the energy landscape necessary 
for the folding and to prevent intermolecular interactions between non-native polypeptides has 
been widely investigated (Ziemienowicz et al 1993, Weissman et al 1995, Bukau & 
Horwich 1998, Brinker et al 2001, Walter & Buchner 2002). 
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1.3.1 Heat shock protein 60 (HSP60) 
HSP60 is a highly conserved and ubiquitously expressed protein. It belongs to the 
chaperonin family, which is subject to inducible expression following heat shock (Lund 1995). 
HSP60 is one of the major molecular chaperones in both stressed and unstressed cells. In 
mammalian cells it is primarily found in mitochondria (Soltys & Gupta 1996; Gupta 1990). The 
HSP60 found in mitochondria is the mature form of the protein that lacks the mitochondrial 
targeting sequence (Ikawa & Weinberg 1992; Jones et al 1994; Khan et al 1998). Besides being 
part of the protein folding machinery, HSP60 has a number of significant functions in the immune 
response of an organism. Immune responses to HSP60 from bacteria, protozoa, fungi and 
helminths have frequently been detected after infection with these organisms. Moreover, during 
bacterial infections, the bacterial members of the HSP60 family (GroEL) are common targets of 
humoral and cell-mediated immune responses in mammals (Kaufmann 1992; van Noort et al 
1995). Analysis of T cell responses in mice immunised with Mycobacterium tuberculosis showed 
that ~10-20% of the M. tuberculosis–specific T cells respond to M. tuberculosis HSP60 
(Kaufmann et al 1987). They were identified as the main goals for antibodies and T-cell immune 
responses in patients infected by pathogenic bacteria, fungi or parasites (Weigl et al 1999). 
Furthermore, various studies have shown that HSP-reactive T cells have an immunoregulatory 
phenotype, indicating that in particular HSP60 is an autoantigen with the potential to trigger 
immunoregulatory pathways, which can suppress immune responses that occur in human 
inflammatory diseases, such as rheumatoid arthritis, type 1 diabetes, and possibly atherosclerosis 
and allergy (Graeff-Meeder et al 1991; Jones et al 1993; Xu et al 1993; Elias et al 1990; Barton et 
al 1998). This has led to an interest in studying HSP molecules with respect to the biology of 
parasitism, from the dual perspectives of up-regulated expression by parasites coming from a 
poikilothermic environment entering a homothermic environment, and over-expression by host 
cells responding to the stress of infection (Maresca & Carratu 1992; Young 1990). Auto-immune 
responses to HSP60, potentially triggered by infection, have been associated with the 
pathogenesis of a range of illnesses– including rheumatoid arthritis, atherosclerosis, diabetes 
mellitus and gastro-duodenal disease.  
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1.3.2 Heat shock protein 10 (HSP10) 
Among other presumptive functions such as immunosuppressive activity (Akyol et al 
2006), HSP10 serves as a co-chaperone for HSP60 during protein folding. HSP10 is a heptameric 
complex and functions as “lid” for the HSP60 cavity. The opening and closing of the cage 
depends on the ATPase activity of HSP60 (Ellis 2003). Besides being localised in the matrix 
compartment of mammalian mitochondria, it is localised in the cellular localisations, such as 
zymogene granules, hormone granules, secretory granules, and mature red blood cells 
(Sadacharan et al 2001). Many clinical studies have shown the discrepancy between HSP60 and 
HSP10 expression in normal (Cappello et al 2004) and tumoral (Cappello et al 2003b) cells. High 
levels of HSP10 in the cytoplasm of cancer cells have been reported in the past (Sadacharan et al 
2001, Cappello et al 2003a, 2003c; Hansen et al 2003). HSP10 was additionally related to 
immunosuppressive activity (Akyol et al 2006). A protein corresponding to HSP10 was originally 
independently identified as early pregnancy factor (EPF) (Morton et al 1992). 70% of the human 
platelet-derived EPF amino acid sequence has been purified (Cavanagh & Morton 1994). Except 
for a single residue, the sequence is identical to that of rat HSP10. Not only the identical amino 
acid sequence is surprising, but also the differences in cellular localisation and function. EPF is 
now known to be essential for the initiation and maintenance of pregnancy (Athanasas-Platis et al 
1989, 1991, 2000), but is not confined to gestation. EPF is secreted by normal, transformed, and 
neoplastic cells during growth and division, but not during quiescent phases and is required for 
continued cellular growth, both in vitro and in vivo (Quinn et al 1990, 1994; Quinn & Morton 
1992). In addition to growth-regulatory effects, EPF exhibits immunomodulatory properties 
(Morton 1998). It suppresses the delayed type hypersensitivity (DHT) response (Noonan et al 
1979; Zhang et al 2003), prolongs skin graft survival time (Morton et al 2000) and suppresses 
clinical signs of experimental autoimmune encephalomyelitis (EAE) (Zhang et al 2000, 2003), the 
animal model of multiple sclerosis (MS).  
Nevertheless, little is known to date about either the physical interactions of HSP10 with 
other proteins within the cell, or its involvement in signal transduction pathways. Most literature 
describes a well-known interaction between HSP10 and HSP60 (Ryan et al 1997). According to 
my knowledge, nothing is known about the role of HSP10 and HSP60 in the nematode 
S. stercoralis and S. ratti. 
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1.4 Objective of this thesis 
Strongyloidiasis is a neglected disease, mostly confined to tropical regions. According to 
World Health Organisation (WHO) estimates, 100 to 200 million individuals are infected by 
Strongyloides (Awasthi et al 2003; WHO, 2003). Individuals, who are immunosuppressed either 
by drug treatment or by other disease, e.g. HTLV, are susceptible to a disseminated, and usually 
fatal, Strongyloides infection. The hyperinfection syndrome has a high mortality rate (15% to 
87%). Once diagnosed, the disease may be managed effectively with anthelmintic drugs, 
including ivermectin. But the hyperinfection syndrome causes diverse symptoms and signs, with 
unusual manifestations leading to misdiagnosis and medical errors. Hence, the hyperinfection 
syndrome is an emerging tropical infection migrating to developed countries and requires 
attention (Marcos et al 2008). 
To better understand the parasite-host relationship, the study of host defence-modulating 
molecules in parasitic systems may likely reveal new principles of their function. HSP60 and 
HSP10 are of fundamental significance for protein biosynthesis, have a potential significance for 
the host immune response, and can be utilised as immunodominant antigens for vaccination. 
Moreover, these two proteins may, on the other hand, play a role as model for other helminth 
parasite proteins, revealing novel ways to manipulate the human immune system to treat 
autoimmune and idiopathic inflammatory diseases. Therefore, the objective of this study was to 
identify, isolate and molecularly characterise the S. ratti HSP10 
(SrHSP10) and S. ratti HSP60 (SrHSP60) genes and proteins.
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2 Materials and Methods 
2.1 Reagents, disposals, instruments 
2.1.1 Solutions and buffers 
Solutions & buffers  Composition Application  
 
APS:  10% ammonium peroxodisulphate (Amersham) in 
dH2O  
Protein gel  
Acetylation buffer: 100 mM triethanolamine (Sigma), 5 M 0,9% NaCl, 
250ml/l acetic anhydride (Sigma) 
Kryo histology  
Cracking buffer (stock 
solution):  
8 M urea; 5% (w/v) SDS; 40 mM Tris (pH 6.8); 
0.1 mM EDTA; 0.4 mg/ml bromphenol blue; in 
dH2O 
Yeast protein extraction  
 
Buffer 1: 100 mM Tris-HCl pH 7.5, 150 mM NaCl, 
0.1% Tween 
In situ hybridisation 
Buffer 2: 100 mM Tris-HCl, pH 9.5; 100 mM NaCl In situ hybridisation 
Buffer a 2xSSC; 0.5% SDS Southern blot 
Buffer b 0.2x SSC; 0.1XSDS Southern blot 
Buffer B: 8 M urea, pH 8.1; 10 mM Tris-HCl; 100 mM 
NaH2 PoH4 
Protein purification 
Buffer C: 8 M urea, pH 6.3; 10 mM Tris-HCl; 100 mM 
NaH2 PoH4 
Protein purification 
Buffer D: 8 M urea, pH 5.9; 10 mM Tris-HCl; 100 mM 
NaH2 PoH4 
Protein purification 
Buffer E: 8 M urea, pH 4.5; 10 mM Tris-HCl; 100 mM 
NaH2 PoH4 
Protein purification 
Blotting buffer 
(Bjerrum-Schöfer-
Nielsen Buffer): 
48 mM Tris, 39 mM glycine, 20% methanol; pH 9.2 Western blot 
Coomassie blue 
staining solution: 
0.05% (w/v) Coomassie brilliant-blue R-250; 40% 
ethanol; 10% ice acetic acid; 50% dH2O 
Protein gel staining  
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Coomassie blue 
destaining solution: 
40% ethanol; 10% ice acetic acid 50% dH2O  Protein gel staining  
CTAB:  5% CTAB (trimethyl cetylammonium bromide) 
0.5 M NaCl 
Mini scale plasmid 
preparation 
DEPC- dH2O:  0.1% diethylpyrocarbonate in dH2O; autoclaved RNA isolation  
Developer solution: 2.5% Na2CO3, 0.01% formaldehyde (v/v); pH 11.3-
11.8 at 25°C 
Silver staining 
Ethidium bromide 
(EtBr):  
1 g/100 ml dH2O; stored shaded Staining of nucleic acids  
Fixation buffer I: 30% ethanol (v/v); 10% acetic acid (v/v) Silver staining 
Fixation buffer II: 30% ethanol (v/v); sodium acetate 0.5 M; 
25% glutaraldehyde (v/v); 0.2% Na2S2O3 (v/v) 
Silver staining 
Herring sperm DNA: 10 mg/ml in H2O; boil in microwave 3x; cool on ice; 
15 min ultra sound; freeze 
Southern blot analysis 
Loading buffer:  0.1% bromphenol blue; 0.1% xylencyanol; 50% 
glycerol; in 1 x TAE-buffer 
DNA gel electrophoresis  
PBS (10x):  1.37 M NaCl; 27 mM KCl; 74 mM Na2HPO4; 
15 mM KH2PO4; dH2O ad 1 l (pH 7.0 – 7.2); 
autoclaved 
Washing buffer  
Phenol:  phenol, saturated with equivalent volume 0.5 mM 
Tris pH 7.8 
Nucleic acid purification 
PEG solution:  50% PEG 1500 (polyethylene glycol)  Yeast transformation 
PEG/LiAc solution:  40% PEG 4000; 1 x TE-solution; 1 x LiAc-solution Yeast transformation 
Polyacrylamide stock 
solution:  
0.8% N’N’-methylbisacrylamide; 30% acrylamide; 
in dH2O (Rotiphorese® Gel 30; Carl Roth)  
Protein gel preparation 
Ponceau-red S:  2% ponceau-red S; 30% sulfoacyl acid; 30% sodium 
deoxycholate aqueous; in dH2O  
Western blot  
Proteinase K buffer: Qiagen In situ hybridisation 
RNA Loading buffer:  900 µl formamide (deionised); 100 µl MOPS-buffer 
(1 x); 160 µl formaldehyde; 20 µl bromphenol blue 
(1% in DEPC-dH2O); 20 µl xylene cyanol (1% in 
DEPC-dH2O); 10 µl ethidium-bromide (10 µg/µl)  
RNA gel electrophoresis 
SDS-PAGE stacking 
gel buffer (4 x):  
0.5 M Tris (pH 6.8); 0.4% SDS  Protein gel preparation 
SDS-PAGE running 
buffer (10 x):  
1.92 M glycine; 250 mM Tris; 10% (w/v) SDS; 
dH2O ad 1 l (pH 8.3; to be adjusted before SDS 
addition)  
Protein gel preparation 
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SDS-PAGE running 
buffer (1 x):  
100 ml 10 x stock solution; dH2O ad 1 l  Protein gel preparation 
SDS-PAGE sample 
buffer:  
8 ml glycerin; 4 ml ß - mercaptoethanol; 12 ml 20% 
SDS; 16 ml 4 x staking gel buffer; (if necessary 4% 
bromphenol-blue)  
Protein gel preparation 
SDS-PAGE separation 
buffer (4 x):  
1.5 M Tris (pH 8.8); 0.4% SDS Protein gel preparation 
SSC (20 x):  3 M NaCl; 0.3 M trisodium citrate 2H2O; dH2O ad 1 
l; pH 7.0, autoclaved 
In situ hybridisation, 
Southern blot analysis 
SSPE(20 x): 3 M NaCl; 0,2 M NaH2PO4xH20; 0.02 M EDTA; 
pH 7.4 with NaOH 
Southern blot analysis 
Staining solution: 0.1% silver nitrate (v/v); 0.01% formaldehyde (w/v) Silver staining 
STET-buffer:  8% sucrose; 50 mM Tris (pH 8.0); 50 mM EDTA; 
5% Triton X-100  
Mini-scale plasmid 
preparation  
Stop solution: 0.005 M EDTA sodium salt  Silver staining 
TAE-buffer (50 x):  2 M Tris base, 50 mM EDTA, 5.71% glacial acetic 
acid pH 8.0 
DNA gel electrophoresis 
TE-solution (10 x):  0.2 M Tris; 10 mM EDTA; pH 7.5; autoclaved Yeast transformation 
1T 1/10E (1x): 10 mM Tris, pH 8.0; 1 mM EDTA, pH 8.0, 
autoclaved 
gDNA precipitation 
TEMED:  tetramethylethylenediamine, Amersham Biosciences Protein gel preparation 
TRIzol®-Reagenz:  phenyl, guanidine-isothiocyanate (GIBCO) RNA isolation  
Washing buffer A: 2 x SSC; 0.5% SDS Southern blot analysis 
Washing buffer B: 0.2 x SSC; 0.1 x SDS Southern blot analysis 
X-Gal-stock solution:  5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside 
(X-Gal) in N, N -dimethylformamide (DMF); 
20 mg/ml  
ß-galactosidase assay 
   
Z-buffer:  60 mM Na2HPO4·7H2O; 40 mM NaH2PO4·H2O; 
10 mM KCl; 1 mM MgSO4·7H2O; pH 7.0; 
autoclaved 
ß-galactosidase assay 
Z-buffer/X-Gal-
solution:  
100 ml Z-buffer; 0.27 ml β-mercaptoethanol; 
1.67 ml X-Gal stock solution 
ß-galactosidase assay 
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2.1.2 Media and additives 
Media & additives  Composition Application 
DYT-medium:  1.6% bacto tryptone; 1% bacto yeast extract; 
100 mM NaCl 
E. coli - medium (fluid)  
LB-agar:  see LB-medium; additional 15 g/l agar; autoclaved  E. coli - medium (solid)  
SOC-medium:  2% bacto-tryptone, 0.5% yeast-extract; 10 mM 
NaCl; 2.5 mM KCl; 5 N NaOH pH 7.0; autoclaved; 
subsequent addition of 10 mM MgCl2; 10 mM 
glucose solution (sterile)  
E. coli - medium 
[following heat shock] 
(fluid)  
Ampicillin:  Ampicillin trihydrate [D-(-)-α-
aminobenzyl penicillin]; stock conc. 100 m/ml 
dH2O; end conc. 100 µg/ml  
LB-medium and LB-plate 
additives (selection)  
X-Gal:  5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside; 
stock conc. 2% in dimethylformamide; end conc. 
0.004%  
Blue-white selection 
IPTG:  isopropylthiogalactoside; stock conc. 1 M in dH2O; 
end conc. 0.2 mM  
Blue-white selection 
YPD-medium:  20 g/l peptone; 10 g/l yeast extract; 950 ml dH2O; 
autoclaved; subsequent addition of 50 ml 40% 
glucose solution (sterile) 
Yeast fluid culture  
(full medium)  
YPD-plates:  see YPD-medium; additional 20 g/l agar; 
autoclaved; subsequent addition of 50 ml 40% 
glucose solution (sterile) 
Yeast culture plates (full 
medium)  
YPDA-medium:  see YPD-medium; additional 0.2% adenine 
hemisulfate solution (sterile; end conc. 0.003%)  
Yeast fluid culture  
(full medium)  
SD-medium:  6.7 g/l yeast nitrogen base (YNB, without amino 
acids); addition of the corresponding 100 x amino 
acid stock solution; dH2O ad 950 ml; autoclaved; 
subsequent addition of 50 ml 40% glucose solution 
(sterile) 
Yeast fluid culture 
(minimal medium)  
SD-Agar:  see SD-medium; additional 20 g/l agar; autoclaved; 
subsequent addition of 50 ml 40% glucose solution 
(sterile) 
Yeast culture plates 
(minimal medium)  
SG-medium:  6.7 g/l yeast nitrogen base (YNB, without amino 
acids); 20 g galactose; dH2O ad 1 l; autoclaved 
Yeast fluid culture 
(minimal medium)  
Amino acids (Merck; 
Sigma):  
adenine (20 mg/l), L-histidine (20 mg/l), L-leucine 
(100 mg/l), L-lysine (30 mg/l), L-methionine 
(20 mg/l), L-tryptophan (20 mg/l), uracil (20 mg/l); 
prepared in 100 x stocks in dH2O 
SD-medium and SD plate 
additives 
Materials and Methods 
 
23 
 
2.1.3 Enzymes 
Enzymes  Company/Origin  Description  
alkaline phosphatase  New England Biolabs  Calf Intestinal Mucosa Phosphatase 
(CIP)  
DNase  Roche Diagnostics, Mannheim, Germany  RNase-free DNase I  
Proteinase K  Qiagen Cystein-protease  
Restriction enzymes  New England Biolabs, Fermentas, Roche  Type II restriction endonuclease 
Reverse transcriptase  Qiagen Invitrogen  SensiScript SuperScriptII, 
SuperScriptIII  
RNaseA  Roche  DNase-free RNase  
RNasin  Promega  RNase-inhibitor  
Taq-polymerase  Invitrogen DNA-polymerase 
 
T4-DNA-ligase  New England Biolabs, Fermentas  DNA ligation  
T7- , T3- RNA-
polymerase 
Roche In situ hybridisation 
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2.1.4 Molecular weight standards  
•  DNA Standard: 1 KB ladder (Invitrogen) 
75; 135; 154; 201; 220; 298; 344; 396; 506; 1,010; 1,636; 2,036; 3,054; 4,072; 5,090; 6,108; 
7,126; 8,144; 9,162; 10,180; 11,198; 12,216 [bp]  
•  RNA Standard: RNA Ladder High Range (Fermentas)  
6,000; 4,000; 3,000; 2,000; 1,500; 1,000; 500; 200 [bp]  
•  Protein Standard: Roti-Mark 10-150 (Carl Roth)  
150; 100; 80; 60; 40; 30; 20; 10 [kDa]  
2.1.5 Primer 
The primers sequences and temperature Tm values used in this study are as given below. The 
Tm values were calculated using the formula Tm = 2x (A + T) + 4x (G + C). Artificially added 
restriction sites are printed in grey, start- or stop-codons are bold. 
 
 
Primer name Tm (°C) Primer sequence (5’ → 3’) 
SR_HSp60_RACE_GSP_F 68°C gcc att gct aca gga gct aaa gtc ttt g 
SR_HSp60_RACEGSP_R 67°C ctt tag ctc ctg tag caa tgg caa tat c 
Spliced Leader (SL1) 56°C ctc aaa ctt ggg taa tta aac c 
HSP60_PCR1_FW  50°C ggt tca aga t g ttg cag  
HSP60_PCR1_RV 55°C ctt cag caa tgg taa taa gtg  
HSP60_PCR2_FW 56°C gtt cca gct ctt gaa tta gc  
HSP60_PCR2_RV 55°C caa gaa ctt tga cag cac g  
HSP60Sal-For 
(SalI) 
72°C a gtc gac atg ctt ctt tcc gct gtt cg tag 
HSP60Stop_rev 67.64°C tta gaa cat tcc acc acc cat tcc gcc 
HSP60-Xba-rev 
(XbaI) 
72°C atc tag att aac cac cca ttc cgc cca tac ct 
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HSP60Xba-rev-D50 
(XbaI) 
68°C atc tag att aaa taa tac cag ttt gga tca tat caa ca 
HSP60_Sonde1_for 59.86°C gtcaaagatcttaaatttggagctga 
HSP60_Sonde1_rev 59.86°C acggctaatactttcaaatccttctt 
pJC45HSP60_HindIII 
(HindIII) 
64.63°C aagcttatgcttcgtcttgctgctcataat 
pJC45HSP60_52HindIII 
(HindIII) 
64.64°C ggaagcttgctaaagatcttaaatttggagc 
pjC45HSP60_BamHIR 
(BamHI) 
64.63°C ggatccttagaacattccaccacccattcc 
GSP_HSP60rev3’UTR 61.3°C ggaaagattggaagcagaaggtaaaa 
SSHSP10FAN 65°C ctt act gtt acc cgt aga tgt tgt tc 
SSHSP10Rend2 62°C gtt ggt gag ttt agc aat gag atc 
OdT-T7 primer 78°C gag aga gga tcc aag tac taa tac gac tca cta tag gga  
gat ttt ttt ttt ttt ttt ttt ttt ttt  
gene specific 1 69°C agt acg aag tcc tgg acc agc agc 
ODT-T7 II 74°C gag aga gga tcc aag tac taa tac gac tca cta tag g 
SL 56°C ggt tta att acc caa gtt tga g 
gene specific 2 69°C gct gct ggt cca gga ctt cgt act 
HSP10salfor 
(SalI)  
72°C a gtc gac atg ctt ctt tcc gct gtt cgt ag 
HSP10xbarev 
(XbaI) 
67°C a tct aga tta gtt agt gag ttt ggc gat ga 
 
HSP10Sondefor14 62.86°C ct gtt cgt aga tgt tca tca gct c 
HSP10Sonderev330 61.15°C tta gtt agt gag ttt ggc gat gag 
HSP10rev174xba 
(XbaI) 
66°C tct aga tta acc atc ctc agt acg aag tcc 
HSP10for168sal 
(SalI) 
67.98°C gtc gac ggt cca gga ctt cgt act 
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HSP10BDpAct3sense 
(SalI, XbaI) 
74.78°C tcg acg ctg ctg aag taa aat cta aag gag gta ttt aca ttc  
cag aga aag ccc aag gaa ag gtt ctt gaa ggt taa t 
HSP10BDpAct3Antisense 
(SalI, XbaI) 
74.78°C ct aga tta acc ttc aag aac ctt tcc ttg ggc ttt ctc tgg aat  
gta aat acc tcc ttt aga ttt tac ttc agc agc g 
pBridgeHSP10EcoR1for 
(EcoRI) 
66°C agaa ttc atc ttc ttt ccg ctg ttc gta g 
pBridgeHSP10Sal1rev 
(SalI) 
67.29°C a gtc gac tta gtt gtg agt ttg gcg atg ag 
pAct2HSP10Nco1for 
(NcoI) 
69.78°C acc atg gag atg ctt ctt tcc gct gtt cgt ag 
pAct2HSP10EcoR1rev 
(EcoRI) 
64.64°C agaa ttc tta gtt agt gag ttt ggc gat gag 
HSP10for168NCOI 
(NcoI) 
69.16°C acc atg gag ggt cca gga ctt cgt act 
HSP10rev174EcoRI 
(EcoRI) 
66°C gaa ttc tta acc atc ctc agt acg aag tcc 
HSP10BDpAct2Sense 
(EcoRI, NcoI) 
75.56°C c atg gag gct gct gaa gta aaa tct aaa gga ggt att tac  
att cca gag aaa gcc caa gga aag gtt ctt gaa ggt taa g 
HSP10BDpAct2Antisense 
(EcoRI, NcoI) 
74.54°C aa ttc tta acc ttc aag aac ctt tcc ttg ggc ttt ctc tgg aat  
gta aat acc tcc ttt aga ttt tac ttc agc agc ctc 
HSP10pJC45for 
(NdeI) 
67.75°C ggg cat atg ctt ctt tcc gct gtt cg 
HSP10pJC45rev 
(EcoRI) 
59.44°C gaa ttc tta gtt agt gag ttt ggc 
pAcSG2_HSP10EcoRIfor 
(EcoRI) 
64.6°C gaa ttcacc atg ctt ctt tcc gct gtt 
pAcSG2_HSP10NotIrev 
(NotI) 
78.07°C gc ggc cgc cta gtg atg gtg gtg atg atg ttt atc atc gtc 
gtc ttt gta gtc gtt agt gag ttt ggc gat 
GSP_HSP10_330-304for 61.44°C aat caa tca ctc aaa ccg cta ctc ta 
GWHSP10revnested 64.4°C cat cta cga aca gcg gaa aga agc ata  
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2.1.6 Plasmids  
Plasmid Description Company/Origin 
pGemTeasy  Cloning vector Promega 
TOPT TA  Cloning vector Invitrogen 
pBluescript II SK +/– Cloning vector, Southern blot, in situ 
hybridisation 
Fermentas 
pBINDdelta renilla Mammalian two-hybrid GAL4-BD vector Promega, modified by Dr. 
Borgmeyer, ZMNH 
pAct Mammalian two-hybrid GAL4-AD vector Promega 
pBridge Yeast two-hybrid GAL4-BD vector Clontech 
pAct2 Yeast two-hybrid GAL4-AD vector Clontech 
pJC45 Expression vector Kindly provided by Dr. J. Closs 
BNI, Hamburg 
pAcSG2 Baculo virus transfer vector BD Bio Sciences 
   
 
The following recombinant plasmids have been constructed on the basis of the above-
mentioned plasmids (* NucleoBond Xtra Midi (Plus) (Macherey and Nagel 2007) plasmid prep 
preparation). All mini and midi plasmid preps were sequenced. 
 
Plasmid names Description Origin 
TOPOTA_HSP10 Insert: S. ratti HSP10 sequence obtained from 
S. stercoralis primers, lacking 3’and 5’end 
Backbone: TOPOTA 
Self made 
TOPOTA_HSP10_3’RACE Insert: HSP10 3’ RACE product 
Backbone: TOPOTA 
Self made 
TOPOTA_HSP10_5’SL Insert: HSP10 5’ Spliced leader product 
Backbone: TOPOTA  
Self made  
pGemTeasy_HSP10_FL 
 
Insert: HSP10 full-length cDNA sequence (5’SalI, 
3’XbaI) 
Backbone: pGemTeasy 
Self made 
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pGemTeasy_HSP10_FL Insert: HSP10 full-length cDNA sequence for 
pBridge cloning 
(5’EcoRI, 3’SalI) 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP10_FL Insert: HSP10 full-length cDNA sequence for pAct2 
cloning 
(5’NcoI, 3’EcoRI) 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP10_FL Insert: HSP10 full-length cDNA sequence for E. coli 
expression 
(5’Nde, 3’EcoRI) 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP10_FL  Insert: HSP10 full-length cDNA sequence for 
pACSG2 cloning 
(5’NcoI, 3’EcoRI) 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP10_BD Insert: HSP10 binding domain sequence 
(5’NcoI, 3’EcoRI) 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP10_5’ Insert: HSP10 5’ end cDNA sequence gained from 
SL PCR 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP10_3’ Insert: HSP10 3’ end cDNA sequence gained from 
RACE PCR 
Backbone: pGemTeasy 
Self made 
PCR.2.1HSP10GEN Insert: HSP10 subfragment (gen1; gen2, gen3) for 
binding domain localisation 
Backbone: PCR.2.1 
MWG 
pGemTeasy_HSP10_1gen Insert: HSP10 subfragment for binding domain 
localisation 
(5’NcoI, 3’XbaI) 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP10_2gen Insert: HSP10 subfragment for binding domain 
localisation 
(5’BamHI, 3’xhoI) 
Backbone: pGemTeasy 
Self made  
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pGemTeasy_HSP10_3gen Insert: HSP10 subfragment for binding domain 
localisation 
(5’smaI, 3’sacI) 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP10_Sonde Insert: HSP10 subfragment for pBluescript cloning 
(5’BamHI, 3’NotI) 
Backbone: pGemTeasy 
Self made  
pGemTeasy_pACSG2_HSP10 Insert: HSP10 subfragment for baculo virus 
expression 
(5’NotI, 3’StuI) 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP60 Insert: HSP60 cDNA sequence lacking 3’end 
(5’SalI, 3’XbaI) 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP60_3’RACE Insert: HSP60 3’ end cDNA sequence gained from 
RACE PCR 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP60_5’SL Insert: HSP60 5’ end cDNA sequence gained from 
SL PCR 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP60_FL Insert: HPS60 full-length cDNA sequence 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP60_FL Insert: HPS60 full-length cDNA sequence (5’SalI, 
3’XbaI) 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP60_FL Insert: HPS60 full-length cDNA sequence for 
pBridge cloning 
(5’BamHI, 3’EcoRI) 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP60_FL Insert: HPS60 full-length cDNA sequence for pAct2 
cloning 
(5’SmaI, 3’EcoRI) 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP60_FL 
 
Insert: HPS60 full-length cDNA sequence 
(5’HindIII, 3’BamHI) 
Backbone: pGemTeasy 
Self made 
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pGemTeasy_HSP60-52 Insert: HSP60 exclusive mitochondrial leading 
sequence subfragment for pJC45 cloning 
(5’HindIII, 3’BamHI) 
Backbone: pGemTeasy 
Self made 
pGemTeasy_HSP60_1 Insert: HSP60 subfragment for pAct2, pAct3 and 
pBind cloning 
(5’SalI, 3’XbaI) 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP60_2 Insert: HSP60 subfragment for pAct2, pAct3 and 
pBind cloning 
(5’SalI, 3’XbaI) 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP60_3 Insert: HSP60 subfragment for pAct2, pAct3 and 
pBind cloning 
(5’SalI, 3’XbaI) 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP60_4 Insert: HSP60 subfragment for pAct2, pAct3 and 
pBind cloning 
(5’SalI, 3’XbaI) 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP60_Sonde1 Insert: HSP60 subfragment for pBluscript cloning 
(5’BamHI, 3’NotI) 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP60_Sonde2 Insert: HSP60 subfragment for pBluscript cloning 
(5’BamHI, 3’NotI) 
Backbone: pGemTeasy 
Self made  
pGemTeasy_HSP60_Sonde3 
 
Insert: HSP60 subfragment for pBluscript cloning 
(5’BamHI, 3’NotI) 
Backbone: pGemTeasy 
 
Self made  
pGemTeasy_HSP60_Sonde4 Insert: HSP60 subfragment for pBluscript cloning 
(5’NotI, 3’BamHI) 
Backbone: pGemTeasy 
Self made  
pBindSRHSP10fl Insert: HSP10 full-length cDNA sequence  
(5’SalI, 3’XbaI) 
Backbone: pBind 
Self made* 
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pAct3SRHSP10fl Insert: HSP10 full-length cDNA sequence 
(5’SalI, 3’XbaI) 
Backbone: pAct3 
Self made* 
pAct3SRHSP10a Insert: HSP10 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pAct3 
Self made* 
pAct3SRHSP10b Insert: HSP10 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pAct3 
Self made* 
pAct3SRHSP10c Insert: HSP10 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pAct3 
Self made* 
pBind_HSP60_FL 
 
Insert: HSP60 full-length cDNA sequence 
(5’SalI, 3’XbaI) 
Backbone: pBind 
Self made* 
pBind_HSP60_1 Insert: HSP60 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pBind 
Self made* 
pBind_HSP60_2 Insert: HSP60 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pBind 
Self made* 
pBind_HSP60_3 Insert: HSP60 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pBind 
Self made* 
pBind_HSP60_4 Insert: HSP60 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pBind 
Self made* 
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pAct_HSP60_FL Insert: HSP60 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pAct3 
Self made* 
pAct_HSP60_1 Insert: HSP60 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pAct3 
Self made* 
pAct_HSP60_2 Insert: HSP60 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pAct3 
Self made* 
pAct_HSP60_3 Insert: HSP60 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pAct3 
Self made* 
pAct_HSP60_4 Insert: HSP60 subfragment for binding domain 
localisation 
(5’SalI, 3’XbaI) 
Backbone: pAct3 
Self made* 
pBridgeSRHSP10 Insert: HSP10 full-length cDNA sequence 
(5’EcoRI, 3’SalI) 
Backbone: pBridge 
Self made* 
pAct2SRHSP10fl Insert: HSP10 full-length cDNA sequence 
(5’NcoI, 3’EcoRI) 
Backbone: pAct2 
Self made* 
pAct2SRHSP10a Insert: HSP10 subfragment for binding domain 
localisation 
(5’NcoI, 3’EcoRI) 
Backbone: pAct2 
Self made* 
pAct2SRHSP10b Insert: HSP10 subfragment for binding domain 
localisation 
(5’NcoI, 3’EcoRI) 
Backbone: pAct2 
Self made* 
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pAct2SRHSP10c Insert: HSP10 subfragment for binding domain 
localisation 
(5’NcoI, 3’EcoRI) 
Backbone: pAct2 
Self made* 
pAct2SRHSP10gen Insert: HSP10 subfragment for binding domain 
localisation 
(5’BamHI, 3’NcoI) 
Backbone: pAct2 
Self made* 
pAct2SRHSP10gen2 Insert: HSP10 subfragment for binding domain 
localisation 
(5’BamHI, 3’XhoI) 
Backbone: pAct2 
Self made* 
pAct2SRHSP10gen3 Insert: HSP10 subfragment for binding domain 
localisation 
(5’SmaI, 3’SacI) 
Backbone: pAct2 
Self made* 
pAct2_HSP60_FL Insert: HSP60 full-length cDNA sequence 
(5’SmaI, 3’EcoRI) 
Backbone: pAct2 
Self made* 
pBluescript_HSP10_Sonde Insert: HSP10 subfragment for Southern blotting and 
in situ hybridisation 
(5’BamHI, 3’NotI) 
Backbone: pBluescript 
Self made* 
pBluescript_HSP60_Sonde1 Insert: HSP60 subfragment for Southern blotting and 
in situ hybridisation 
(5’BamHI, 3’NotI) 
Backbone: pBluescript 
Self made* 
pBluescript_HSP60_Sonde2 Insert: HSP60 subfragment for Southern blotting and 
in situ hybridisation 
(5’BamHI, 3’NotI) 
Backbone: pBluescript 
Self made* 
pBluescript_HSP60_Sonde3 Insert: HSP60 subfragment for Southern blotting 
(5’BamHI, 3’NotI) 
Backbone: pBluescript 
Self made* 
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pBluescript_HSP60_Sonde4 Insert: HSP60 subfragment for Southern blotting 
(5’NotI, 3’BamHI) 
Backbone: pBluescript 
Self made* 
pJC45_HSP10 Insert: HSP10 full-length cDNA sequence for E. coli 
expression 
(5’Nde, 3’EcoRI) 
Backbone: pJC45 
Self made* 
pJC45_HSP60 Insert: HSP60 full-length cDNA sequence for E. coli 
expression 
(5’BamHI, 3’HindIII) 
Backbone: pJC45 
Self made* 
pJC45_HSP60-52 Insert: HSP60 exclusive mitochondrial leading 
sequence subfragment for E. coli expression 
(5’BamHI, 3’HindIII) 
Backbone: pJC45 
Self made* 
pACSG2_HSP10 Insert: HSP10 full-length cDNA sequence for baculo 
virus  expression 
(5’EcoRI, 3’NcoI) 
Backbone: pACSG2 
Self made* 
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2.1.7 Bacteria and yeast strains 
Bacterial strains 
 
XL1-Blue Heat-shock-competent E. coli–cells (Bullock et al 1987) [endA1, hsdR17 
(rk-,mk+), supE44, thi-1, λ-, recA1, gyrA96, relA1,∆(lac), F’, Pro A+B+, lacIq  
Z ∆M15, Tn10(tet1)] 
BL21(DE3)-pLysS  Heat-shock-competent E. coli–cells for proteinexpression (Novagen) 
[F-, omT, hsdS(rB-, mB-), gal dcm (DE3) pLysS (CamR)] 
 
 
Yeast strains 
 
AH109 Mat a, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal80∆, 
LYS2::Gal1UAS - Gal1TATA-HIS3, GAL2UAS -GAL2 TATA -ADE2, 
URA3::MEL1UAS -MEL1 TATA -lacZ (James et al 1996) 
 
 
2.1.8 Antibodies 
Goat Anti-Mouse IgG, Goat Anti-Rabbit IgG (Dianova; peroxidase-conjugated)  
Anti-FLAG, polyclonal, rabbit (Sigma, F7425)  
Anti-His, monoclonal, mouse (Qiagen; Anti-His Antibody Selector Kit, 34698)  
Anti-Digoxygenin (Fab-Fragment) (Roche) 
Anti-GAL monoclonal 
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2.1.9 Computer-based sequence analysis 
Computer-based sequence analysis and alignments of DNA or protein sequences were 
performed using the Lasergene- program (DNASTAR, Inc., www.dnastar.com). The following 
public databases were used:  
• NCBI (http://www.ncbi.nlm.nih.gov) 
• Pubmed (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) 
• BLASTN and BLASP server of NCBI (National Center for Biotechnology Information, 
www.ncbi.nlm.nih.gov);  
• ExPASy Proteomis server (http://expasy.org/);  
• Ensemble (http://www.ensembl.org/index.html);  
• Nematode.net (http://www.nematode.net) 
• Promotoranalyse (MatInspector): (http://www.genomatix.de/cgi-bin/eldorado/main.pl) 
• GENSCAN: http://genes.mit.edu/GENSCAN.html 
• Protein Pilot (Applied Biosystems) 
• iPSORT: http://hc.ims.u-tokyo.ac.jp/iPSORT/ 
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2.2 Strongyloides ratti life cycle and culturing 
2.2.1 Animals 
S. ratti infectious larva (iL3) and parasitic females (Bernhard-Nocht-Institute) were obtained 
from infected male Wistar rats (Rattus norvegicus), 3-4 weeks of age. There was no systematic 
bias in terms of weight. The Wistar rats were housed singly in stainless steel cages with food and 
water available ad libitum. 
2.2.2 Host infection 
Each rat was infected with 2,000 iL3, diluted in 0.3 ml tapwater and directly injected with a 
1 ml injection subcutaneously between the scapulae. 
2.2.3 Host immunisation  
Six male Wistar rats were immunised with E. coli-expressed protein by subcutaneous 
injection of rSr-HSP10 protein in the neck. The animals were primed at 10 weeks of age with 
20 µg rSr-HSP10 protein in alum/PBS and boosted in the same way 14 days later. Sera were 
obtained 14 days post prime immunisation and 14 days post boost immunisation, respectively. For 
each sample, the respective pre-immune serum served as the negative control. 
2.2.4 Baermann technique 
After subcutaneous infection of the Wistar rats with 2000 iL3 (Keiser et al 2008; Lok 2007) 
millions of iL3 were harvested from charcoal coprocultures during days 6-21 applying the 
Baermann technique (WormBook 2007; Figure 2.1). The charcoal coprocultures were set up with 
stool pellets from the infected rats and stored at 26°C for 5 days in H2O. The S. ratti infectious 
larvae are harvested after 3 hours. After washing in a ceramic sieve (Filternutsche Por 3., Roth) 
the larvae are stored at 4°C in deionised water until further use. For the recovery of parasitic 
females, male Wistar rats were sacrificed on day 6 post infection with 2000 iL3. The small 
intestine was removed, cleaned and opened longitudinally. After collection using the Baermann 
method the parasitic females were extensively washed in HBSS. 
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Figure 2.1: Baermann apparatus 
A Baermann apparatus to isolate Strongyloides ratti stages from coprocultures. F, 150mm glass or plastic funnel; W, 
tap water at 43°C; FL (dashed line) fluid level in funnel; SB, Sample basket shown on the right in exploded view 
(FCC, fecal charcoal culture contents; KW, two layers of Kimwipes or other laboratory tissue; LRM Lucite ring with 
nylon mesh affixed with cement); T, rubber or plastic tubing; PC, pinch clamp; CV, catch vessels, conical centrifuge 
tube, or beaker. Source: www.wormbook.org 
 
2.3 Molecular biological methods 
2.3.1 Production of competent bacteria (Nishimura et al 1990) 
Bacteria (E .coli XL1 blue) were grown on LB-agar dishes overnight at 37°C. 2 ml of Y-
broth were inoculated with several colonies picked with a pipette tip and grown for 2 hours at 
37°C under constant shaking (>200). Subsequently, 500 ml of Y-broth was inoculated with the 
preparatory culture until the culture had reached a density (OD600) of 0.5. The culture was split 
into two polypropylene tubes and the growth of bacteria was stopped by a 5-min incubation step 
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on ice. Cells were pelleted at 2,000 g for 15 min (4°C) and – after removal of the supernatant - 
resuspended in 15 ml prechilled TFB 1 solution. Following 60-90 min incubation on ice, the 
centrifugation was repeated. The cell pellet was resuspended in 2 ml TFB and immediately frozen 
as 200 µl aliquots in liquid nitrogen and stored at -80°C. Transformation efficacy of cells was 
tested by transformation with a defined amount of purified supercoiled plasmid DNA. 
2.3.2 Transformation of DNA into bacteria 
Plasmid DNA (0.5 ng), or 5 µl of a ligation mixture were added to 50 µl of ice-thawed 
competent XL 1 blue cells and incubated for 30 min on ice. After a heat shock (3 min, 37°C) and 
successive incubation on ice (3 min), 600 µl of SOC medium were added to the bacteria and 
incubated at 37°C for 30 min with constant agitation. 50 µl and 250 µl of transformed cells were 
plated on LB plates containing the appropriate antibiotics and incubated at 37°C for 12-16 h to 
allow single colonies to grow. 
2.3.3 Purification of plasmid DNA 
2.3.3.1 Plasmid purification from bacterial cultures 
2.3.3.1.1 Mini-scale plasmid isolation 
Three ml LB/Amp-Medium (200 µg/ ml ampicillin) were inoculated with a single colony 
and incubated overnight at 37°C with constant agitation. Cultures were transferred into 2 ml 
Eppendorf tubes, and the cells pelleted by centrifugation (13,000 g; 1 min; RT). Plasmids were 
isolated from the bacteria using the Macherey-Nagel NucleoSpin Plasmid prep system, according 
to the manufacturer’s protocol. The DNA was eluted in 50 µl elution buffer with subsequent 
centrifugation (13,000 g; 2 min; RT). Plasmid DNA was stored at -20°C. 
2.3.3.1.2 Alternative mini-scale plasmid isolation 
All steps were performed at RT. The overnight cultures were transferred into 1.5 ml 
Eppendorf tubes, the cells pelleted by centrifugation (2,400 g, 1 min), and the supernatant 
discarded. Subsequently, 200 µl STET/lysozyme (1 µg/ml STET) solution was added and 
resuspended under constant agitation. Prior to 15 min centrifugation at 16,000 g, the solution was 
heated at 95°C for 2  min. The cell detritus was removed. To bind the DNA, 10 µl 5% CTAB was 
added, vortexed and 10 min centrifuged at 16,000 g. The supernatant was removed, 300 µl 7.5 M 
Na-acetate were added to the pellet and shaken for 5 min. Subsequently, 750 µl 100% ethanol 
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were added, vigorously vortexed and centrifuged for 10 min at 16,000 g. The supernatant was 
discarded, and the DNA washed with 1 ml 75% ethanol followed by a 5 min centrifugation step at 
16,000 g. The supernatant was discarded, and the DNA pellet air-dried and resuspended in 40 µl 
dH20. 
2.3.3.1.3 Plasmid-DNA isolation from 100 ml cultures (Midi preps) 
For the preparation of large quantities of DNA, the Macherey-Nagel Nucleobond AX Xtra 
Midi kit was used. A single colony was inoculated in 5 ml LB/amp (100 µg/ml ampcillin) medium 
and grown at 37°C for 8 h with constant agitation. Afterwards, this culture was added to 100 ml 
LB/amp (100 µg/ml ampcillin), and the culture was incubated at 37°C with constant agitation 
overnight. Cells were pelleted (6,000 g; 15 min; 4°C), and DNA was isolated as described in the 
manufacturer’s protocol. Finally, the DNA pellet was resuspended in 200 µl of TE (10 mM, pH 
8.0), and the DNA concentration was determined (2.2.13). 
2.3.3.1.4 DNA-fragment purification 
For the purification of DNA fragments, the Macharey-Nagel NucleoSpin Extract II kit was 
used according to the manufacturer’s protocol. The DNA was eluted from the column by the 
addition of 25-50 µl of elution buffer, depending on the DNA gel concentration.  
2.3.3.1.5 DNA-fragment extraction from agarose gels 
For the isolation and purification of DNA fragments from agarose gels, 
ethidium-bromide-stained gels were illuminated with UV-light, and the appropriate DNA band 
was excised from the gel with a clean scalpel and transferred into an Eppendorf tube. The 
fragment was isolated using the Macherey-Nagel NucleoSpin Extract II kit according to the 
manufacturer’s protocol. The fragment was eluted from the column by the addition of 25-50 µl of 
elution buffer, depending on the DNA gel concentration (optical gel evaluation by comparison 
with the 1600 bp band of the 1 kb ladder). 
2.3.4 Total RNA isolation from S. ratti infectious larvae or parasitic females 
2.3.4.1 Total RNA isolation 
The Trizol LS reagent (Invitrogen) was used to isolate the RNA from S. ratti (larval or adult 
stages). The reagent is formulated for use with tissues in buffer solution, therefore, the procedure 
was based on the volume of worms not on the weight of tissue. 
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Worms for RNA isolation were washed in 1xPBS buffer in a 2 ml Eppendorf tube, quickly 
frozen in liquid nitrogen, and stored at -80°C degrees. For RNA isolation, the worms were 
defrosted on ice, and for every 250 µl of worm solution (worms in buffer) 750 µl Trizol LS (1:3) 
was added. Subsequently, one 3 mm stainless steel ball (peqGold RNAPure™, peqLAB; 
Erlangen) was added and vortexed at highest speed, using a special vortex adaptor (Mo Bio 
Laboratories, Inc. vortex adapter), for 30 minutes. 200 µl chloroform (per 750 µl of Trizol LS) 
were added and vortexed for 15 seconds. After incubation at RT, the entire sample including 
smashed worms, Trizol LS, and chloroform, but without the bead, was transferred to a clean 
Eppendorf tube and centrifuged at 4°C for 15 min at 13,000 g. The aqueous phase (top phase) was 
transferred to a fresh tube and kept on ice. To precipitate the RNA sample, 500 µl ice-cold 
isopropanol (Merck) per 750 µl of Trizol LS were added, followed by vortexing. After 10 min 
incubation at RT, the sample was centrifuged at 4°C for 10-30 min at 13,000 g. The supernatant 
was removed with an RNase-free pipette. To ensure optimal purity, the pellet was washed with 
1 ml 75% ethanol (Merck) made with DEPC H2O (Roth) and centrifuged at 4°C for 5 min at 
5,300 g. The supernatant was carefully removed, inverted, and air-dried for 5-10 min. Depending 
on the yield, the pellet was resuspended with 50-100 µl of DEPC H2O (Roth) and measured (see 
below). The RNA was precipitated as described below and stored at -80°C. 
2.3.4.2  Phenol/chloroform extraction 
200 µl of TE (pH 8.0) was added to a 100 µl DNA-containing sample to obtain a volume of 
300 µl (1V). An equal volume of phenol/chloroform/isoamylalcohol (25:24:1) was added to the 
DNA-TE-containing sample and vortexed for 1-2 min to create an emulsion. To avoid shearing, 
samples containing genomic DNA were mixed gently. After centrifugation at 16,000 g (RT) for 
5 min, the aqueous layer was carefully transferred to a new tube, avoiding any flocculent material 
at the interface. The phenol/chloroform/isoamylalcohol (25:24:1) step was repeated. In order to 
remove residual phenol, 1 V of chloroform/isoamylalcohol (24:1) was added to the aqueous 
DNA-containing sample, vortexed and centrifuged for 5 min at 16,000 g (RT). The aqueous layer 
was transferred to a new Eppendorf tube, designated for further DNA precipitation (2.2.7.3). 
2.3.4.3 Precipitation of RNA  
The salt concentration of aqueous RNA solutions was adjusted by adding 1/10 volume of 
3 M sodium acetate, pH 5.2. Cold 96% ethanol (-20°C, 2.5 volumes) was then added, and the 
samples were mixed well. The samples were centrifuged for 30 min (16,000 g, RT). For optimal 
Materials and Methods 
 
42 
 
purity, the pellet was washed in 75% ethanol. After removal of the supernatant, a quick 
(1-2 seconds) centrifugation step was performed, and residual ethanol was aspirated. The 
supernatant was removed, and the DNA pellets dried on air (approximately 5 min at RT). The 
RNA was resuspended in 25 µl or 50 µl RNase- free water, depending on the size of the pellet. 
2.3.5 gDNA isolation from S. ratti infectious larvae and precipitation 
A pellet of approximately 250,000 S. ratti iL3 was washed three times with 1xPBS and 
digested overnight at 56°C with 40 µl proteinase K (Qiagen) and 200 µl ATL buffer (Qiagen) 
under constant agitation. The sample was then precipitated as described below and stored at 4°C. 
For precipitation, the salt concentration of the aqueous DNA solution was adjusted by adding 
1/10 volume of 3 M sodium acetate (pH 5.2). Cold 96% ethanol (-20°C, 2.5 volumes) was then 
added, and the samples were mixed (not vortexed to avoid shearing). For optimal purity, the pellet 
was fished from the tube, washed with 80% ethanol (-20°C), and air dried in a new Eppendorf 
tube (approximately 15 min at RT). The DNA was resuspended in 25µl or 50µl 1xT 1/10xE 
buffer depending on the pellet size. 
2.3.6 Polymerase chain reaction (PCR) 
To amplify DNA, qTaq (Invitrogen) was used. The PCR reactions were performed in 0.2 ml 
Eppendorf tubes according to the standard protocols. The template (~100 ng DNA) used was 
plasmid DNA, or first strand cDNA. Primer sequences were designed manually. The number of 
cycles required for optimal amplification varied between 25 and 35 depending on the amount of 
starting material and the efficiency of each amplification step. A final incubation step at the 
extension temperature ensured complete formation of double-stranded molecules from all nascent 
products. Following cycling (T-Gradientencycler, Biometra), aliquots (10-15 µl) were analysed by 
agarose gel-electrophoresis to visualise the amplified products, cloned into the pGemTeasy 
vector, and sequenced.  
2.3.7 5’and 3’ cDNAs amplification 
To obtain the 3’cDNA ends, 3’RACE (rapid amplification of cDNA ends) experiments 
were performed. To this end, full-length cDNAs were generated by using 3’oligo-dT-containing 
primers complementary to the poly(A) tail of mRNAs. 5 µg total RNA was reverse-transcribed 
using SuperscriptIII (Invitrogen) and GeneRacer (Invitrogen) oligo(dT) primers according to the 
manufacturer’s instructions. RACE fragments were then amplified by RT-PCR (Sambrook et al 
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1989) using Taq polymerase, gene-specific forward primers and the GeneRacer 3’oligo as reverse 
primers (primer sequences given in chapter 2.1.5). The amplified 3’cDNA fragments were 
analysed by agarose gel-electrophoresis to visualise the amplified products, cloned into the 
pGemTeasy vector and sequenced. 5’ cDNA fragments were obtained performing Spliced Leader 
(SL) RT-PCR. For this, 5 µg total RNA was reverse-transcribed using SuperscriptIII (Invitrogen) 
and a gene-specific primer according to the manufacturer’s instructions. RT-PCR was performed 
using Taq polymerase (Invitrogen), SL forward primers and the gene-specific reverse primers 
(primer sequences given in chapter 2.1.5). The amplified 5’cDNA fragments were analysed by 
agarose gel-electrophoresis to visualise the amplified products, cloned into the pGemTeasy 
vector, and sequenced. 
2.3.8 DNA agarose gel electrophoresis  
To analyse restriction digestions or the quality of nucleic acid preparations, horizontal 
agarose gel-electrophoresis was performed. Gels were prepared by heating 0.8-2.5% (w/v) 
agarose (SeaKem LE agarose) in Tris–acetate buffer (TAE), depending on the size of fragments to 
be separated. DNA samples were diluted in 1 x DNA sample buffer and were adjusted to 
electrophoresis at 10 V/cm in Kodak BioMAX MP1015 gel chambers in 1xTAE running buffer. 
Afterwards, gels were stained in 0.5 µg/ ml ethidium bromide containing 1xTAE solution for 
approximately 20  min RT. Thermographs of transilluminated gels were taken, or bands were 
made visible on a UV-screen (λ = 360nm). If required, fragments were cut out of the gel with a 
clean scalpel. The extraction of fragments from agarose gel is described in chapter 2.3.3.1.4. 
2.3.9 Sequencing of DNA 
DNA sequence analysis was carried out using the Sanger method (Sanger et al 1977) by the 
service laboratory of the Center for Molecular Neurobiology Hamburg (ZMNH) using ABI Prism 
377 DNA sequencer (Perkin Elmer, www.perkin-elmer.de) and the Prism Dye Terminator Cycle 
Sequencing Ready Reaction Kit (Perkin Elmer). 
2.3.10 Enzymatic manipulation of DNA  
2.3.10.1 Restriction analysis 
Restriction digests were performed by incubating dsDNA molecules with an appropriate 
amount of restriction enzyme(s), the respective buffer as recommended by the supplier(s), and at 
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the optimal temperature for the specific enzyme(s). In general, 20 µl digests were done. For 
preparative restriction digests, the reaction volume was scaled up to 50 µl. Digestion reactions 
were set up with DNA, 1 x restriction buffer, the appropriate number of units of the respective 
enzyme(s) (due to the glycerol content, the volume of the enzyme(s) added should not exceed 
1/10 of the digested volume), and nuclease-free H2O. After incubation at the optimal temperature 
(25°C to 37°C) and time (2-3 h or overnight), digests were stopped by incubation for 20 min at 
65°C. If reaction conditions of enzyme mixes were incompatible, DNA was digested successively 
with the individual enzymes. Between individual reactions, DNA was purified (see DNA 
fragment purification). 
2.3.10.2  Plasmid DNA fragment 
For cloning of distinct regions of plasmid DNA, donor molecules were digested with 
appropriate restriction enzyme(s). Even though direct ligation using DNA from inactivated 
restriction digest was possible, mostly complete digests were applied to agarose gel 
electrophoresis. Appropriate bands were cut out, and the DNA was eluted from agarose plugs 
(2.3.3.1.4), thus avoiding unwanted by-products during subsequent ligation reactions. Non-
complementary ends were converted to blunt ends prior to ligation using the Klenow enzyme 
according to the manufacturer’s protocol. 
2.3.10.3 Enzymatic manipulation of vector DNA prior to ligation 
When used as vectors, plasmids were digested by two restriction enzymes to achieve 
insertion of target DNA in a defined orientation. Digestion reactions were carried out using 5-
10 µg of plasmid DNA as starting material. Digestions were checked by agarose gel-
electrophoresis, and subjected to preparative agarose gel-electrophoresis. Appropriate bands 
representing digested vectors were cut out, and vector DNA was extracted from agarose plugs. 
The plasmid DNA was used for ligation without further purification.  
2.3.10.4 Ligation of plasmid vector and insert DNA 
Ligation of DNA fragments was performed by mixing 50 ng vector with the threefold molar 
excess of insert DNA. One µl of T4-Ligase (Fermantas) and 1 µl of 10x ligation buffer 
(Fermantas) were added, and the reaction mix was brought to a final volume of 10 µl. The 
reaction was incubated overnight at room temperature. The reaction mixture was used directly for 
transformation of bacteria (2.3.2) without any further purification. 
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2.3.11 Photometric quantification of nucleic acids 
DNA, RNA and oligonucleotide concentrations were estimated in TE solutions (1:200) by 
measuring absorptions at λ = 260 nm against blank probes (Spectrophotometer Shimadzu UV 
160A). The determined optical density (OD) values were multiplied by 50, 40 and 30 for double 
stranded dsDNA, RNA or oligonucleotides, respectively, to calculate concentrations in g/ ml 
(1OD at 260 nm = 50 µg DNA/ml, 1OD at 260 nm = 40 µg RNA/ml, 1 OD at 260 nm = 30 µg 
oligonucleotides/ml). Interference by contaminants was recognised by calculation of ratios. The 
ratio A260/280 was used to estimate the purity of nucleic acid, since proteins absorb at 280 nm. 
Pure DNA should have an A260/A280 ratio of 1.8, whereas pure RNA should give a value of 
approximately 2.0. Absorption at λ = 230 nm reflects contamination of the sample by substances 
such as carbohydrates, peptides, phenols or aromatic compounds. In the case of pure samples, the 
ratio A 260/230 should be approximately 2.2. 
2.3.12 Southern blot analysis 
S. ratti genomic DNA (10 µg) was digested with BamHI, EcoRI, EcoRV and HindIII 
(Roche) restriction enzymes (50 u at 37°C for 16 hours) and electrophoresed in a 1% (w/v) 
agarose gel. The DNA was depurinated by incubation of the gel in 0.25 M HCL for 10 min at RT 
- until the bromphenol blue turned yellow – and equilibrated for 15 min in a solution containing 
0.4 M NaOH. The capillary blot procedure was used to transfer the DNA onto Hybond XL1-
membrane (GE Health Care) by 0.4 M NaOH solution. After transfer overnight, the membrane 
was floated for not more than 10 min in 2x SSC and baked for 3 h at 80°C. The membranes were 
tightly rolled and placed into hybridisation bottles with pre-warmed hybridisation buffer and 
denatured herring sperm DNA. The pre-hybridisation was performed at 65°C in a hybridisation 
oven for >60 min. The pre-hybridisation mixture was discarded. 
The S. ratti HSP10 and HSP60 probes were derived by BamHI and NotI cleavage of the 
pBluescript +/+ vector resulting in 300-350 bp DNA fragments. The DNA fragments were eluted 
from the gel and their concentration adjusted to 5 ng/ µl. (For random prime labelling, see 
2.3.12.1) 
The random prime labelled probes (2.5x105-5x105 cpm/ ml hybridisation mixture) were 
denaturated at 95°C for 5 min. The genomic DNA was hybridised with each of the radioactively 
labelled probes in prewarmed (65°C) fresh hybridisation solution containing denatured herring 
sperm DNA overnight at 65°C in a hybridisation oven. Unspecifically bound probe was washed 
from the membrane by washing steps with prewarmed buffer a. The buffer was directly discarded, 
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and new buffer a was added for 10-15 min at 65°C. The washing steps were repeated until <30 
radioactive decays per s were detected on the membrane. Subsequently, the membrane was 
washed with buffer b for 10 min. The procedure was repeated until no radioactivity was detected 
in the wash buffer b. Prior to detection of the signals (Fuji FLA 3000 Imaging reader) the blot was 
saran wrapped and exposed to the Fuji (Raytest) Imaging Plate for 1 hour and 18 hours 
respectively. 
2.3.12.1 Random prime RNA labelling 
The cDNA probes used for Southern blot analysis were [32P]-dCTP-labelled with the 
Ready-to-go DNA labelling beads (Amersham Biosciences). The DNA was first denatured by 
heating for 3 min at 95°C and placed immediately on ice for 2 min. 25 ng of the designated cDNA 
probes were filled up with DEPC-H2O to 45 µl and together with 5 µl [32P]-dCTP added to the 
reaction mix bead. For labelling, mixtures were incubated at 37°C for 15 min. Prior to the 
application of the probes to the prehybridised blots, the molecules were denatured by boiling for 
5 min. 
2.3.13 Whole mount in situ hybridisation 
2.3.13.1 Tissue preparation 
2.3.13.1.1 Primary fixation of iL3 
Approximately 250,000 iL3 were washed with M9 by centrifugation (375 g; 1 min; 4°C). 
The worms were transferred into 2 ml Eppendorf tubes at 200 µl (packed volume) worms per 
tube. To let the worms settle down, the tubes were centrifuged at 1,100 g for 10 sec at 4°C and left 
standing for 30 sec. The supernatant was removed, and 10mM DTT, 0.1% Tween-20 in 1x BO3, 
(pH9) was added and equilibrated at 22°C. The tubes were rotated for 20 min at 22°C. The buffer 
was changed to PBS (4°C) and rotated for 2 min at RT, this was repeated twice. For Proteinase K 
(Qiagen) digestion, PBT (22°C) to a total of 1 ml and 5 µl of Proteinase K (20 mg/ ml) was added. 
The tubes rotated for 12 min at 22°C. The buffer was changed to glycine in PBT (at 4°C) and the 
tubes rotated for 2 min at RT. The buffer was changed to PBS and the tubes rotated again for 
2 min at RT; this was repeated twice. To fix the worms the buffer was changed to Dent 
(MeOH:DMSO=8:2), pre-cooled at -20°C and the worms rotated for 5 min in a cold room. For 
redydration, the buffers were changed and the tubes rotated as follows: MeOH 4°C 5 min, 
MeOH:0.2N HCl = 1:1 4°C 10 min, PBS 4°C 2 min, PBS 22°C 5 min, 10mM DTT in 1x BO3 
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(pH9) 22°C 10 min, 1x BO3(pH9) 22°C 3 min, 2 min, 2 min (3 times), 0.6% H2O2 in 1x BO3 
22°C 10 min, PBS 22°C 2 min (3 times), 3.7% formaldehyde in hepes-PBS 22°C 2 hrs (freshly 
prepared and stored in a refrigerator until use.) For dehydration, the buffers were changed and the 
tubes rotated at RT as follows: EtOH:PBS = 3:7 5 min, EtOH:PBS = 1:1 5 min, EtOH:PBS = 7:3 
5 min, EtOH 5 min (twice). The fixed worms were stored at -20°C in EtOH. 
2.3.13.1.2 Fixation of iL3 onto slides 
The fixed iL3 (stored in ethanol at -20°C) were resuspended and 900 µl/ tube of iL3 quickly 
transferred into siliconised 2 ml Eppendorf tubes. For rehydration, the buffers were changed, and 
the tubes rotated at RT as follows: EtOH:PBS = 7:3 5 min, EtOH:PBS = 1:1 5 min, EtOH:PBS = 
3:7 5 min. The larvae were washed with PBT 3 times for 5 min each and resuspended in about 
700 µl of PBT. The density of the iL3 was checked by counting in an aliquot of the suspension 
under a dissecting microscope. The iL3 were stuck to the slides as follows: poly-L-lysine coated 
test slides were placed on the top of an aluminium block pre-cooled on ice. Ice-cold PBS was 
dispended to the slides at 240 µl/slide. The rehydrated iL3 were dispensed to the slides at 
40 µl/slide. After 5 min to settle iL3 to the bottom, they were fixed by soaking the slides in MeOH 
pre-cooled at 4°C arranging the slides in a stainless steel holder (15 slides/holder) placed in 
MeOH for 5 min. The holder with the slides was then soaked in the following series of solutions 
at 4°C in a cold room: MeOH:formaldehyde in hepes-PBS = 7:3 2 min, MeOH:formaldehyde in 
hepes-PBS = 1:1 2 min, MeOH:formaldehyde in hepes-PBS = 3:7 2 min, 3.7% formaldehyde in 
hepes-PBS 60 min, PBT 5 min x 5 times at RT. A second Proteinase K digestion was performed 
by adding 60 µl of Proteniase K (20 mg/ml, Qiagen) in 180 ml of PBT pre-warmed at 37°C 
(final conc. µg/ml). The solution was well mixed by stirring; the holder containing the slides was 
soaked in this Proteinkinase K solution and subsequently incubated at 37°C for 30 min. The 
holder was transferred to glycine in PBT (pre-cooled at 4°C) and incubated for 2 min to stop 
digestion. The holder was then soaked in 0.1% triethanol for 2 min at RT and in 0.05% acetic 
anhydride in triethanol for 10 min. Subsequently, it was dehydrated by soaking in the following 
series of solutions at RT: PBT 2 min, PBT 2 min, formaldehyde in hepes-PBS 20 min, 
EtOH:PBS = 3:7 5 min, EtOH:PBS = 1:1 5 min, EtOH:PBS = 7:3 5 min, EtOH 5 min twice. 
Finally, the slides were stored in EtOH at -80°C. 
2.3.13.1.3 Kryo-block preparation 
Approximately 1000 iL3 were washed 3 times with tapwater and carefully transferred to 
micro-boxes made of plastic 1×1×1 cm in size. The box was filled with tissue freezing medium 
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(Tissue Freezing Medium, Jung Leica Microsystems, Nussloch) and stored overnight on dry ice. 
Up to 10 tissue sections, cut at -20°C (Leica Kryostat CM 3000), with 16 µm thickness are 
mounted on a positively charged glass slide (SuperFrost Plus; Menzel, Braunschweig, Germany), 
fixed in 4% paraformaldehyd for 20 min at 4°C and washed twice for 5 min in 1xPBS. For 
consistent results the slides were soaked in acetylation buffer for 10 min. Subsequently, they were 
dehydrated in following series of solution at RT: 60%, 80%, 90%, 95%, 100% chloroform for 
5 min each and air dried. 
2.3.13.2 Dig-labelling of RNA probes 
Non-radioactively labelled RNA probes were prepared by in vitro transcription using 
linearised, phenol-extracted plasmids (pBluescript) containing S. ratti HSP10 and HSP60 
sequences, 300 – 350 bp respectively. The RNA probe-labelling was performed according to the 
manufacturer’s protocol (Dig RNA labelling mix, Roche), using 1 µg DNA/20 µl assay. Sense 
(negative control) and anti-sense RNA probes were synthesised using T7 or T3 RNA polymerase 
(T7 and T3 RNA Polymerase, Roche). After 1 hour incubation at 37°C, labelled probes were 
resuspended in 50 µl STET buffer. The probes were cleaned on a probe Quant column according 
to the manufacturer’s advice (GE Healthcare illustra Microspin G 50 Column) and stored at -20°C 
until used. The final concentration of nucleotides was as follows: ATP, GTP, CTP: each 1000 µM 
(= 20 µM in 20 µl), UTP: 650 µM; Dig-UTP: 300 µM.  
2.3.13.3 Prehybridisation, hybridisation and posthybridisation procedures 
Prehybridisation was performed to prevent background staining. The prehybridisation 
mixture contained all components of the hybridisation mixture except for the probe and dextran 
sulfate. The slides were placed horizontally in a humidified chamber. 0.5 - 1 ml prehybridisation 
buffer was applied to each slide and incubated at 50°C for 2 - 3 hours. 
The prehybridisation buffer was removed, and 100 µl hybridisation buffer was added to 
each slide containing 20 ng DIG-labelled RNA probes. The slides were covered with coverslips 
and incubated in a humidified chamber overnight at 50°C. After incubation the coverslips were 
removed by rinsing in 2 x SSC (4 x 5 min in 2 x SSC at RT). Subsequently, a 
series of washing steps was performed: 20 min at 50°C in 2 x SSC/50% formamide/0.05% 
Tween 20, 30 min at 50°C in 1 x SSC/50% formamide/0.05% Tween 20 and 30 min at 50°C in 
washing solution in 0.1 x SSC/50% formamide/0.05 % Tween 20. 
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2.3.13.4 Detection procedure 
The detection procedure for the performed in situ hybridisation is based on the alkaline 
phosphatase enzyme reaction. The slides were washed for 5 min in buffer 1. Unspecific 
background was blocked by incubating the sections for 30 min in buffer 1 (buffer 1 with 1% 
Blocking Reagent, Boehringer). Afterwards, the slides were incubated with 100 µl anti-DIG-
antibody conjugated with alkaline phosphatase (FAB-fragments) (diluted 1:500 in buffer 1 with 
1% blocking reagent) for 2 hours at RT. After rinsing the slides in buffer 1 at RT and washing 
them twice for 15 min, the slides were incubated for 5 min in buffer 2 at RT. 500 µl staining 
solution (containing 5-Bromo-4-chloro-3-indolylphosphate/Nitro-blue tetrazolium (BCIP/NBT)) 
was applied, and the slides were incubated in a humidified chamber for several hours, up to 
24 hours depending on the staining, to obtain optimal staining results. The staining was stopped 
by rinsing the slides in dH2O for 10 min at RT and the slides were mounted with glycerin gelatine. 
2.4 Cell cultures 
Spodoptera frugiperda cells (SF21) were grown in serum-free BD BaculoGold Max-XP 
medium supplemented with 1% penicillin and streptomycin at 27°C. 
Spodoptera frugiperda cells (SF9) were grown in serum-free Novagen BacVector® Insect 
Cell Medium supplemented with 1% penicillin and streptomycin at 27°C. 
Murine neuroblastoma cells (N2a) were cultured in DMEM (Dulbecco's Modified Eagle 
Medium Invitrogen) supplemented with 5% FCS and 1% penicillin and streptomycin at 37%, 5% 
CO2. 
Human embryonic kidney cells (HEK) were cultured in DMEM supplemented with 5% 
FCS and 1% penicillin and streptomycin at 37%, 5% CO2.  
2.4.1 Yeast cell culture 
The glycerol stocks were prepared according to the Yeast Protocols Handbook, 2001. 
The liquid overnight cultures were prepared according to the Yeast Protocols Handbook, 
2001. 
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2.5 Protein biochemical methods 
2.5.1 Mammalian two-hybrid 
The two-hybrid system is used to detect protein:protein interactions in vivo. Originally 
developed in yeast (Fields & Song 1989; Chien et al 1991), the two-hybrid system has been 
adapted for use in mammalian cells (Dang et al 1991; Fearon et al 1992). The CheckMate 
Mammalian Two-Hybrid System (Promega) used here is based on the pBIND, pACT and pG5luc 
vector. The pBind vector contains the yeast GAL4 DNA-binding domain upstream of a multiple 
cloning region. The pBIND3 vector used is a derivate of pBIND (Promega). The oligonucleotide 
GATC GTC GAC CCG CGG GGA TCC A was cloned into the BamHI/ Mlu digested vector. 
BamHI and SalI site have been replaced by SalI and BamHI sites, and the reading frame was 
shifted. Furthermore, the Renilla luciferase site was eliminated (Hentschke et al 2009). All 
modifications were kindly performed by PD Dr. Uwe Borgmeyer, Insitut for Developmental 
Neurobiology, (ZMNH, Hamburg). The pACT Vector contains the herpes simplex virus VP16 
activation domain upstream of a multiple cloning region. The pACT3 Vector used is a derivate of 
pACT. The oligonucleotide GATC GTC GAC CCG CGG GGA TCC A was cloned into the 
BamHI/MluI digested vector. The BamHI and SalI sites were replaced by SalI and BamHI sites, 
and the reading frame was shifted. The pG5luc Vector contains five GAL4 binding sites upstream 
of a minimal TATA box, which in turn is upstream of the firefly luciferase gene (luc+). The 
pGAL4 and pVP16 fusion constructs were transfected along with the pG5luc Vector into 
mammalian HEK and N2A cells. The cells were lysed for 24 h and 48 hours respectively after 
transfection, and the amount of firefly luciferase was quantified using the Bright-Glo Luciferase 
Assay System. The empty pBIND3 and pACT3 vectors were used as negative control. The 
following vectors were used for mammalian two-hybrid analyses: 
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Table 2.1: Overview of the bait (pBind) and prey (pAct3) vectors used in the mammalian 
two-hybrid assay 
Mammalian 
two-hybrid 
vector name 
Vector description Primer 
pBindSRHSP10fl Includes the full-length S. ratti HSP10 
sequence. Subcloned to bait vector 
pBind3delta renilla XbaI and SalI site. 
HSP10flfor 
HSP10re330xba 
pAct3SRHSP10fl Includes full-length S. ratti HSP10 sequence. 
Subcloned to prey vector pAct3 XbaI and SalI 
site. 
HSP10flfor 
HSP10re330xba 
pAct3SRHSP10a Includes S. ratti cDNA HSP10 fragment 
ranging from bp 1 to bp 174. Subcloned to 
prey vector pAct3 XbaI and SalI site. 
HSP10flfor 
HSP10rev174xba 
pAct3SRHSP10b Includes S. ratti cDNA HSP10 fragment 
ranging from bp 85 to bp 138. Richardson et 
al 2001 described this HSP10 binding site. 
Subcloned to prey vector pAct3 XbaI and SalI 
site. 
HSP10BDpAct3sense 
HSP10BDpAct3Antiense 
pAct3SRHSP10c Includes S. ratti cDNA HSP10 fragment 
ranging from bp 168 to bp 330. Subcloned to 
prey vector pAct3 XbaI and SalI site. 
HSP10for168 
HSP10rev330 
pBindHSP60fl Includes full-length S. ratti HSP60 sequence. 
Subcloned to bait vector pBind3delta renilla 
XbaI and SalI site. 
Hsp60Sal-For 
pBindHSP60_1-6 Includes S. ratti cDNA HSP60 fragment 
ranging from bp 1 to bp 873. Subcloned to 
bait vector pBind3delta renilla XbaI and SalI 
site. 
Hsp60Sal-For 
HSP60-Xba291rev 
pBindHSP60_4-6 Includes S. ratti cDNA HSP60 fragment 
ranging from bp 624 to bp 873. Subcloned to 
bait vector pBind3delta renilla XbaI and SalI 
site. 
HSP60-Sal208F 
HSP60-Xba291rev 
pBindHSP60_5-6 Includes S. ratti cDNA HSP60 fragment 
ranging from bp 739 to bp 873. Subcloned to 
bait vector pBind3delta renilla XbaI and SalI 
site. 
HSP60-Sal247F 
HSP60-Xba291rev 
pBindHSP60_4-2 Includes S. ratti cDNA HSP60 fragment 
ranging from bp 624 to bp 1683. Subcloned to 
bait vector pBind3delta renilla XbaI and SalI 
site. 
HSP60-Sal208F 
HSP60Xba-rev 
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pAct3HSP60fl Includes full-length S. ratti HSP60 sequence. 
Subcloned to prey vector pAct3 XbaI and SalI 
site. 
Hsp60Sal-For 
HSP60Stop_rev 
pAct3HSP60_1-2 Includes S. ratti cDNA HSP60 fragment 
ranging from bp 1to bp 1683. Subcloned to 
prey vector pAct3 SbaI and SalI site. 
Hsp60Sal-For 
HSP60Xba-rev 
pAct3HSP60_4-6 Includes S. ratti cDNA HSP60 fragment 
ranging from bp 624 to bp 873. Subcloned to 
prey vector pAct3 XbaI and SalI site. 
HSP60-Sal208F 
HSP60-Xba291rev 
pAct3HSP60_4-2 Includes S. ratti cDNA HSP60 fragment 
ranging from bp 624 to bp 1683. Subcloned to 
prey vector pAct3 XbaI and SalI site. 
HSP60-Sal208F 
HSP60Xba-rev 
   
2.5.1.1 Transfection 
For transfection of human embryonic kidney cells, the cells were separated. One day before 
transfection, the HEK cells were stripped with 10x Trypsin EDTA for 1 min at 37°C in a 5% CO2 
incubator. Depending on the density, the cells were diluted with Opti-MEM (5% FCS 
Gibco/Invitrogen, 1% Pen/Strep PAA Laboratories) and plated in a 96-well plate (Greiner) at a 
concentration of 1 x 104/well. The HEK cells were transfected using 3:1 ratios of FuGENE6 
(Roche) Transfection Reagent ( µl) to DNA ( µg), respectively (2 µg DNA/well : 6 µl 
FuGENE6/well). (2 µg DNA/well containing 0.3 µg pBind Vector DNA, 0.7 µg pAct Vector 
DNA, 0.7 µg EGFP, 0.3 µg UAS.) 1010 µl Opti-MEM (Invitrogen) was then mixed with 80 µl 
FuGENE in a polysterol tube. After 5 min incubation, 85 µl Opti-MEM/FuGENE were added to 
each well (96-well plate), containing the DNA mixture. After 30 min of incubation, 12 µl of the 
FuGENE- Opti-MEM-DNA mixture was plated onto HEK cells in a 96-well plate, leaving the last 
row blank. 
For transfection with murine neuroblastoma cells (N2a), the cells were separated. One day 
before the transfection, the N2a cells were lysed with 10x Trypsin EDTA for 1 min at 37°C in a 
5% CO2 incubator. Depending on the cell density, the cells were diluted in Opti-MEM (5% FCS 
Gibco/Invitrogen, 1% Pen/Strep PAA Laboratories) and plated in a 96-well plate (Greiner) at a 
concentration of 1 x 104/well. The N2a cells were transfected using a 2.5 : 1 ratio of 
Lipofectamine 2000 (Invitrogen) : DNA (µl/µg), (5 µl Lipofectamine 2000/well : 2 µg 
DNA/well). (2 µg DNA/well containing 0.3 µg pBind Vector DNA, 0.7 µg pAct Vector DNA, 
0.7 µg EGFP, 0.3 µg UAS.)  
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1235 µl Opti-MEM (Invitrogen) were mixed with 65 µl Lipofectamine 2000 in a polysterol 
tube. After a 5 min incubation, 100 µl Opti-MEM/Lipofectamine 2000 was added to each well 
(96 - well plate) containing the DNA mixture. After 30 min of incubation, 
25 µl Lipofectamine 2000-Opti-MEM-DNA mixture was plated onto the N2a cells of a 96-well 
plate, leaving the last row blank. 
2.5.1.2 Renilla luciferase assay  
24 hours (HEK cells), or 48 hours (N2a) respectively after transfection, the cells were lysed, 
and the amount of firefly luciferase was quantitated using the Bright-Glo Luciferase Assay 
System (Promega).  
The supernatant was discarded from the 96-well plate. 25 µl Opti-MEM/well and 25 µl 
Bright-Glo/well were added, the 96-well plate wrapped in aluminium foil and shaken for 5 min at 
200 rpm. The 50 µl Opti-MEM-Bright-Glo mixture was immediately transferred to an opaque 96-
well plate (Microplate 96-well PS white, Greiner) and the luminescence was measured. The EGFP 
and Luciferase luminescence was measured in the Wallac Victor3, 1420 Multilabel Counter, 
luminometer (PerkinElmer). The data were evaluated with the Wallac 1420 Manager Program. 
2.5.2 Yeast two-hybrid 
The yeast two-hybrid system (YTH-system) identifies the interaction of two proteins in vivo 
(Chien et al 1991). In this study the Matchmaker GAL4 Two-Hybrid System was used 
(Clontech). Matchmaker systems use the transcription-activating (AD) and DNA-binding domains 
(DNA-BD) of GAL4, a well-characterised yeast transcription factor (Zhu & Hanes 2000). In a 
two-hybrid assay, a cDNA is fused to the GAL4 DNA-binding domain and expressed, while 
another gene or cDNA is expressed as a fusion to the GAL4 activation domain, prey protein, 
(Fields & Song 1989; Chien et al 1991). When bait and prey proteins interact in a yeast reporter 
strain such as AH109, the DNA-BD and AD are brought into a physical proximity as a 
prerequisite for the activation of reporter gene transcription: ADE2, HIS3, lacZ, and MEL1.  
Gal4 DNA-BD and AD fusions were created by cloning cDNAs into the yeast expression 
vectors pBridge or pACT. pBridge expresses proteins as fusions with the GAL4 DNA-BD, while 
pACT expresses proteins as fusions with the GAL4 AD. In yeast, both fusions are expressed from 
the constitutive ADH1 promoter (PADH1). The following vectors were used for yeast two-hybrid 
analyses: 
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Table 2.2: Overview of the bait (pBridge) and prey (pAct2) vectors used in the yeast two-hybrid 
assay 
Yeast two-hybrid 
vector name 
Vector description Primer 
pBridgeSRHSP10 Includes full-length S. ratti HSP10 sequence 
subcloned to bait vector pBridge EcoRI and 
SalI site. 
pBridgeHSP10EcoR1for 
pBridgeHSP10Sal1rev 
pAct2SRHSP10fl Includes full-length S. ratti HSP10 sequence 
subcloned to prey vector pAct2 NcoI and 
EcoRI site. 
pAct2HSP10Nco1for 
pAct2HSP10EcoR1rev 
pAct2SRHSP10a Includes S. ratti cDNA fragment ranging from 
bp 1 to bp 174. Subcloned to prey vector 
pAct2 pAct2 NcoI and EcoRI site. 
pAct2HSP10Nco1for 
HSP10rev174EcoRI 
pAct2SRHSP10b Includes S. ratti cDNA fragment ranging from 
bp 85 to bp 138. Richardson et al 2001 
described this HSP10 binding site. Subcloned 
to prey vector pAct2 multiple cloning site. 
HSP10BDpAct2Sense 
HSP10BDpAct2Antisense 
pAct2SRHSP10c Includes S. ratti cDNA fragment ranging from 
bp 168 to bp 330. Subcloned to prey vector 
pAct2 NcoI and EcoRI site. 
HSP10for168NCOI  
HSP10revEcoRI 
pAct2SRHSP10gen1 Includes ncoI and xbaI digested out of 
pCR2.1-pAct2_HSP10 plasmid. Ranging 
from bp 1 to bp 84. Subcloned to prey vector 
pAct2 NcoI and xbaI site. 
 
pAct2SRHSP10gen2 Includes bamHI and XhoI digested out of 
pCR2.1-pAct2_HSP10 plasmid. Ranging 
from bp 46 to bp 138. Subcloned to prey 
vector pAct2 BamHI and XhoI site. 
 
pAct2SRHSP10gen3 Includes smaI and sacI digested out of 
pCR2.1-pAct2_HSP10 plasmid. Ranging 
from bp 85 to bp 168. Subcloned to prey 
vector pAct2 smaI and EcoRI site. 
 
pBridgeSRHSP60 Includes full-length S. ratti HSP60 sequence. 
Subcloned to bait vector pBridge BamHI  and 
EcoRI site. 
 
pAct2SRHSP60 Includes full-length S. ratti HSP60 sequence. 
Subcloned to prey vector pAct2 smaI and 
EcoRI site. 
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2.5.2.1 Filter and fluid ß-Galactosidase assays 
 Filter ß-Galactosidase assays were carried out according to the Yeast Protocols Handbook, 
2001. The fluid ß-Galactosidase assays were carried out according to the Yeast Protocols 
Handbook, 2001. 
2.5.3 Western blot analyses 
Western blot analyses were performed to detect SrHPS10 and SrHSP60 proteins in S. ratti 
extracts, to confirm the expression of HSP10 and HSP60 recombinant proteins, and to detect 
specific antibodies against HSP10 and HSP60 in S. ratti infected rats. Protein extracts of S. ratti 
iL3 or recombinantly expressed proteins were separated according to their protein molecular 
weight by SDS-PAGE (2.5.3.1) and transferred (2.5.3.2) to a nitrocellulose membrane by 
electroblotting. Subsequently, the proteins were probed with specific antibodies. 
2.5.3.1 Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE)  
SDS-PAGE was performed by mixing an aliquot of a protein extract with sample buffer, 
which was incubated at 95°C for 10 min before the samples were loaded onto 6-13% slab gels, 
depending on the protein size to be detected. 
Table 2.3: Separating and stacking gel composition 
      Separating gel Stacking gel 
Percentage 6 7 8 9 10 12 13 3.90 
Polyacrylamide-Solution [ml]  3.00 3.5 4.00 4.50 5.00 6.00 6.50 0.65 
Stacking gel-/Separating gel 
buffer [ml]  
3.75 3.75 3.75 3.75 3.75 3.75 3.75 1.25 
dH2O [ml]  8.25 7.75 7.25 6.75 6.25 5.25 4.75 3.05 
  + 50 µl 10% APS, 10 µl TEMED 
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2.5.3.2 Electropheric transfer (semi dry blot) and immunological detection of proteins 
After electrophoresis, the proteins were transferred onto nitrocellulose membranes by using 
a mini-Trans Blot Cell in Bjerrum-Schafer-Nielsen transfer buffer for 50 min at 50 V. The 
membrane was blocked with 5% skim milk in PBS (w/v) overnight under constant agitation at 
4°C. Subsequent to a wash step with TBS/ 0.05 % Tween 20 for 10  min at RT, the nitrocellulose 
membrane was probed with 1:20 dilutions of sera from S. ratti infected Wistar rats. Unbound 
antibodies were removed by 2 wash steps with TBS/0.05 % Tween 20 and PBS for 10 min 
respectively. The appropriate diluted (5% skim milk in PBS (w/v)) horseradish peroxidase-
conjugated goat anti-rat IgG (Roche) secondary antibody was used. Immunoreactive bands were 
visualised using 4-chloro-1-naphtol (Roche) colour development reagent according to the 
manufacturer’s protocol. 
2.5.3.3 Coomassie staining of polyacrylamide gels 
After SDS-PAGE, the gel was washed three times in 2.5% Triton X-100 mM NaCl and 
stained with 0.1% (v/v) Coomassie brilliant blue, Roti®-Blue (Carl Roth). Under acidic 
conditions, the dye is most stable as a doubly-protonated red form. Upon binding to protein, 
however, it is most stable as an unprotonated, blue form. After destaining (Coomassie destaining 
solution), proteolytic degradation of the gelatine substrate was visible as unstained bands on the 
blue gel. 
2.5.3.4 Silver staining of polyacrylamide gels  
After SDS-PAGE, gels were fixed with fixation solution I and II for 10 min at RT 
respectively, washed in distilled water during at least 10 min, and visualised by incubating in 
freshly prepared silver nitrate solution. Afterwards, the gels were silvered, washed twice in 
distilled water and developed, depending on the protein density, for 3-30 min with developing 
solution. When a sufficient degree of staining was obtained, the reaction was stopped by washing 
the gels in stopping solution. The gel was stored in distilled water until drying. 
2.5.3.5  Ponceau-S staining 
Ponceau-S staining was performed using 1.0% Ponceau-S in 5% acetic acid for 5 min 
followed by a wash step in distilled water. To completely remove the stain from the protein bands, 
the membrane was washed several times in distilled water. 
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2.5.3.6 Drying of polyacrylamide gels 
Polyacrlyamide gels were incubated in 10% glycerol for 30 min at RT and dried using Gel 
Drying Frame (Roth). The gels were placed between two cellophane sheets, fixed using a metal 
frame and plastic clips, and dried for 1 day at RT. 
2.5.4 Protein expression  
2.5.4.1 Expression of recombinant protein in E. coli 
For protein expression, appropriate DNA inserts were cloned in-frame into the pJC45 
Vector (kindly provided by Dr. Joachim Closs, BNI) containing a N-terminal His tag. Competent 
bacteria, E. coli strain DH5-α, were transformed with plasmid DNA and plated onto LB plates 
containing appropriate antibiotics. After overnight culture, positive colonies were transferred to 
25 ml LB medium with 100 µg/ ml ampicillin and incubated overnight at 37°C under constant 
agitation. The non-induced overnight culture was transferred to a 1 l LB expression-medium and 
cultivated at 37°C under constant agitation until the culture reached an optical density (OD600) of 
0.6. The protein synthesis was induced by adding 1 M IPTG (isopropyl-D-thiogalactopyranoside). 
The protein expression was controlled by collecting small aliquots of the culture after IPTG 
induction every hour. After 4 h of growth at 37°C, the bacteria were harvested by centrifugation 
(4,000 g; 30 min; 4°C). 
The bacterial pellet was resuspended in 50 ml Buffer B for 2 hours under constant rotation. 
Subsequently, the bacteria were centrifuged at 15,000 g for 30 min. For purification, the proteins 
were loaded onto a NINTA Agarose Column according to the manufacturer’s protocol (Qiagen). 
The purified protein was then washed twice in 16 ml Buffer C (pH 6.3) and eluted 4 x in 2 ml 
Buffer D (pH 5.9), 4 x in 2 ml Buffer E (pH 4.5). The eluted protein fractions were loaded onto 
SDS PA gels, and the positive fractions pooled. The pooled proteins were dialysed (VISKING 
Dialysis Tubing), according to the manufacturer’s protocol, overnight in 4 M Urea Buffer 
(pH 8.0). Subsequently, PEG 1500 (Merck) was used to a final concentration of 114 µg/ ml. The 
concentrations were measured using the Bradford assays.  
2.5.4.2 Transfection and expression of recombinant protein in the Baculovirus system 
The baculovirus expression system (FlashBACTM System, Oxford Expression Technologies 
LTD) uses a transfer vector, which contains sequences that flank the polyhedron gene in the virus. 
The transfer-vectors, containing the foreign gene, and the virus genome are introduced into the 
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host insect cell. The homologous recombination between the flanking sequences, common to both 
DNA molecules, effects insertion of the foreign gene into the virus genome. This results in a 
recombinant virus genome.  
The 6-well plate was seeded 1 hour prior to transfection with a cell density of 1.5x106 SF21 
or 1x106 SF9 cells/well in a 2 ml volume of appropriate medium (BD BaculoGold Max-XP Insect 
Cell Medium from BD Biosciences Pharmingen; BacVector Insect Cell Medium from Novagen 
respectively). To ensure the use of healthy cells before passaging, cell samples were taken and 
observed under a phase-contrast microscope. 20 µl of cell medium were counted using the 
Neubauer chamber. The co-transfection mix of DNA and liposome reagent (GeneJuice® 
Transfection Reagent, Novagen) was prepared as follows:  
Table 2.4: Overview of the baculovirus assay reagents 
Reagent 1 
 
pAcSG2 HSP10 (500ng) + Baculo DNA (100ng) 
Reagent 2 
 
pAcSG2 HSP10 (500ng) + Baculo DNA (100ng) 
Reagent 3 
 
pAcSG2 HSP10 (500ng) + Baculo DNA (100ng) 
Reagent 4 
 
negative control mock-transfection 
(media with omitted DNA) 
  
Reagent 5 
 
positive control K+ (500ng) + Baculo DNA (100ng) 
Reagent 6 pIEX-GFP (2500ng) 
transfection control 
  
 
Appropriate media, depending on the cell type (SF21: BD BaculoGold Max-XP Insect Cell 
Medium from BD Biosciences Pharmingen; SF9: BacVector Insect Cell Medium from Novagen 
respectively) was added to a total volume of 60 µl/reagent. 18 µl GeneJuice/600 ng DNA and 
12.5 µl GeneJuice/2500ng DNA were added and incubated for 15 minutes. Just before the end of 
the incubation period, the culture medium from the 6 well plate was removed, 940 µl/reagent of 
appropriate media was added and 1 ml reagent/well was transferred to the insect cells. After 
5 hours incubation, the reagent medium was discarded and 2 ml fresh appropriate media was 
added. Following a 5-day incubation period, the media containing the recombinant virus (seed 
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stock) was harvested into sterile 1.5 ml Eppendorf tubes and stored at -70°C until use. The cells 
were also harvested into sterile 1.5 ml Eppendorf tubes and stored at -20°C until use. To amplify 
the recombinant virus, 200 µl seed stock/1000 µl medium was transferred to a 6-well plate with 
freshly split cells (cell density: 1.5x106 SF21 or 1x106 SF9 cells/well in a 2 ml volume of 
appropriate medium). Prior to transfer, the cell media was discarded. Following a 1 hour-
incubation period, 1 ml of appropriate media was added and incubated for 5 days. After 
incubation, the media containing the recombinant virus (1st passage) was harvested into sterile 
1.5 ml Eppendorf tubes and stored at -70°C until use. The cells were also harvested into sterile 
1.5 ml Eppendorf tubes and stored at -20°C until use. To verify the expression success, the 
harvested cells were analysed by Western blot. 
2.5.5 Enzyme-linked immunosorbent assay (ELISA) 
Rat sera was analysed by ELISA for IgG antibodies to S. ratti HSP10 antigens. 96-well 
microtiter plates (polystyrene microtiter plate, Maxi-Sorb, Nunc) were coated with 100 µl/well 
S. ratti extract and S. ratti HSP10 recombinant protein respectively at a concentration of 
200 ng/well in carbonate buffer (pH 9.6), sealed with Saran wrap, and incubated over night at 
4°C. After removal of unbound S. ratti extract and S. ratti HSP10 recombinant protein 
respectively by washing three times with 300 µl/well washing-buffer PBS/0.05% Tween 20, the 
plate was blocked with 200 µl/well 5% BSA in PBS for 1 hour at 37°C. Serum was diluted 1:300, 
1:600, 1:1200 in PBS/0.5%BSA prior to incubation at 37°C for 1 hour. Unspecifically bound 
antibodies were removed by 3 washing steps. 100 µl/well 1:5000 diluted Anti-Rat IgG 
peroxidase–conjugate antibody was added and incubated at RT for 1 hour followed by 3 washing 
steps. 100 µl/well peroxidase substrate solution was added for 5 min prior to 100 µl/well 1 N 
H2SO4 stop solution. For detection of antibody binding in all ELISA experiments, the optical 
density (OD) was measured at the absorbance at 450 nm (ref. 630 nm) using an ELISA reader 
(Dynatech). 
2.5.6 Mass spectrometry (Liquid Chromatography Electrospray Ionisation Tandem MS- 
LC ESI MS/MS) 
2.5.6.1 Supernatant extraction 
The iL3 and parasitic females were extensively washed with Hanks balanced salt solution 
(Invitrogen) supplemented with 200 IU penicillin/200 mg streptomycin/ml. The iL3 and parasitic 
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females were either (i) homogenised using one steel bead (PeqLab Biotech., Erlangen, Germany) 
and subsequently the proteins extracted in the presence of proteinase inhibitors, or (ii) incubated 
for the generation of E/S products. Infective larvae (4x104/ml) and parasitic females (100/ml) 
were cultured in RPMI 1640 medium, at 37°C using previously described protocols (Maruyama et 
al 2003). Secreted adhesion molecules of Strongyloides venezuelensis are produced by 
oesophageal glands and are components of the wall of tunnels constructed by adult worms in the 
host intestinal mucosa. The incubation times were 24 h for the iL3 and 72 h for parasitic females 
with changes of media every 24 h. E/S products were concentrated 250x (Amicon Ultra 10.000 
MWCO filters; Millipore GmbH, Schwalbach, Germany) after supplementing protease inhibitors 
(Roche). In experiments inhibiting the protein synthesis, cycloheximide (Sigma-Aldrich) was 
added to the culture medium with a final concentration of 70 µM. 
The larvae were pelleted by centrifugation, the excretory and secretory protein-containing 
supernatants (ESP-SN) harvested and analysed for sterility by blood agar growing test. The ESP-
SN was concentrated 100-200 fold by 10 kDa ultrafilter centrifugation and analysed for protein 
composition by SDS-PAGE as well as for proteolytic activity by gelatine gel electrophoresis 
according to earlier reports (Borchert et al 2007). The fractions were subjected to 12% SDS-
PAGE followed by staining with colloidal Coomassie (Invitrogen). The entire lane was cut into 36 
gel blocks of equal size. All gel blocks were in-gel digested with trypsin using published 
procedures (Shevchenko et al 1996). 
The mass spectrometric analyses were kindly performed by Hanns Soblik (Bernhard-Nocht 
Institute) supervised by Hanno Steen, Director of the Proteomics Center, Department of 
Pathology, Children’s Hospital, Harvard Medical School in Boston. All MS datasets were 
searched against combined protein sequence database containing EST sequences from S. ratti and 
S. stercoralis as well as the RefSeq protein sequences for C. elegans and C. briggsae. Searches 
were performed using the ProteinPilot search engine (v2.0). The following search parameters 
were selected: Sample Type: Identification; Cys. Alkylation: Iodoacetamide; Digestion: Trypsin; 
Instrument: LTQ; Special Factors: Gel-based ID; ID Focus: Amino acid substitutions; Search 
Effort: Thorough. Proteins were identified based on a minimum of 4.00 ‘unused score’ equivalent 
to two or more unique peptides of confidence 99. 
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3 Results 
3.1 Identification and cloning of the putative S. ratti HSP10 sequence 
To identify a homologue of HSP10 in S. ratti, a nucleotide search for potential S. stercoralis 
HSP10 ESTs (expressed sequence tags) was performed using the NCBI nucleotide database 
(http://www.ncbi.nlm.nih.gov). The search resulted in a designated S. stercoralis chaperonin 
10-like EST (GenBank accession number BE580000) (Figure 3.1). 
 
cttactgttacccgtagatgttgttcagctcttaagaatgtccaaccactttttgatcgtgtaatggttaa 
aaaagctgctgcagaagtacaatctaagggtggcatttatattccagaaaaagcccaaggaaaagttcttg 
aaggaactgttgttgctgctggtccaggacttcgtactgaagatggtaaagtaattcctttatctgttggt 
gttggggatcgtgtaatgttaccagagtatggtggaaataaagttgttatggatgataaagaatacttcat 
ctaccgtgagtcggatctcattgctaaactcaccaactaagaaatacatgaagtgtaattttatataaata 
t 
 
Figure 3.1: HSP10 homologue of S. stercoralis  
HSP10 homologue of S. stercoralis (GenBank accession number BE580000). Degenerate primers used for the 
performed S. ratti RT-PCR are underlined. 
 
Using the degenerate primer pair SSHSP10FAN and SSHSP10Rend2, an RT-PCR was 
performed with cDNA of S. ratti iL3 as template. Agarose gel electrophoresis of the RT-PCR 
product showed a band of the expected size of about 300bp. The RT-PCR product was cloned into 
the TOPO TA vector and sequenced. The sequence analysis confirmed a product of 295 bp. The 
BLAST search (BLAST resources available at HTTP://www.ncbi.nlm.nih.gov.blast) revealed a 
high degree of sequence similarity to S. stercoralis HSP10. To obtain the full-length sequence, 
3’RACE and spliced leader (SL)-RT-PCRs were performed. For the 3’RACE, S. ratti mRNA was 
reverse transcribed with an oligodt-T7 primer and the PCR was performed using the gene-
specific 1 and ODT-T7 II primers. 
SLs have been identified in a variety of eukaryotes including nematodes (Krause & Hirsh 
1987). SL1 (a non-coding 22 bp-nucleotide sequence) was the first SL sequence identified in 
nematodes (Krause & Hirsh 1987; Bektesh et al 1998). Since it was speculated that the mRNA of 
S. ratti could also contain a SL, a SL RT-PCR was performed to obtain the 5’end. S. ratti cDNA 
was used as template, SL as sense primer and the gene-specific 2 as antisense primer. 
Agarose gel electrophoresis of the 3’RACE product revealed a band of approximately 
250 bp, the SL RT-PCR product had a size of approximately 300 bp. The RT-PCR products were 
cloned separately into TOPO TA vectors. The subsequent sequence analysis showed a 229 bp 
insert for the 3’RACE RT-PCR product and a 302 bp insert for the SL RT-PCR product. The 
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overlapping sequence fragments of the already obtained putative S. ratti HSP10 sequence and the 
3’end and 5’RACE products showed 100% identity.  
Finally, to amplify the full-length S. ratti HSP10 mRNA/cDNA, an RT-PCR was done with 
S. ratti iL3 cDNA as template using the primer combination HSP10flfor and HSP10flrev. The RT-
PCR product was cloned into pGemTeasy vector. Subsequent sequence analyses confirmed the 
correct putative full-length sequence of HSP10. The pGemTeasy_HSP10_FL clone served then as 
basis for further subclonings to generate expression-clones coding for S. ratti HSP10 full-length 
or S. ratti HSP10 fragments. 
3.2 Characterisation of the S. ratti HSP10 transcript 
The full-length cDNA of the S. ratti HSP10 is 507 bp long. The translation initiation codon 
(ATG) is 43 bp downstream of the 5’ untranslated region (UTR) starting with the SL sequence. 
There are 2 stop codons (TAA), one at position bp 327-330, followed by one in-frame stop at 
position bp 339-342 (Figure 3.2). The 5’ UTR does not exhibit any Kozak consensus sequences, 
or Kozak consensus-like sequences upstream of the ATG codon (Kozak 1987). The sequence 
contains a majority of A-T bases (61%) within the open reading frame (ORF), of which 69% are 
in the 5’UTR and 82% in the 3’ UTR. Alignment results indicated that the S. ratti HSP10 full-
length cDNA has significant homology (93%) to the HSP10 homologue of S. stercoralis 
(Fig. 3.3). The ORF comprises 330 bp and codes for 110 amino acid residues and has a predicted 
molecular mass of 11.8 kDa. Moreover, the SrHSP10 ORF has a mitochondrial targeting peptide 
(AA 1-30, iPSORT prediction). Furthermore, its N-terminal sequence has the ability to form an 
amphipathic alpha helix, which enables it to cross the mitochondrial membrane. The S. ratti 
HSP10 protein has a high homology (93%) to S. stercoralis, with the exception of 8 amino acid 
exchanges, of which 4 are conservative (Figure 3.4). An additional multi alignment analysis 
indicated that the amino acid sequence of S. ratti HSP10 is 63% identical with the HSP10 
homologue of C. elegans and 57% identical with the HSP10 homologue of homo sapiens. 
Furthermore, the S. ratti HSP10 sequence shows similarity of 57% to the Brugia malayi 
(B. malayi) HSP10 (Figure 3.5). 
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  -43  ggtttaattacccaagtttgaggttcttgtaattttggtaaatatgcttctttccgctgtt  18 
  V  -  L  P  K  F  E  V  L  V  I  L  V  N  M  L  L  S  A  V  
 19  cgtagatgttcatcagctcttaaaaatgttcaaccactttttgatcgtgttatgatcaaa   78 
  R  R  C  S  S  A  L  K  N  V  Q  P  L  F  D  R  V  M  I  K  
 79  aaagctgctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaagga  138 
  K  A  A  A  E  V  K  S  K  G  G  I  Y  I  P  E  K  A  Q  G  
139  aaggttcttgaaggtactgttgttgctgctggtccaggacttcgtactgaggatggtaaa  198 
  K  V  L  E  G  T  V  V  A  A  G  P  G  L  R  T  E  D  G  K  
199  cttatacctttatcagttagtgttggagatcgtgttatgttgccagagtatggtggaaat  258 
  L  I  P  L  S  V  S  V  G  D  R  V  M  L  P  E  Y  G  G  N  
259  aaagttgttatggatgatacagaatatttcatctatcgtgagtcagatctcatcgccaaa  318 
  K  V  V  M  D  D  T  E  Y  F  I  Y  R  E  S  D  L  I  A  K  
319  ctcactaactaaggaatacattaaagtgtaatttttatatattattttgttgttttttgc  378 
   L  T  N  -  G  I  H  -  S  V  I  F  I  Y  Y  F  V  V  F  C  
379  atagttgatattgtagtttgtattcttgttggttggttaaagactataaaaaattttaca  438 
  I  V  D  I  V  V  C  I  L  V  G  W  L  K  T  I  K  N  F  T  
439  caaaaaaaaaaaaaaaaaaaaaaaaa          464 
  Q  K  K  K  K  K  K  K    
 
Figure 3.2: Complete coding sequence and deduced amino acid sequence of the S. ratti HSP10 gene 
The translation initiation and termination codons are printed in bold. The predicted amino acid sequence is shown 
below the nucleotide sequence. The spliced leader sequence is pinted in grey. The putative mitochondrial targeting 
sequence is shaded grey. Numbering starts at the first nucleotide of the initiation codon, with upstream sequences 
indicated as negative numbers. 
 
SrHSP10         ggtttaattacccaagtttgaggttcttgtaattttggtaaatatgcttctttccgctgt 60 
SsHSP10         -------------------------------------------------cttactgttac 11 
                                                                 *** * * *   
 
SrHSP10         tcgtagatgttcatcagctcttaaaaatgttcaaccactttttgatcgtgttatgatcaa 120 
SsHSP10         ccgtagatgttgttcagctcttaagaatgtccaaccactttttgatcgtgtaatggttaa 71 
                 **********  *********** ***** ******************** *** * ** 
 
SrHSP10         aaaagctgctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaagg 180 
SsHSP10         aaaagctgctgcagaagtacaatctaagggtggcatttatattccagaaaaagcccaagg 131 
                ************ ****** ******* ** ** ***** ******** *********** 
 
SrHSP10         aaaggttcttgaaggtactgttgttgctgctggtccaggacttcgtactgaggatggtaa 240 
SsHSP10         aaaagttcttgaaggaactgttgttgctgctggtccaggacttcgtactgaagatggtaa 191 
                *** *********** *********************************** ******** 
 
SrHSP10         acttatacctttatcagttagtgttggagatcgtgttatgttgccagagtatggtggaaa 300 
SsHSP10         agtaattcctttatctgttggtgttggggatcgtgtaatgttaccagagtatggtggaaa 251 
                * * ** ******** *** ******* ******** ***** ***************** 
 
SrHSP10         taaagttgttatggatgatacagaatatttcatctatcgtgagtcagatctcatcgccaa 360 
SsHSP10         taaagttgttatggatgataaagaatacttcatctaccgtgagtcggatctcattgctaa 311 
                ******************** ****** ******** ******** ******** ** ** 
 
SrHSP10         actcactaactaaggaatacattaaagtgtaatttttatatattattttgttgttttttg 420 
SsHSP10         actcaccaactaagaaatacat-gaagtgtaatttt---atataaatat----------- 356 
                ****** ******* *******  ************   **** * * *            
 
SrHSP10         catagttgatattgtagtttgtattcttgttggttggttaaagactataaaaaattttac 480 
SsHSP10         ------------------------------------------------------------ 
                                                                             
 
SrHSP10         acaaaaaaaaaaaaaaaaaaaaaaaaa 507 
SsHSP10         --------------------------- 
 
Figure 3.3: Nucleotide sequence alignment of the S. ratti HSP10 and the HSP10 homologue of S. stercoralis 
Nucleotide sequence alignment (CLUSTALW) of the S. ratti HSP10 (SrHSP10) sequence, including the 3’ and 
5’ends, with the S. stercoralis EST (SsHSP10) (GenBank accession number BE580000). Symbol (*) indicates 
identical nucleotides. Numbering starts at the first nucleotide of the initiation codon. 
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SrHSP10         MLLSAVRRCSSALKNVQPLFDRVMIKKAAAEVKSKGGIYIPEKAQGKVLEGTVVAAGPGL 60 
SsHSP10         --LTVTRRCCSALKNVQPLFDRVMVKKAAAEVQSKGGIYIPEKAQGKVLEGTVVAAGPGL 58 
                  *:..***.**************:*******:*************************** 
 
SrHSP10         RTEDGKLIPLSVSVGDRVMLPEYGGNKVVMDDTEYFIYRESDLIAKLTN----------- 109 
SsHSP10         RTEDGKVIPLSVGVGDRVMLPEYGGNKVVMDDKEYFIYRESDLIAKLTN-EIHEV-FYIN 116 
                ******:*****.*******************.****************            
 
Figure 3.4: Amino acid sequence alignment of the S. ratti HSP10 and the HSP10 homologue 
of S. stercoralis 
Amino acid sequence alignment (CLUSTALW) of the S. ratti HSP10 (SrHSP10)-like sequence with the HSP10 
homologue of S. stercoralis (SsHSP10) (GenBank accession number BE580000). Symbol (*) indicates identical 
amino acids, (:) indicates strongly similar amino acids and (.) indicates weakly similar amino acids. Numbering starts 
at the first amino acid. 
 
 
 
 
 
 
SrHSP10         MLLSAVRRCS--SALKNVQPLFDRVMIKKAAAEVKSKGGIYIPEKAQGKVLEGTVVAAGP 58 
SsHSP10         --LTVTRRCC--SALKNVQPLFDRVMVKKAAAEVQSKGGIYIPEKAQGKVLEGTVVAAGP 56 
BmHSP10         MASMSVARKALGDLIKAFKPLSDRVLVERFAAETKTKGGIMIPDKAQGKVLEATVISTGP 60 
CeHSP10         MFLTAVRRSS--NVLKTFKPLYDRVLVERVAAETKTKGGIMLPEKSQGKVLEATVVSAGA 58 
                     . * .  . :* .:** ***:::: ***.::**** :*:*:******.**:::*. 
 
SrHSP10         GLRTEDGKLIPLSVSVGDRVMLPEYGGNKVVMDDTEYFIYRESDLIAKLTN 109 
SsHSP10         GLRTEDGKVIPLSVGVGDRVMLPEYGGNKVVMDDKEYFIYRESDLIAKLTN 107 
BmHSP10         GGRDSKGNLVPMTVQAGDHVLLPEYGGTKVVVDEKEYHIFREADILGKFDQ 111 
CeHSP10         GLRNEKGELVALTVKPGDRVLLPEYGGTKVVVEDKEYSIFRESDLLGVFH- 108 
                * * ..*:::.::*  **:*:******.***:::.** *:**:*::. :   
 
Figure 3.5: Amino acid alignment of the S. ratti HSP10 and the HSP10 homologues of S. stercoralis, C. elegans and 
Brugia malayi 
Amino acid alignment (CLUSTALW) of the S. ratti HSP10 (SrHSP10)-like sequence with S. stercoralis (SsHSP10, 
GenBank accession number BE580000), C. elegans (CeHSP10, GenBank accession number NP497428) and Brugia 
malayi (BmHSP10, GenBank accession number XM001902716). Symbol (*) indicates identical amino acids, (:) 
indicates conserved substitutions, (.) indicates semi-conserved substitutions. Numbering starts at the first amino acid. 
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3.3 Identification and cloning of the putative S. ratti HSP60 transcript 
To identify the putative HSP60 sequence of S. ratti, a BLAST search was performed using 
the Onchocerca volvulus HSP60 sequence (AF121264) as a matrix. The data entry in the library 
Nematode.net for S. ratti showed a 1078 bp sequence comprising 5 ESTs: 
Table 3.1: Overview of the S. ratti HSP60 EST Nematode.net data entry 
EST EST description Derived primers 
EST 1 ku55f08.y1 bp 1 - 412 equivalent to S. ratti 
ORF bp 268 - 679. Database entry CB098615. 
PCR1 FW 
EST 2 kt27c10.y3 bp 1 – 470 equivalent to S. ratti 
ORF bp 613 - 1083. Database entry BI703957. 
PCR1 RV 
PCR2 FW 
EST 3 kt26f04.y3 bp 389 - 523 equivalent to S. ratti 
ORF bp 1083 - 1216. 
Database entry BI703954. 
 
EST 4 kt26f04.y3 bp 237 - 395 equivalent to S. ratti 
ORF bp 1217 – 1375. 
Database entry CB097948. 
PCR2 RV 
PCR3 FW 
EST 5 kt72a12.y1 bp 41 - 372 equivalent to S. ratti 
ORF bp 1814 – 2141. 
Database entry BI323502. 
PCR3 RV 
 
To obtain the putative S. ratti HSP60 full-length cDNA sequence, three separate RT–PCR 
analyses were performed. First strand S. ratti iL3 cDNA served as template for each RT–PCR. 
PCR1 FW / PCR1 RV, PCR2 FW / PCR2 RV and PCR3 FW / PCR3 RV, primer pairs derived 
from the 5 ESTs were used as forward (FW) and reverse (RV) primers. Two RT-PCR products 
were obtained from the PCR1 and PCR2 primer pairs. They consisted each of a cDNA fragment 
of about 500 bp. The amplicons were separately cloned into pGemTeasy. Sequencing and 
alignment analyses confirmed their identity as putative S. ratti HSP60 cDNAs. No amplicon was 
obtained using the primer pair PCR3 FW/RV. To obtain the full-length sequence of the putative 
S. ratti HSP60 transcript, again, 3’RACE fragments were generated and a spliced leader (SL) RT-
PCR was performed. 
For 3’RACE, S. ratti mRNA was reverse transcribed with the oligo(dT)-T7 primer, 
subsequently an RT-PCR was performed using the primers SR_HSp60_RACE_GSP_F and ODT-
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T7 II. For SL-RT-PCR, S. ratti iL3 cDNA was used as template, SL as sense primer and the 
SR_HSp60_RACEGSP_R as antisense primer. The obtained 3’RACE and SL-RT-PCR fragments 
were cloned each into pGemTeasy (pGemTeasy_HSP60_3’RACE, pGemTeasy_HSP60_5’SL). 
Agarose gel electrophoresis showed a band of approximately 1 kb for the 3’RACE, and a band of 
approximately 0.8 kb for the SL-RT-PCR. Sequencing confirmed their identity as putative S. ratti 
HSP60 cDNAs. 
To confirm the full-length cDNA sequence of HSP60 of S. ratti, a RT-PCR analysis was 
performed using S. ratti iL3 cDNA as template, and HSP60Stop_rev and HSP60Sal-For as 
primers. The PCR product was checked on agarose gel and cloned into pGemTeasy. Subsequent 
sequencing and alignment with the already obtained putative S. ratti HSP60 transcript fragments 
showed 100% identity. 
3.4 Characterisation of S. ratti HSP60 iL3 transcript 
The full-length HSP60 cDNA of S. ratti is 1914 bp in size. The translation initiation codon 
starts 52 bp downstream of the 5’ UTR. The stop codon (TAA) is located at position 1742, 
followed by two in-frame stop codons within the 174 bp long 3’ UTR. The open reading frame 
(ORF) is 1695 bp in size and codes for 565 amino acid residues (Figure 3.6). The sequence 
contains a majority of A-T bases (67%) within the ORF, of which 75% are in the 5’UTR and 80% 
in the 3’UTR. A putative mitochondrial targeting sequence with 25 amino acid residues was 
identified in the N-terminal region (Figure 3.6, grey shaded sequence) (Claros and Vincens 1996). 
The deduced amino acid sequence has a predicted molecular mass of 64 kDa, which is expected 
for the products of HSP60 genes (Hemmingsen et al 1988; Jindla et al 1989; Lund 1995). The 
sequence contains the canonical chaperonin 60 signature (AAAVEEGIVPGGG, Figure 3.6 
(ProSite document PS00296 1997)) between amino acid residues 420 and 432. BLAST P analysis 
revealed high sequence similarity with HSP60 genes from Strongyloides sterocaris (Figure 3.7a) 
and other organisms, including the human, Onchocerca volvulus (O. volvulus) and B. malayi 
HSP60 (Figure 3.7b). The HSP60 gene promoter is characterised by the absence of a classical 
TATA box and by the presence of a single heat shock response element (HSE), nGAAn, located 
25 bp upstream of the start codon (ATG). Promoters of other heat shock protein genes frequently 
contain several such elements (Xiao & Lis 1988; Amin et al 1988; Xiao et al 1991). 
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   -52 ttggtttaattacccaagtttgaggaatatattaacagtacaactttaaaaaatgcttcgt   9 
        W  F  N  Y  P  S  L  R  N  I  L  T  V  Q  L  -  K  M  L  R  
    10 cttgctgctcataatttttctaaatctattatcagatcatatgctaaagatcttaaattt   69 
        L  A  A  H  N  F  S  K  S  I  I  R  S  Y  A  K  D  L  K  F  
    70 ggagctgatggaagaaaggccatgcttgttggagtagatcttttagctgacgctgtatct  129 
        G  A  D  G  R  K  A  M  L  V  G  V  D  L  L  A  D  A  V  S  
   130 gttacaatgggaccaaaaggaagaaatgttattattgaacaaagttttggtggaccaaaa  189 
        V  T  M  G  P  K  G  R  N  V  I  I  E  Q  S  F  G  G  P  K  
   190 attacaaaagacggtgttaccgttgctaaggctattgatctcgaagataaatatcaaaat  249 
        I  T  K  D  G  V  T  V  A  K  A  I  D  L  E  D  K  Y  Q  N  
   250 atgggtgcaaaattggttcaagatgttgcagataaggctaacgaacaagctggtgacgga  309 
        M  G  A  K  L  V  Q  D  V  A  D  K  A  N  E  Q  A  G  D  G  
   310 acaacttgcgctactgttcttgccagagctattgctaaagaaggatttgaaagtattagc  369 
        T  T  C  A  T  V  L  A  R  A  I  A  K  E  G  F  E  S  I  S  
   370 cgtggtgctaatccaattgaagttagaaaaggtgtcatgtcatccgttgaagctattgtt  429 
        R  G  A  N  P  I  E  V  R  K  G  V  M  S  S  V  E  A  I  V  
   430 gaagagttaaagaagatgtcaaagcaagttacaactccagaagaaattgctcaagttgct  489 
        E  E  L  K  K  M  S  K  Q  V  T  T  P  E  E  I  A  Q  V  A  
   490 actatttctgctaatggagataaagatatcggaaaattgatatctgaagctatgaaaaaa  549 
        T  I  S  A  N  G  D  K  D  I  G  K  L  I  S  E  A  M  K  K  
   550 gttggaaataaaggtgtcattaccgttaaggatggaaaaactcttgacgatgaattagaa  609 
        V  G  N  K  G  V  I  T  V  K  D  G  K  T  L  D  D  E  L  E  
   610 attattgaaggaatgaaatttgaccgtggatatatttctccatatttcatgaatacttcc  669 
        I  I  E  G  M  K  F  D  R  G  Y  I  S  P  Y  F  M  N  T  S  
   670 aagggtggaaaatgtttctttgaaaaatgtttagtccttctttctgagaaaaaaatttcc  729 
        K  G  G  K  C  F  F  E  K  C  L  V  L  L  S  E  K  K  I  S  
   730 caagttcaagatattgttccagctcttgaattagcaaataaatatcgtcaaccacttatt  789 
        Q  V  Q  D  I  V  P  A  L  E  L  A  N  K  Y  R  Q  P  L  I  
   790 attattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaacagattaaag  849 
        I  I  A  E  D  V  D  G  E  A  L  T  T  L  V  L  N  R  L  K  
   850 gttggtcttcaagtttgtgctgtaaaagctcctggttttggagacaaccgcaaaaacaca  909 
        V  G  L  Q  V  C  A  V  K  A  P  G  F  G  D  N  R  K  N  T  
   910 ttgaaagatattgccattgctacaggagctaaagtctttggagatgaatctaatttacac  969 
        L  K  D  I  A  I  A  T  G  A  K  V  F  G  D  E  S  N  L  H  
   970 aaacttgaagatattcaagcaggtgactttggtgaagttgctgaagttacagttacaaaa 1029 
        K  L  E  D  I  Q  A  G  D  F  G  E  V  A  E  V  T  V  T  K  
  1030 gatgatactcttatgcttaatggaaaaggtgatgctgaacaagttgagaagagaattcaa 1089 
        D  D  T  L  M  L  N  G  K  G  D  A  E  Q  V  E  K  R  I  Q   
  1090 caaattgaatttgagattgaacaatctacttctgagtatgaaaaagaaaaacttaatgaa 1149 
        Q  I  E  F  E  I  E  Q  S  T  S  E  Y  E  K  E  K  L  N  E   
  1150 cgtttagctaaattatcaaaaggtgttgctgtccttaaaattggaggtgcttctgaagtt 1209 
        R  L  A  K  L  S  K  G  V  A  V  L  K  I  G  G  A  S  E  V   
  1210 gaagttagtgaaaagagagatcgtgtcacagatgcgctctgtgcaacacgtgctgctgta 1269 
        E  V  S  E  K  R  D  R  V  T  D  A  L  C  A  T  R  A  A  V   
  1270 gaagaaggaatcgtaccaggaggtggtgttgctcttcttcgtgctgtcaaagttcttgat 1329 
        E  E  G  I  V  P  G  G  G  V  A  L  L  R  A  V  K  V  L  D   
  1330 aacatcaaagtcggtaattctgaccaagaattgggagttagaattgtccaaaaagccgtt 1389 
        N  I  K  V  G  N  S  D  Q  E  L  G  V  R  I  V  Q  K  A  V   
  1390 cgtcaaccaatttctaccattattaagaatgctggacttgaaccagctagtatcgttgaa 1449 
        R  Q  P  I  S  T  I  I  K  N  A  G  L  E  P  A  S  I  V  E   
  1450 aaagtttatgcaaatgaatcagtcagtttcggttacgatgctttgaatgataagtttgtt 1509 
        K  V  Y  A  N  E  S  V  S  F  G  Y  D  A  L  N  D  K  F  V   
  1510 gatatgatccaaactggtattattgatccaaccaaagttgtccgtacatcacttcaagac 1569 
        D  M  I  Q  T  G  I  I  D  P  T  K  V  V  R  T  S  L  Q  D   
  1570 gctgctggtgttgcttcacttttagccactactgaatgtgttgttacagaagttccaaaa 1629 
        A  A  G  V  A  S  L  L  A  T  T  E  C  V  V  T  E  V  P  K   
  1630 gaaactccagcacctccaatgggtggtatgggaggtatgggcggaatgggtggtggaatg 1689 
        E  T  P  A  P  P  M  G  G  M  G  G  M  G  G  M  G  G  G  M   
  1690 ttntaaatcactagtcatttttttaccttctgcttccaatctttccttatttttaagatc 1749 
        X  -  I  T  S  H  F  F  T  F  C  F  Q  S  F  L  I  F  K  I   
  1750 aataattataatgtatttaaagtatcaaactagattattgttttagggttgttacatttt 1809 
        N  N  Y  N  V  F  K  V  S  N  -  I  I  V  L  G  L  L  H  F   
  1810 tgttttggttttcaacaaataaataaaatataanccaaaaaaaaaaaaaaaaaaaaaaaa 1869 
        C  F  G  F  Q  Q  I  N  K  I  -  X  K  K  K  K  K  K  K  K   
 
Figure 3.6: Complete coding sequence and deduced amino acid sequence of the S. ratti HSP60 gene 
The translation initiation and termination codon is printed in bold. The predicted amino acid sequence is shown below 
the nucleotide sequence. The spliced leader sequence is printed in grey. The putative mitochondrial targeting 
sequence is shaded grey. The canonical HSP60 signature is shaded black. Numbering starts at the first nucleotide of 
the initiation codon, with upstream sequences indicated as negative numbers. 
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SrHSP60         MLRLAAHNFSKSIIRSYAKDLKFGADGRKAMLVGVDLLADAVSVTMGPKGRNVIIEQSFG 60 
SsHSP60         ---LATRNFSKSFLRSYAKDLKFGADGRKAMLVGVDLLADAVSVTMGPKGRNVIIEQSFG 57 
                   **::*****::********************************************** 
 
SrHSP60         GPKITKDGVTVAKAIDLEDKYQNMGAKLVQDVADKANEQAGDGTTCATVLARAIAKEGFE 120 
SsHSP60         GPKITKDGVTVAKAIDLEDKYQNMGAKLVQDVADKANEQAGDGTTCATVLARAIAKEGFE 117 
                ************************************************************ 
 
SrHSP60         NISRGANPIEVRKGVMSSVEAIVEELKKMSKQVTTPEEIAQVATISANGDKDIGKLISEA 180 
SsHSP60         NISRGANPIEVRKGVMSSVEAIVGEVNEMSKQVATPEEIASVATISANGEKEMGKCISTO 177 
                *********************** *:::*****:******.********:*::** **   
 
Figure 3.7a: Amino acid sequence alignment of the S. ratti HSP60 and the HSP60 homologue of S. stercoralis 
Amino acid alignment (CLUSTALW) of the S. ratti HSP60 (SrHSP60)-like sequence with HSP60 homologue of 
S. stercoralis (SsHSP60) (Nematode.net accession number kq35f01.y1). Symbol (*) indicates identical amino acids, 
(:) indicates strongly similar amino acids and (.) indicates weakly similar amino acids. Numbering starts at the first 
amino acid. 
 
 
 
SrHSP60         ---------MLRLAAHNFSKSIIRSYAKDLKFGADGRKAMLVGVDLLADAVSVTMGPKGR 51 
HhHSP60         MLRLPTVFRQMRPVSRVLAPHLTRAYAKDVKFGADARALMLQGVDLLADAVAVTMGPKGR 60 
OvHSP60         ---------MARLVSR-TVRSGLRHYAKDVKFGADGRASMLYGVDTLADAVAVTMGPKGR 50 
BmHSP60         -MFRIGGQSVARLVSR-TVQSGLRHYAKDVKFGADGRASMLYGVDTLADAVAVTMGPKGR 58 
                           * .::       * ****:*****.*  ** *** *****:******** 
 
SrHSP60         NVIIEQSFGGPKITKDGVTVAKAIDLEDKYQNMGAKLVQDVADKANEQAGDGTTCATVLA 111 
HhHSP60         TVIIEQSWGSPKVTKDGVTVAKSIDLKDKYKNIGAKLVQDVANNTNEEAGDGTTTATVLA 120 
OvHSP60         NVVIEQSWGSPKITKDGVTVAKAIDFKDKYKNLGAKLVQDVANKTNEEAGDGTTCATVLA 110 
BmHSP60         NVVIEQSWGSPKITKDGVTVAKAIDFKDKYKNLGAKLVQDVANKTNEEAGDGTTCATVLA 118 
                .*:****:*.**:*********:**::***:*:*********:::**:****** ***** 
 
SrHSP60         RAIAKEGFENISRGANPIEVRKGVMSSVEAIVEELKKMSKQVTTPEEIAQVATISANGDK 171 
HhHSP60         RSIAKEGFEKISKGANPVEIRRGVMLAVDAVIAELKKQSKPVTTPEEIAQVATISANGDK 180 
OvHSP60         RAIAKEGFENISKGANPVEVRRGVMKAVELLVAELKKMSKDVTTPEEIAQVATISANGDS 170 
BmHSP60         RAIAKEGFENISKGANPVEVRRGVMKAVELLVAELKKMSKDVTTPEEIAQVATISANGDS 178 
                *:*******:**:****:*:*:*** :*: :: **** ** ******************. 
 
SrHSP60         DIGKLISEAMKKVGNKGVITVKDGKTLDDELEIIEGMKFDRGYISPYFMNTSKGGKCFFE 231 
HhHSP60         EIGNIISDAMKKVGRKGVITVKDGKTLNDELEIIEGMKFDRGYISPYFINTSKGQKCEFQ 240 
OvHSP60         SVGKLISEAMKTVGNKGVITVKDGKTLHDELETIEGMKFDRGYISPYFINTSKGAKVEFE 230 
BmHSP60         TVGKLISEAMKKVGNKGVITVKDGKTLHDELETIEGMKFDRGYISPYFINTTKGAKVEFE 238 
                 :*::**:***.**.************.**** ***************:**:** *  *: 
 
SrHSP60         KCLVLLSEKKISQVQDIVPALELANKYRQPLIIIAEDVDGEALTTLVLNRLKVGLQVCAV 291 
HhHSP60         DAYVLLSEKKISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNRLKVGLQVVAV 300 
OvHSP60         KCLLLFSEKKISQVQDIVPALELANKYRKPIVIIAEDVDGEALTTLVLNRLKVGLQVAAV 290 
BmHSP60         KCLLLFSEKKISQVQDIVPALELANKYRKPIVIVAEDVDGEALTTLVLNRLKVGLQVAAV 298 
                .. :*:******.:*.******:** :*:*::*:*********:************* ** 
 
SrHSP60         KAPGFGDNRKNTLKDIAIATGAKVFGDESNLHKLEDIQAGDFGEVAEVTVTKDDTLMLNG 351 
HhHSP60         KAPGFGDNRKNQLKDMAIATGGAVFGEEGLTLNLEDVQPHDLGKVGEVIVTKDDAMLLKG 360 
OvHSP60         KAPGFGDNRKNTLKDMAIATGGTVFGDDANLLKIEDVQISDLGEAEEVSITKDDTLILRG 350 
BmHSP60         KAPGFGDNRKNTLKDMAIATGGTVFGDDANLLKIEDVQISDLGEA--------------- 343 
                *********** ***:*****. ***::.   ::**:*  *:*:. 
 
Figure 3.7b: Amino acid sequence alignment of S. ratti HSP60 and the HSP60 homologues Homo sapiens, 
Onchocerca volvulus and Brugia malayi 
Amino acid sequence alignment (CLUSTALW) of S. ratti HSP60 (SrHSP60)-like sequences with Homo sapiens 
(HhHSP60, GenBank accession number NM002156); Onchocerca volvulus (OvHSP60, GenBank accession number 
AF121264); Brugia malayi (BmHSP60, GenBank accession number XM001902738). Symbol (*) indicates identical 
amino acids, (:) indicates conserved substitutions, (.) indicates semi-conserved substitutions. Numbering starts at the 
first amino acid. 
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3.5 Characterisation of putative S. ratti HSP10 and HSP60 transcripts of parasitic females  
To detect the presence and putative isoforms of HSP10 and HSP60 transcripts in parasitic 
females of S. ratti, further RT-PCR experiments were performed as follows. Primers were derived 
based on the putative full-length cDNA sequence of S. ratti iL3 HSP10 and HSP60, respectively. 
RNA of S. ratti parasitic females was isolated and reverse transcribed. HSP10 and HSP60 
amplicons were generated separately using appropriate primers (HSP10flfor and HSP10flrev or 
HSP60for and HSP60rev, respectively). Agarose gel electrophoresis revealed an S. ratti HSP10 
amplicon of 330 bp, and for HSP60 an amplicon of about 1700 bp (Figure 3.8). These products 
were cloned into pGemTeasy (pGemTeasy_HSP10_FLPF, pGemTeasy_HSP60_FL). Subsequent 
sequence analysis showed a 330 bp cDNA insert for HSP10 and a 1695 bp cDNA insert for 
HSP60. Sequence alignment analysis of the obtained HSP10 cDNAs showed 100% identity. It 
contains a 330 bp-long open reading frame, including start (ATG) and stop (TAA) codons. The 
deduced amino acid sequence has a predicted molecular mass of 10 kDA and is identical with the 
putative full-length HSP10 cDNA sequence of S. ratti iL3. The identity of the putative S. ratti 
HSP60 parasitic female cDNA sequence was confirmed by BLAST analysis revealing a 100% 
similarity with HSP60 from iL3 and comprising a 1695 bp open reading frame including start 
(ATG) and stop (TAA) codons. The deduced amino acid sequence has a predicted molecular mass 
of 60 kDA and showed 100% similarity to the S. ratti HSP60 translation product of iL3. 
 
 
Figure 3.8: Analyses of the putative parasitic female S. ratti HSP10 and S. ratti HSP60 transcripts 
RT-PCR analyses of the putative S. ratti parasitic female HSP10 (1) and HSP60 (2) transcripts. S. ratti total RNA was 
extracted from the small intestine of S. ratti infected Wistar rats at day 7 post infectionem. PCR products were 
separated on a 1.5% agarose gel and stained with ethidium bromide. Numbers on the left panels are in kb. M = 
molecular weight marker (Invitrogen) 
 
 
1.6 
0.3 
M    1   2 
Results 
 
70 
 
3.6 Localisation of putative HSP10 and HSP60 transcripts in S. ratti iL3 by 
in situ hybridisation 
In situ hybridisation was done to localise the HSP10 transcripts in S. ratti iL3. To this end, 
cryo- and whole-mount techniques were used. The S. ratti iL3 are thin filamenteous structures and 
approximately 300–500 µm thick. The whole-mount slides contained approximately 100 S. ratti 
iL3. For cryo-sectioning, all blocks contained multiple cross- and longitudinal sections. Prior to 
hybridisation, RNA-probes of HSP10 and HSP60 were generated. To amplify the HSP10 probe 
with the appropriate primers (HSP10_sonde_for and HSP10_sonde_rev), the 
pGemTeasy_HSP10_FL clone served as template. For the amplification of the S. ratti HSP60 
probe, the pGEmteasy_HSP60FL clone served as template, HSP60_sonde1_for and 
HSP60_sonde1_rev served as primers. The resulting PCR products, were cloned into pGemTeasy 
(pGemTeasy_HSP10_Sonde, pGemTeasy_HSP60_Sonde1). Sequence analyses confirmed the 
identity of both probes (HPS10: 307 bp, HSP60: 321 bp). Both clones were digested, each with 
NotI and BamHI, the resulting HSP10 and HSP60 fragments each ligated directionally into 
pBluescript (pBluescript_HSP10_Sonde and pBluescript_HSP60_Sonde1). To generate antisense 
probes, the pBluescript_HSP10_Sonde and pBluescript_HSP60_Sonde1 clones were each 
linearised with the restriction enzyme NotI, and DIG-labelled transcripts were generated by T7 
RNA polymerase. The sense probes were generated by linearising the clones 
pBluescript_HSP10_Sonde and pBluescript_HSP60_Sonde1 with the restriction enzyme BamHI, 
respectively, and Dig-labelled transcripts were generated by T3 RNA polymerase. The sense 
probes served as a negative control. 
For HSP10 and HSP60 in situ hybridisations, 3 S. ratti iL3 whole-mounts and 3 S. ratti iL3 
cryo-slides were each hybridised with 20ng DIG-labelled RNA sense and antisense HSP10. For 
HSP60 hybridisation, 3 S. ratti iL3 whole-mounts and 3 S. ratti iL3 cryo-slides were each 
hybridised with 20ng DIG-labeled RNA sense and antisense HSP60 probes as described (see 
2.3.13.2). The detection procedure used is based on the alkaline phosphatase enzyme reaction. 
The slides were incubated with anti-DIG-antibody conjugated with alkaline phosphatase and 
subsequently stained in 500µl staining solution (see 2.3.13.4). The anti-DIG antibody is then 
visualised with colometric NTB and BCIP alkaline phosphatase substrates. After 3 and 18 hours, 
respectively, the staining was stopped. 
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Both the HSP60 sense probe (Figure 3.9 a) and the HSP10 sense probes (Figure 3.9 c+d) 
showed no hybridisation after 3 hours and weak signals after 18 hours staining.  
a        b 
 
 
c        d 
 
 
e        f 
 
 
Figure 3.9: In situ hybridisation in S. ratti iL3 
(a) S. ratti iL3 cryo-slides stained for 18 hours with HSP60 sense probes (b) S. ratti iL3 cryo-slides hybridised for 
18 hours with HSP60 antisense probes (c) S. ratti iL3 cryo-slides hybridised for 18 hours with HSP10 sense probes (d) 
S. ratti iL3 cryo-slides hybridised for 18 hours with HSP10 antisense probes (e) S. ratti iL3 wholemount-slides 
hybridised for 18 hours with HSP10 sense probes (f) S. ratti iL3 wholemount-slides hybridised for 18 hours with 
HSP10 antisense probes 
 
The HSP60 antisense probe hybridised with the cryo cut S. ratti iL3. A pattern of 
transcription was indicated within the digestive tract and not in the cuticula (Figure 3.9 b) 
The HSP10 antisense probe also hybridised with the cryo (Figure 3.9 d) cut S. ratti iL3 and 
additionally with the whole mount S. ratti iL3 (Figure 3.9 f). A pattern of transcription was 
observed in the digestive tract and not in the cuticula. 
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3.7 Identification of HSP10 and HSP60 proteins in supernatants of S. ratti iL3 and 
parasitic females 
The secreted products of in vitro-cultured S. ratti iL3 and parasitic females were collected 
under serum-free conditions using previously optimised protocols (Kwan-Lim et al 1989). SDS-
PAGE analysis of all stages revealed a general consistency in protein concentration and 
composition of 10 kDa bands and 60 kDa bands. To address the question whether S. ratti iL3 and 
parasitic female worms selectively secrete a specific subset of proteins, the excretory/secretory 
S. ratti products were compared to a soluble worm homogenate. SDS gel electrophoresis revealed 
that both excretory/secretory S. ratti products and the soluble worm homogenate had distinct 
banding patterns at 10 kDa and 60 kDA (Figure 3.10). To identify the proteins present in 
excretory/secretory S. ratti, the excretory/secretory band and the soluble worm homogenate band 
at 10 kDa and 60 kDA were excised from the SDS gel and subjected to LC ESI MS/MS analysis. 
By using LC-MS/MS and the Protein Pilot database (Protein PilotTM Software), S. ratti HSP10 
and HSP60 were identified in excretory/secretory S. ratti products and soluble worm homogenate. 
Prior to the database search, the Protein Pilot database was complemented with the S. ratti HSP10 
and HSP60 amino acid sequences previously obtained. 
 
Figure 3.10: One-dimensional SDS-PAGE of iL3, parasitic females and S. ratti worm homogenate proteins 
10 independent batches of S. ratti iL3 excretory/ secretory products (2) and S. ratti parasitic female (3) were 
compared to S. ratti soluble worm homogenate (4) by one-dimensional SDS-PAGE; each lane was loaded with 2 µg 
of protein. Molecluar weight markers (1) are indicated on the left in kDA. 60 kDa bands are red framed, 10 kDa 
bands are black framed 
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3.8 Characterisation of the putative S. ratti HSP10 and HSP60 genes 
3.8.1 S. ratti HSP10 and HPS60 Southern blot analyses  
To determine the genomic structure and the approximate site of the putative S. ratti HSP10 
and HSP60 genes, a Southern blot analysis was carried out with S. ratti genomic DNA. The 
gDNA was isolated from 250 000 S. ratti iL3. The S. ratti genomic DNA was digested with the 
restriction enzymes BamHI, EcoRI, EcoRV and HindIII, split into 2 equivalent portions, 
separately electrophoresed in a 1% (w/v) agarose gel, and transferred onto a Hybond XL1-
membrane. 
To generate the Southern blot probe, both, the pGemTeasy_HSP10_Sonde clone and the 
pGemTeasy_HSP60_Sonde1 clone were digested separately with the restriction enzymes Not I 
and Spe I and each ligated directionally to the pBluescript II SK +/– vector multiple cloning site 
(pBluescript_HSP10_Sonde, pBluescript_HSP60_Sonde1). Subsequent sequence analyses of the 
pBluescript_HSP10_Sonde clone (307 bp) and pBluescript_HSP60_Sonde1 (313 bp) confirmed 
the correctness of DNA insert and direction.  
Both clones (pBluescript_HSP10_Sonde clone and pBluescript_HSP60_Sonde1) were 
digested separately with the restriction enzymes Not I and Spe I and the inserts eluted from the gel 
and purified. 25 ng HSP10 probe and 25 ng HSP60 probe were each random prime-labelled. 
The filter-bound genomic DNA of S. ratti, was separately hybridised with the 
S. ratti HSP10 or the S. ratti HSP60 radioactively labelled probes. Hybridisations with both 
probes showed a 7 kb band with EcoRV-digested DNA, and a 5 kb band with HindIII-digested 
DNA (Figure 3.11). The detection of one common EcoRV and HindIII fragment suggests a 
cistronic arrangement as single copy genes.  
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 (A) EcoRV HindIII   (B) EcoRV HindIII 
              
Figure 3.11: Southern blot analyses of S. ratti genomic DNA 
DNA (10µg) was digested with EcoRV and HindIII, fractionated on 1% agarose gels, blotted to nylon membranes 
and separately hybridised to (A) a HSP10 probe or to (B) a HSP60 probe. Numbers on the right indicate fragment 
sizes in kb. 
 
 
3.8.2 S. ratti HSP10 and HSP60 gene analyses 
The Southern blot data suggested that the putative S. ratti HSP10 and HSP60 genes are 
located in a cistronic manner. To confirm this, PCR analyses were done. For amplification 1 µg 
S. ratti genomic DNA was used as template and HSP10_fl_for as well as HSP10_fl_rev as 
primers. A band of approximately 400 bp was detected on agarose gels and cloned into 
pGemTeasy. Sequence analysis showed a 372 bp DNA insert. Alignment with the putative S. ratti 
full-length HSP10 cDNA sequence revealed that the coding region shows 100% identity with the 
putative S. ratti full-length HSP10 cDNA sequence. Furthermore, alignment showed that the 
coding region is interrupted by one intron at position bp 27 to bp 69 with a length of 42 bp 
(Figure 3.12). 
 
atgcttctttccgctgttcgtagatgtgtaggttattttatttctatataaaattatatttctttttagtc 
atcagctcttaaaaatgttcaaccactttttgatcgtgttatgatcaaaaaagctgctgctgaagtaaaat 
ctaaaggaggtatttacattccagagaaagcccaaggaaaggttcttgaaggtactgttgttgctgctggt 
ccaggacttcgtactgaggatggtaaacttatacctttatcagttagtgttggagatcgtgttatgttgcc 
agagtatggtggaaataaagttgttatggatgatacagaatatttcatctatcgtgagtcagatctcatcg 
ccaaactcactaactaa 
 
Figure 3.12: S. ratti HSP10 genomic DNA sequence 
The intron (position 27 to position 69) is shaded grey. The translation initiation and termination codons are printed in 
bold. 
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To further investigate the gene location of HSP60 to HSP10, again, PCR was performed 
using 1 µg S. ratti genomic DNA as template and HSP60 and HSP60Stop_rev as primers. A 
product of approximately 1600 bp was obtained and cloned into pGemTeasy. Sequence analysis 
showed a 1600 bp DNA insert containing the HSP60 sequence. Alignment with the S. ratti full-
length HSP60 cDNA revealed a 100% identity and showed that the coding region is without 
intron (Figure 3.13). 
 
atgcttcgtcttgctgctcataatttttctaaatctattatcagatcatatgctaaagatcttaaatttgg 
agctgatggaagaaaggccatgcttgttggagtagatcttttagctgacgctgtatctgttacaatgggac 
caaaaggaagaaatgttattattgaacaaagttttggtggaccaaaaattacaaaagacggtgttaccgtt 
gctaaggctattgatctcgaagataaatatcaaaatatgggtgcaaaattggttcaagatgttgcagataa 
ggctaacgaacaagctggtgacggaacaacttgcgctactgttcttgccagagctattgctaaagaaggat 
ttgaaagtattagccgtggtgctaatccaattgaagttagaaaaggtgtcatgtcatccgttgaagctatt 
gttgaagagttaaagaagatgtcaaagcaagttacaactccagaagaaattgctcaagttgctactatttc 
tgctaatggagataaagatatcggaaaattgatatctgaagctatgaaaaaagttggaaataaaggtgtca 
ttaccgttaaggatggaaaaactcttgacgatgaattagaaattattgaaggaatgaaatttgaccgtgga 
tatatttctccatatttcatgaatacttccaagggtggaaaatgtttctttgaaaaatgtttagtccttct 
ttctgagaaaaaaatttcccaagttcaagatattgttccagctcttgaattagcaaataaatatcgtcaac 
cacttattattattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaacagattaaaggtt 
ggtcttcaagtttgtgctgtaaaagctcctggttttggagacaaccgcaaaaacacattgaaagatattgc 
cattgctacaggagctaaagtctttggagatgaatctaatttacacaaacttgaagatattcaagcaggtg 
actttggtgaagttgctgaagttacagttacaaaagatgatactcttatgcttaatggaaaaggtgatgct 
gaacaagttgagaagagaattcaacaaattgaatttgagattgaacaatctacttctgagtatgaaaaaga 
aaaacttaatgaacgtttagctaaattatcaaaaggtgttgctgtccttaaaattggaggtgcttctgaag 
ttgaagttagtgaaaagagagatcgtgtcacagatgcgctctgtgcaacacgtgctgctgtagaagaagga 
atcgtaccaggaggtggtgttgctcttcttcgtgctgtcaaagttcttgataacatcaaagtcggtaattc 
tgaccaagaattgggagttagaattgtccaaaaagccgttcgtcaaccaatttctaccattattaagaatg 
ctggacttgaaccagctagtatcgttgaaaaagtttatgcaaatgaatcagtcagtttcggttacgatgct 
ttgaatgataagtttgttgatatgatccaaactggtattattgatccaaccaaagttgtccgtacatcact 
tcaagacgctgctggtgttgcttcacttttagccactactgaatgtgttgttacagaagttccaaaagaaa 
ctccagcacctccaatgggtggtatgggaggtatgggcggaatgggtggtggaatgttctaa 
 
Figure 3.13: Putative S. ratti HSP60 genomic DNA sequence 
Putative S. ratti HSP60 genomic DNA sequence. The translation initiation and termination codons are printed in bold 
 
3.8.3 Analyses of the intergenic region of S. ratti 
To analyse the entire genomic structure of the two genes, PCR analysis was performed 
using 1 µg S. ratti genomic DNA as template and GSP_HSP60rev3’UTR and GSP_HSP10_330-
304for as primers. A PCR product of approximately 2500 bp was obtained and cloned into 
pGemTeasy. By sequencing, the entire genomic structure of the two genes covering 
approximately 2.5 kb was determined (GenBank accession no. FJ694974). This analysis 
demonstrated that the HSP10 and HSP60 genes are organised in a head-to-head orientation with a 
413 bp sequence separating the two ATG start codons (Figure 3.14). To confirm this sequence 
structure, 3 further PCRs with S. ratti genomic DNA were performed using a primer pair in the 
5’UTR HSP10 region (GWHSP10revnested) and in the HSP60 3’UT region (HSP60_3’UTR). 
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Sequence analyses confirmed the predicted structure. The intergenic sequence was analysed by 
Genomatix MatInspector (http://www.genomatix.de) on the basis of the transcription factor 
databank TRANSFEC (Quandt et al 1995; Heinemeyer et al 1999). Core and matrix similarities 
are the parameters used. The “core sequence” of a matrix is defined as the highest conserved 
positions of the matrix. The maximum core similarity of 1.0 is only reached when the highest 
conserved bases of a matrix matches exactly in the sequence. The matrix similarity is calculated 
as described in Cartharius et al 2005. Given that each sequence position corresponds to the 
highest conserved nucleotide at that position in the matrix, a perfect match to the matrix exists. 
This is valuated with a score of 1.0. Analysis revealed several putative promoter elements 
including heat shock element binding sites (HSEs), TATA-box binding sites and GATA element 
binding sites. All these binding sites indicate individual transcriptional functions. The putative 
S. ratti HSP60 promoter region shows two family matches with putative HSE at position bp 213-
237 and at position bp 285-309 with 1.00 core and 0.97 matrix similarity, respectively. Family 
matches with putative TATA-box binding sites are located at bp 33-48 with 0.75 core and 
0.81 matrix similarity. The putative S. ratti HSP60 promoter region also shows a putative GATA 
element binding site at bp 318-330 with 1.00 core- and matrix similarity. The S. ratti HSP10 
promoter region contains two putative HSEs at bp 213-237 and at bp 276-300 with 1.00 core and 
0.97 matrix similarity. A putative TATA-box binding site is located at bp 222-238 with 1.00 core 
and 0.91 matrix similarity. Furthermore, the entire intergenic region is AT-rich (88%), which is 
typical for regions of strong promoters (Maseda & Hoshino 1995). 
 
 
cattttttaaagttgtactgttaatatattcctaaaaatttaaatattaaacaaacttttaattgaaaaaa 
ttttcaaaaaaattataatttttaaaaactgaaaactaatttttataacgaaagtattaaagatatacttt 
aaattaaaataaattggaatagaataaacatttcttgctgcactattgcgaaatattaatataggaatttt 
cgcgaaatttctttaaaaaaaatctacaaattaataaattgctcctacaacgatagtagagacgatcttgt 
tgcagaatgttctagaatgacttttaagttatgatggtaatctgcggctcgtccatataacttagagatta 
ttttaattttaaattattttttaactaattgcaggttcttgtaattttggtaaatatg 
 
 
Figure 3.14: Intergenic region of HSP10 and HSP60 of S. ratti 
The S. ratti HSP10 start codon is shaded black and printed grey, the S. ratti HSP60 start codon is shaded grey. The 
5’upstream region of each gene is printed in bold. The remaining sequence comprises the intergenic region. Within 
this region, the black-shaded base pairs (bp) show family matches with the HSP10 TATA-box. The grey-marked bp 
show family matches with the HSP60 TATA-box.  
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Table 3.2: Overview of the SrHSP10 and SrHSP60 intergenic sequence analysis 
Heat shock elements 
binding site 
HSP60 upstream sequence 
bp 276-300 
aaagaaatttcgCGAAaattcctat 
Heat shock elements 
binding site 
HSP10 upstream sequence 
bp 213-237; bp 276-300 
taggaattttcgCGAAatttcttta 
TATA-box binding site HSP60 upstream sequence 
bp 33-48 
taatattTAAAttttta 
TATA-box binding site HSP10 upstream sequence 
bp 105-121 
ttcttTAAAaaaaatct 
AT-rich sequence HSP60 upstream sequence 
bp 37-51 
tttAATAtttaaatt 
Special AT-rich sequence  HSP10 upstream sequence 
bp 197-211 
attAATAtaggaatt 
GATA element binding 
site 
HSP60 upstream sequence 
bp 318-330 
cgcaGATTaccat 
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3.9 Characterisation of the S. ratti HSP10 and HSP60 as putative binding partners using 
two-hybrid approaches 
To investigate the putative binding of HSP10 to HSP60 and test whether S. ratti HSP10 
occurs as homo-dimers, mammalian and yeast two-hybrid assays were performed 
3.9.1 Mammalian two-hybrid analysis 
Co-chaperonin interaction with chaperonin is mediated by the co-chaperonin mobile loop 
that folds into a ß-hairpin conformation upon binding to the chaperonin. The ability of HSP10 to 
interact specifically with HSP60 lies within the mobile loop sequence (Richardson et al 2001). 
Since the mobile loop of the co-chaperonin mediates interaction with the chaperonin, it is 
probable that this specific mobile loop sequence is also important for HSP10-HSP10 or 
HSP10-HSP60 binding in S. ratti. Alignment analyses between the human and E. coli HSP10 
mobile loop sequences were performed, to identify the putative SrHSP10 mobile loop. To perform 
the mammalian two-hybrid analysis, the S. ratti HSP10 full-length and S. ratti HSP60 full-length 
cDNAs were cloned separately into the prey (pAct3) and bait (pBind) vectors. Furthermore, 
HSP10 fragments (HSP10a, HSP10b and HSP10c) surrounding the putative mobile loop sequence 
were chosen. To investigate the HSP60 binding capacity of S. ratti, different HSP60 cDNA 
fragments were chosen (HSP60-1_2, HSP60-4_6, HSP60-5_6, HSP60-1_6, HSP60-4-2). S. ratti 
HSP10 and HSP60 fragments were amplified separately by RT-PCR. For HSP10 full-length and 
HSP10 fragment amplifications, the linearised pGemTeasy_HSP10_FL clone served as template. 
The linearised pGemTeasy_HSP60_FL clone also served as template for the amplification of 
HSP60 full-length cDNA and HSP60 fragments. The resulting putative S. ratti HSP10 and HSP60 
PCR products were cloned into pGemTeasy. Sequence analyses confirmed their identity. 
Subsequently, the insert-containing plasmids were digested with the appropriate restriction 
enzymes and subcloned into the bait and prey vectors, respectively.  
To optimise transfection and expression, the S. ratti HSP10 and S. ratti HSP60 cDNAs were 
cloned separately into both bait and prey vectors, confirmed by restriction mapping and 
sequencing. To verify the protein expression, the translated Gal4 binding site of the bait vector 
served to perform a Western blot analysis. The analysis showed molecular weight bands 
consistent with the size deduced from the cDNA sequence of the S. ratti HSP10 and HSP60 
proteins and S. ratti HSP10 and HSP60 protein fragments. 
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Table 3.3: Overview of the mammalian two-hybrid bait (pBind) and prey (pAct3) vectors 
Vector name  Vector Description 
pBindSRHSP10fl Includes the full-length S. ratti HSP10 sequence.  
pAct3SRHSP10fl Includes full-length S. ratti HSP10 sequence.  
pAct3SRHSP10a Includes S. ratti cDNA HSP10 fragment ranging from bp 1 to bp 174.  
pAct3SRHSP10b Includes S. ratti cDNA HSP10 fragment ranging from bp 85 to 
bp 138. 
pAct3SRHSP10c Includes S. ratti cDNA HSP10 fragment ranging from bp 169 to 
bp 330.  
pBindHSP60fl Includes full-length S. ratti HSP60 sequence.  
pBindHSP60_1-6 Includes S. ratti cDNA HSP60 fragment ranging from bp 1 to bp 873.  
pBindHSP60_4-6 Includes S. ratti cDNA HSP60 fragment ranging from bp 625 to 
bp 873.  
pBindHSP60_5-6 Includes S. ratti cDNA HSP60 fragment ranging from bp 739 to 
bp 873. 
pBindHSP60_4-2 Includes S. ratti cDNA HSP60 fragment ranging from bp 625 to 
bp 1683. 
pAct3HSP60fl Includes full-length S. ratti HSP60 sequence.  
pAct3HSP60_1-2 Includes S. ratti cDNA HSP60 fragment ranging from bp 1to 
bp 1683. 
pAct3HSP60_4-6 Includes S. ratti cDNA HSP60 fragment ranging from bp 625 to 
bp 873. 
pAct3HSP60_4-2 Includes S. ratti cDNA HSP60 fragment ranging from bp 625 to 
bp 1683. 
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For control, the individual vectors, including the prey and bait cloning vector, were each 
transformed into N2a cells. Briefly, 24 h after transfection, luciferase activities were measured, 
and the values were compared with the basal binding activity of the bait and prey vectors, which 
was set to 1. pBind basic-vector/pAct3SRHSP10, pBind basic-vetor/pAct3SRHSP10a, pBind 
basic-vetor/pAct3SRHSP10b, and pBind basic-vetor/pAct3SRHSP10c displayed very low activity 
(1.02-fold, 0.87-fold, 0.94-fold and 0.80-fold respectively). pBind basic vectot/pAct3SRHSP60 
showed very low activity, too. 
In a second step, the direct binding activities of pBindSRHSP10fl full-length with the 
pAct3SRHSP60 full length, with the pAct3SRHSP10 full-length and with the pAct3SRHSP10 
fragments a, b and c respectively were tested. Furthermore, the direct binding activities between 
pBindSRHSP10fl and pAct3SRHSP60 fragments (1-2; 4-6; 5-6;4-2 respectively), and between 
the pBindHSP60fl and pActSRHSP60 (1-2; 4-6; 5-6;4-2 respectively) fragments were tested. 
Again, 24 h after transfection of N2a cells, luciferase activities were measured. A strong activity 
was detected after transfection of the pBindSRHSP10fl full-length and pAct3SRHPS10fl full-
length vectors (2.41-fold). No significant luciferase activities were observed after transfection of 
the pBindHSP10 full-length with the pAct3SRHSP60, or with the pAct3SRHSP10a, b and c 
constructs respectively (Figure 3.15). 
Furthermore, no significant luciferase binding activities were observed between the 
pBindSRHSP10 and pAct3SRHSP60 fragments (1-2; 4-6; 5-6;4-2 respectively), or between 
pBindSRHSP60fl and pAct3SRHSP60 fragments (1-2; 4-6; 5-6;4-2 respectively). 
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Figure 3.15: Luciferase binding assay 
Binding activities of the indicated constructs in N2a cells were determined by luciferase-based reporter gene assays. 
Luciferase activity is shown as fold activation beyond basal activation due to pBind and pACT binding control. The 
experiment was technically performed sevenfold and biologically repeated three times. 
 
3.9.2 Yeast two-hybrid analysis 
To confirm the binding results in an independent system, yeast two-hybrid analyses were 
performed. To this end S. ratti HSP10 full-length cDNA and the pertinent S. ratti HSP10 
fragments a, b and c were amplified separately with the appropriate primers and cloned into the 
pGemTeasy vector. Subsequently, the encoding sequences were subcloned to the appropriate 
yeast two-hybrid bait (pBridge) and prey (pAct2) vectors respectively. Sequence analyses 
confirmed the identity of the DNA inserts and the in-frame ligations. 
The pBridge S. ratti HSP60 full-length plasmids were obtained by BamHI and EcoRI 
digestion of the linearised pBindHSP60FL clone. The HSP60 DNA insert was subcloned into the 
pBridge vector. The pAct2 S. ratti HSP60 full-length plasmid was obtained by SmaI and EcoRI 
digestion of the linearised pBindHSP60FL clone. The resulting HSP60 DNA insert was subcloned 
into the pAct2 vector. 
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Table 3.4: Overview of the yeast two-hybrid bait (pBridge) and prey (pAct2) vectors 
Vector name  Vector Description 
pBridgeSRHSP10 Includes full-length S. ratti HSP10 sequence. 
pAct2SRHSP10fl Includes full-length S. ratti HSP10 sequence. 
pAct2SRHSP10a Includes S. ratti cDNA fragment ranging from bp 1 to bp 174. 
pAct2SRHSP10b Includes S. ratti cDNA fragment ranging from bp 85 to bp 138.  
pAct2SRHSP10c Includes S. ratti cDNA fragment ranging from bp 169 to bp 330. 
pAct2SRHSP10gen1 Includes ncoI and xbaI digested out of pCR2.1-pAct2_HSP10 plasmid. 
pAct2SRHSP10gen2 Includes bamHI and XhoI digested out of pCR2.1-pAct2_HSP10 
plasmid.  
pAct2SRHSP10gen3 Includes smaI and sacI digested out of pCR2.1-pAct2_HSP10 plasmid.  
pBridgeSRHSP60 Includes full-length S. ratti HSP60 sequence.  
pAct2SRHSP60 Includes full-length S. ratti HSP60 sequence. 
 
The pBridgeSRHSP10fl plasmid was co-transformed into yeast-AH109 cells with the 
pAct2HSP60, the pAct2SRHSP10fl plasmids, or the pAct2SRHSP10a, b and c plasmids 
respectively. The pBridgeSRHSP60 plasmid was co-transformed into yeast-AH109 cells with the 
pAct2SRHSP60 plasmid. These cells were selected on SD-Trp/-Leu/-His/-Ade-plates, a dropout 
media for growth and interaction selection, and incubated for 5 days at 30°C. Furthermore, the 
pBridgeSRHSP60 plasmid was co-transfected with the pAct2SRHSP60 plasmid into 
yeast-AH109 cells. Then, the cells were selected on SD-Trp/-Leu/-His/-Ade-plates and incubated 
for 5 days at 30°C. 
The β-galactosidase filter assay (Breeden & Nasmyth 1985) is a colorimetric control of 
clones that survived the HIS3-/ADE2-Selection. During interaction, the lacZ gene encodes the 
enzyme ß-galactosidase, and clones expressing this enzyme were identified by a blue-staining 
with the chromogenic substrate X-gal. For the quantification of the HSP10 two–hybrid 
interaction, a sensitive colorimetric method, the ß-galactodisase fluid assay (Yeast Protocols 
Handbook, 2001) was used. The ß-galactosidase fluid assay relies on the ability of the enzyme to 
catalyse the hydrolysis of ONPG (o-nitrophenyl-ß-D-galactopyranoside) to free o-nitrophenol, 
which absorbs light at 420 nm. Interactions were detected by performing the β-galactodisase filter 
and fluid assays, between the pBridgeSRHSP10fl protein and the pAct2SRHSP10fl protein 
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(Figure 3.16 A, B). Furthermore, the β-galactodisase filter assay showed an interaction between 
the pBridgeSRHSP10fl protein with the N-terminal pAct2SRHSP10a protein fragment including 
binding domain (Figure 3.16 C). The analysis was extended to investigate a possible interaction 
between the pBridgeSRHSP10fl protein and fragments more exactly defining the HSP10 binding 
domain. No further interactions were detected. The yeast two-hybrid assay showed no interaction 
between the pBridge2SRHSP60 protein and the pAct2SRHSP60 protein, and no interaction 
between the pBridgeSRHSP10 protein and the pAct2SRHSP60 protein. The yeast two-hybrid 
ß-galactosidase filter and fluid assay confirmed the mammalian two-hybrid analyses results 
(Figure 3.16 A, B). 
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Figure 3.16: Yeast two-hybrid protein-protein interaction analysis 
Yeast two-hybrid analyses of protein-protein interaction between S. ratti HSP10 full-length with S. ratti HSP10 full-
length and S. ratti HSP10 N- terminal. Representative interaction profiles between A: pBridgeSRHSP10fl and 
pAct2SRHSP10fl co-transfected yeast AH-109 cells. SD-Trp/-Leu/-His/-Ade-plates after 5 days incubation at 30°C (I) 
and the ß-galactosidase filter assay (II). B: Quantification of the binding strength by ß galactosidase fluid assays (n=6); 
C: pBridgeSRHSP10fl and pAct2SRHSP10a co-transfected yeast AH-109 cells. SD-Trp/-Leu/-His/-Ade-plates after 
5 days incubation at 30°C (I) and the ß-galactosidase filter assay (II). 
         HSP10pBridge                                 HSP10pAct2                         HSP10pBridge+HSP10pAct2 
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3.10 DNA immunisation with recombinantly expressed S. ratti HSP10 
To investigate the presumptive immunological role of S. ratti HSP10, sera of immunised 
rats were obtained and analysed by ELISA and by Western blot. For immunisation the S. ratti 
HSP10 protein was used which was recombinantly expressed in E. coli. 
To generate recombinant S. ratti HSP10, PCR was performed using the linearised 
pGemTeasy_HSP10_FL clone as template, HSP10pJC45 and HSP10pJC45rev as primers. The 
amplicon was cloned into pGemTeasy (pGemTeasy_HSP10_FL_Nde/EcoRI). Sequence analyses 
revealed the identity of the pGemTeasy_HSP10_FL_Nde/EcoRI clone. 3 µg plasmid DNA was 
digested with the appropriate amount of the restriction enzymes NdeI and EcoRI and subsequently 
subcloned into the expression vector pJC45 (Clos and Brandau 1994). Further sequence analyses 
confirmed the in-frame cloning of the DNA insert and affirmed the identity of the sequence. 
The histidine tag of the expression vector pJC45 allows the easy purification of recombinant 
proteins from E. coli. Expression was induced by IPTG. Bacteria were pelleted, the protein 
extracted and analysed by SDS-PAGE and immunoblot analysis. Histidine tag antibodies 
recognised bands at the expected molecular weight of 10 kDa (Figure 3.17). 
6 Wistar rats were immunised with 40 µg S. ratti HSP10 protein at 10 weeks of age, and 
boosted with another 40 µg of protein 16 days after prime immunisation. Sera were obtained 16 
days post prime immunisation and 19 days post boost immunisation, respectively. Sera of 6 
non-immunised Wistar rats (16 days post prime immunisation and 19 days post boost) served as 
negative control. In Western blots, the serum of the immunised rats not only recognised 
rSr-HSP10, but also the native Sr-HSP10 in the extracts of iL3 (Figure 3.17). 
For the ELISA analysis, 2 µg S. ratti HSP10 recombinantly expressed protein was applied 
as antigen. The 50µl sera from the 6 pre immunised, post primed and post boosted rats, 
respectively, were tested in different dilutions starting from 1:100 up to 1:20,480 in comparison to 
6 sera from non-immunised rats.  
Post-prime and post-boost sera showed production of high levels of specific IgG antibody 
detectable at high serum dilutions by ELISA (Figure 3.18) as well as by Western blot analyses 
(Figure 3.17). Significantly higher IgG reactivities were found for the post boost sera compared to 
the post prime sera. The pre-immunised sera and the negative control group sera showed no IgG 
reactivity. 
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Figure 3.17: Western blots of recombinant SrHsp10 
In the Western blot, high titre SrHsp10-specific rat immune serum recognised rSrHsp10 and detected SrHsp10 in 
whole worm extract of S. ratti iL3. Lanes A-D show rSrHsp10 protein, lanes E-H show detection of SrHsp10 in S. ratti 
iL3 extract. Lanes A and E: incubation with serum of the non immunised rats (1:50), all other lanes: incubation with 
immune serum taken day 14 post boost. Dilutions: lanes B and F = 1:50, lanes C and G = 1:1000, lanes D and H = 
1:1x104.  
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Figure 3.18: Humoral response to recombinant SrHSP10 
Humoral response to recombinant SrHSP10 after rat immunisation with recombinantly expressed SrHSP10 protein. 
The mean serum concentration of 6 serum samples of parasite-specific IgG in boosted (arrowed line) and primed 
(dotted line) rats, respectively. The extinction is measured in different serum dilutions (1 : 100; 1 : 200; 1 : 400; 
1 : 800, 1 :1,2800: 1 : 3,200, 1 : 6,400, 1 : 12,800, 1 : 25,600, 1 . 51,200, 1 : 102,400, 1 : 204,800). 
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3.11 Putative S. ratti HSP60 expression in E. coli 
In addition to its essential role as chaperonin, HSP60 has received much attention as a 
dominant cross-reactive antigen, and it has been implicated in the pathogenesis of autoimmune 
diseases (Young 1990, Kaufmann 1992). HSP60 proteins from several microorganisms, including 
human pathogens such as Mycobacterium tuberculosis, elicit a strong and dominant immune 
response in their mammalian hosts (Zugel & Kaufmann 1999a; Shinnick et al 1988). To 
investigate the immunological importance of S. ratti HSP60 protein by ELISA, an attempt to 
express S. ratti HSP60 full-length protein in E. coli was carried out. The open reading frame of 
the HSP60 gene was amplified using the linearised pGemTeasy_HSP60_FL clone as template and 
pJC45HSP60_HindIII and pJC45HSP60_BamHI primers. The PCR product was cloned into 
pGemTeasy. Sequence analysis confirmed the identity of the DNA insert. Subsequently, the 
pGemTeasy_HSP60 clone was HindIII and BamHI digested, and subcloned into the bacterial 
expression vector pJC45 (pJC45_HSP60), a derivative of the pJC40 (Clos and Brandau 1994). 
The vector allows expression of proteins and carries a 10-residue histidine tag for recognition by 
histidine tag antibodies. E. coli was grown and expression was induced by IPTG. Bacteria were 
pelleted, the protein extracted and analysed by SDS-PAGE and immunoblot analysis. Histidine 
tag antibodies did not recognise bacterial protein. 
To further try to induce bacterial expression, an HSP60 version without the mitochondrial 
leading sequence (atgcttcgtcttgctgctcataatttttctaaatctattatcagatcatat) was cloned into pGemTeasy 
(pGemTeasy_HSP60-52). After sequence confirmation, the HSP60 DNA insert was subcloned 
into the bacterial expression vector pJC45 (pJC45_HSP60-52). To verify the expression, SDS-
PAGE and immunoblot analyses were carried out. Again, histidine tag antibodies did not 
recognise a recombinant protein.  
Attempts to express SrHSP60 recombinantly failed, which was probably due to S. ratti 
HSP60 endotoxicity. Further approaches that may provide a successful expression of SrHSP60 
could be the use of the baculovirus expression system, or to explore the feasibility of expressing 
recombinant SrHSP60 peptides on both the E. coli- and the baculovirus expression systems. 
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3.12 Putative S. ratti HSP10 expression in the baculovirus system 
While high levels of expression in bacterial systems are common, problems of proper 
folding and lack of post-translational processing may produce functionally inactive molecules. As 
with other eukaryotic expression systems, baculovirus expression of heterologous genes permits 
folding, post-translational modification and oligomerisation in manners that are often identical to 
those that occur in mammalian cells. The insect cytoplasmic environment allows proper folding 
and S-S bond formation, unlike the reducing environment of the E. coli cytoplasm. Post-
translational processing identical to that of mammalian cells has been reported for many proteins 
(O'Reilly et al 1992). Here, the flashBAC baculovirus expression system was tested to express the 
S. ratti HSP10. To generate a HSP10 expression clone PCR was performed using the linearised 
pGemTeasy_HSP10_FL clone as template, and pAcSG2_HSP10EcoRIfor as well as 
pAcSG2_HSP10NotIrev as primers. The reverse primer contained a 42 bp flag-tag residue. The 
amplicon was cloned into pGemTeasy (pGemTeasy_pACSG2_HSP10). Sequence analyses 
revealed the identity of the pGemTeasy_pACSG2_HSP10 clone. The plasmid was digested with 
the appropriate amount of the restriction enzymes NdeI and EcoRI, and the insert subsequently 
subcloned into the transfer vector pAcSG2 (Oxford expression technologies, flashbackTM 
System). Further sequence analyses confirmed the in-frame cloning of the DNA insert and 
affirmed the correctness of the sequence. The S. ratti HSP10 gene was cloned into the transfer 
vector pAcSG2. The pAcSG2 vector contains sequences that flank the polyhedron gene in the 
virus genome. The virus genome and the pAcSG2HSP10 vector were introduced into the host 
insect cells, which were incubated for 5 days at 28°C before harvesting. To upscale the amount of 
recombinant virus, the suspension cultures of cells were passaged. The passaging was performed 
twice. The suspension cultures were stored cell free at -70°C. The cells were harvested and stored 
at -20°C until use. To verify the expression success, the harvested cells were analysed by Western 
blot. Flag tag antibodies recognised bands at the expected molecular weight of the expressed 
S. ratti HSP10 protein. The basis has been provided to express SrHSP10 recombinantly using the 
baculovirus expression. Further studies are needed to verify if the baculovirus expression system 
is more convenient in comparison to the E. coli expression. 
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4 Discussion 
4.1 Identification of SrHSP10 and SrHSP60 
Drug resistance in parasites of livestock is reaching alarming levels and is consequently 
becoming an issue of growing importance in animal health and well-being. This phenomenon also 
affects humans, particularly with respect to mass drug administration programmes, which exert 
selective pressure on parasitic populations. 
An estimated 100-200 million people are infected with Strongyloides stercoralis 
(S. stercoralis, threadworm) (Viney 2006; Viney et al 2007). Recent reports indicate an increasing 
prevalence of strongyloidiasis and its hyperinfection syndrome, which was evaluated as an 
emerging global infectious disease that has migrated from developing regions to industrialised 
areas (Marcos et al 2008). S. stercoralis is unique in its ability to replicate and multiplicate within 
the human host. Cycles of auto-infection lead to chronic disease that can persist for several 
decades in dangerous disseminated infections, in most cases with a fatal outcome (≥87%) (Keiser 
& Nutman 2004). Furthermore, in comparison to soil-living nematodes, parasitic nematodes such 
as S. stercoralis possess additional genes (Viney 2006).  
To better understand the parasite-host relationship, the study of host defence-modulating 
molecules in parasitic systems may likely reveal new principles of their function. Intensive study 
of immune functions of HSPs within the last years clearly demonstrated that they possess immune 
stimulatory potential. It is well established that HSPs participate in the initiation of adaptive 
immune response by chaperoning peptide antigens for cross-presentation. Moreover, it is now 
emerging that HSPs bind bacterial endotoxins and modulate PAMP-induced stimulation, while, 
on the other hand, there are several hints arguing for an intrinsic immune stimulatory function of 
HSPs that cannot be ascribed to bacterial contaminants (Osterloh & Breloer 2008). HSP10 may 
not only be a component of the folding machinery but also an active player of the cell signalling 
network, influencing cell cycle, nucleocytoplasmic transport, and may be involved in cancer 
ethiology as well as in the inhibition of apoptosis (Czarnecka et al 2006). HSP60, was shown to 
induce the activation of NFκВ (Vabulas et al 2001), and MyD88 and TRAF6 were found to be 
involved in HSP-mediated APC stimulation (Vabulas et al 2001). Furthermore, TLR2 and TLR4 
were identified to be responsible for HSP60 activation. Expression of TLR2 or TLR4 together 
with MD2, which is also part of the TLR4 receptor complex (Takeda & Akira 2004), in otherwise 
non-responsive human cell lines conferred responsiveness to HSP60 as indicated by activation of 
NFκВ-controlled reporter genes (Vabulas et al 2001). Moreover, APC derived from C3H/HeJ 
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mice expressing a nonfunctional mutant TLR4 receptor failed to respond to HSP60 (Ohashi et al 
2000; Flohe et al 2003).  
The objective of this study was to identify, isolate and characterise S. ratti HSP10 
(SrHSP10) and HSP60 (SrHSP60). S. ratti was used as a model for the human pathogen 
S. stercoralis, because S. ratti is not infectious for humans and, in addition, both nematodes share 
almost identical life cycles. 
Initially, we detected SrHSP10 and SrHSP60 in supernatants of all stages of S. ratti by mass 
spectrometry. Supernatants were devoid of proteins when the S. ratti stages were exposed to the 
protein-synthesis inhibitor cycloheximide or to azide, confirming the secretion of Strongyloides 
proteins including HSPs. Based on the knowledge that HSP10 and HSP60 play not only 
intracellular roles as chaperones to prevent the aggregation of proteins or to activate the 
renaturation of unfolded proteins, it is tempting to speculate that these HSPs also exhibit 
extracellular roles in parasite-host interaction such as influencing immune responses of the host. A 
similar role for a HSP was suggested for the small heat shock protein 12.6 from B. malayi, which 
functions as a human IL-10 receptor-binding protein (Gnanasekar et al 2008). On the other hand, 
HSP60 is able to bind to LPS and enhance the LPS-stimulated TNFα production in macrophages 
such as human HSP60 (Habich et al 2005).  
4.2 Characterisation of SrHSP10 and SrHSP60 
The genomes of S. ratti and S. stercoralis have been subjected to expressed sequence tag 
(EST) analyses. Some 14,000 and 11,000 ESTs from both parasites have been discovered, 
representing more than 4,000 genes and about 20% of the nematodes’ genomes (Thompson et al 
2005; Viney 2006; Lok 2007). In the absence of sequence information for SrHSP10 and 
SrHSP60, nucleotide searches for allied S. stercoralis HSP10 ESTs were performed and resulted 
in the designated S. stercoralis HSP10-like EST (GenBank accession number BE580000). For 
HSP60, the data entry in the library Nematode.net for S. ratti showed a 1078 bp sequence 
comprising 5 overlapping EST sequences. These EST sequences were used to construct one 
contig. By using specific primers putative cDNA fragments of S. ratti (SrHSP10, SrHSP60) were 
amplified. To gain the full-length sequences, 3’RACE and spliced leader (SL)-RT-PCRs were 
performed. SLs have been identified in a variety of eukaryotes including nematodes (Krause and 
Hirsh 1987). SL1 (a non-coding 22-nucleotide sequence used in this study) was the first SL 
sequence identified in nematodes (Krause and Hirsh 1987; Bektesh et al. 1988). One-fifth of the 
genes of, for example, C. elegans are organised as sets from 2-8 genes expressed from the same 
promoter, similar to bacterial “operons”. The pre-mRNAs made from these operons are processed 
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by an intermolecular ligation process involving SL-sequences which is called SL trans-splicing 
(Guiliano and Blaxter 2006). Therefore, it was speculated that the HSP genes of S. ratti may 
posses SL-sequences in their 5’UTRs. Indeed, sequence analyses of the obtained and cloned 
RT-PCR products confirmed the presence of SL-sequences as well as the identity of the 
full-length SrHSP10 and SrHSP60 sequence. The full-length SrHSP10 cDNA comprised 507 bp. 
Alignment results showed that the cDNA of SrHSP10 has significant homology (87%) to the 
cDNA of the S. stercoralis HSP10 EST. An additional nucleotide alignment analysis showed that 
SrHSP10 is 60% identical with the HSP10 homologue of C. elegans and 57% with the HSP10 
homologue of Homo sapiens. The open reading frame (ORF) comprised 330 bp and codes for 110 
amino acid residues. Having a predicted molecular mass of 11.8 kDa, SrHSP10 belongs to the 
group of small heat shock proteins (sHSP) which constitutes a diverse family of proteins ranging 
from 12-43 kDa proteins found in several organisms (Ingolia & Craig 1982; Yeh et al 1994). 
SrHSP10 mainly consists of hydrophilic amino acids with short hydrophobic N- and C- terminal 
peptides. However, the SrHSP10 ORF is predicted to have a mitochondrial targeting peptide 
(AA 1-30, iPSORT prediction), and its N-terminal sequence has the ability to form an 
amphipathic alpha helix, which may enable it to cross the mitochondrial membrane. Amino-acid 
alignment analyses showed that SrHSP10 has a very high homology (93%) to HSP10 of the 
human pathogen S. stercoralis, with the exception of eight amino acid exchanges, of which four 
are conserved. In addition, SrHSP10 shows similarity to HSP10 of other nematodes including 
C. elegans (63% identity) and Brugia malayi (57% identity). SrHSP10 has a low homology to 
B. malayi 12.6 (19%), however a more pronounced homology to the purified amino acid sequence 
of the human early pregnancy factor (EPF) (<40%). The first nonfolding HSP10 activity to be 
identified was similar to that of EPF (Summers et al 1998), which was finally shown to be an 
extracellular homologue of HSP10 (Summer et al 1996, Morton 1998). This suggests the 
existence of a further immunoregulative HSP within the group of sHSPs. 
The full-length SrHSP60 cDNA is 1914 bp in size. The HSP60 gene promoter is 
characterised by the absence of a classical TATAA box, and by the presence of a single heat 
shock response element (HSE), nGAAn. Here, the HSE is located 25 bp upstream of the start 
codon (ATG). Promoters of other heat shock protein genes frequently contain several HSEs (Xiao 
& Lis 1988; Amin et al 1988). Furthermore, the cDNA sequence contains the canonical 
chaperonin 60 signature (AAAVEEGIVPGGG; ProSite document PS00296 1997). The ORF, 
comprising 1695 bp, codes for 565 amino acid residues. There is a majority of A-T bases (67%) 
within the ORF, of which 75% are in the 5’UTR and 80% in the 3’UTR. The resulting SrHSP60 
protein has a predicted molecular mass of 64 kDa, a typical size for HSP60 orthologues or 
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homologues (Hemmingsen et al 1988; Jindla et al 1989; Lund 1995). A putative mitochondrial 
targeting sequence with 25 amino acid residues was identified in the N-terminal region. BLAST P 
analysis revealed high sequence similarity with HSP60 proteins from O. volvulus (72.5%), 
B. malayi (72%) and the human pathogen S. stercoralis (94%). 
Using in situ hybridisation (ISH) analyses, SrHSP10 and SrSHP60 transcripts were 
localised in S. ratti iL3. A pattern of SrHSP10 and SrHSP60 transcription was detected in the 
subcuticular and pharyngeal tract tissues. This ubiquitous staining under non-stressed conditions 
indicates additional biological roles to the originally known co-chaperone functions under stress 
conditions. Although there is evidence for secretion, it remains unclear how SrHSP10 and 
SrHSP60 proteins are transported. In filarid nematodes, such as O. volvulus, the existence of a 
system capable of efficiently transporting proteins to the cuticle of the nematode body has been 
hypothesised (McKerrow et al 1999). Based upon immunolocalisation, a more definite 
localisation of the molecules within tissues could be performed to obtain additional information 
for excretory/secretory pathways. This could be the subject of further studies. 
4.3 Characterisation of SrHSP10 and SrHSP60 genes 
Although HSP proteins are well studied, the regulatory features of their coding genes have 
not yet been characterised in detail. To determine the genomic arrangement of the putative 
SrHSP10 and SrHSP60 genes, a Southern blot analysis was carried out with S. ratti genomic 
DNA. Both the SrHSP10 probe and the SrHSP60 probe hybridisations showed two similar bands 
with EcoRV-digested DNA, and hybridisation with the HindIII-digested S. ratti genomic DNA 
showed one 5 kb band in each case. The detection of one fragment suggested a single-copy 
tandem arrangement of both genes. Head-to-head gene arrangements have previously been 
defined as "bidirectional", and the divergent gene pairs have been termed as "bidirectional genes". 
A "bidirectional gene pair" is defined as two adjacent genes, which are located on opposite strands 
of DNA with transcription start sites (TSSs) not more than 1000 base pairs apart. The intergenic 
region between two TSSs is designated as a putative "bidirectional promoter" (Adachi & Lieber 
2002; Trinklein et al 2004). However, it is not clear whether this region has regulatory activity, or 
is enriched of regulatory elements, which are essential for initiation of transcription. 
The postulated "bidirectional" structure of the SrHSP10 and SrHSP60 genes, covering 
approximately 2.5 kb, was confirmed by PCR, amplification, cloning and sequencing. Alignment 
analyses revealed that the SrHSP10 gene is interrupted by one intron (position bp 27 to bp 69) 
with a length of 42 bp. In contrast, the SrHSP60 gene is without an intron. In addition, the 
SrHSP10 and SrHSP60 genes are found to be linked in a head-to-head configuration. The 
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intergenic region comprises 413 bp separating the two ATG start codons. This sequence was 
mapped and analysed in silico. Heat shock elements (HSEs)- and TATA-box factor binding-sites 
have been identified in the intergenic region. The binding to the TATA box is crucial for 
transcription initiation. HSEs are functionally conserved from yeasts to humans, consisting of 
tandem inverted repeats of the short consensus sequence 5_-nGAAn-3 (Xiao et al 1991; Wu 1995; 
Liu et al 1997). HSE sequences confer strong heat-inducibility on heterologous promoters, and 
can act both as TATA-proximal elements and as enhancer (Pelham 1982; Pelham & Bienz 1982; 
Bienz & Pelham 1986). In addition, HSEs are required for promoter activation (Jakobsen and 
Pelham 1988). In eukaryotes, the transcription of heat-shock genes is mediated by HSEs found in 
multiple copies in the promoter regions of heat-shock genes (reviewed by Bienz & Pelham 1987). 
Heat shock transcription factors (HSFs) bind to HSEs, and it has been demonstrated in 
target-deletion studies of the stress-responsive mouse HSF1 gene that it is essential for both basal 
and stress activation of, for example, HSP, gene expression and inflammatory response 
(Christians et al 2002; Xiao et al 1999). The regulatory activity of the SrHSP10 and SrHSP60 
promoter region and, especially the putative HSEs activation under control or stressed conditions, 
remain to be clarified. 
Individual examples of bidirectional gene pairs have been reported for years, and a few 
genome-wide analyses have been studied in mammalian and human genomes (Lennard & Fried 
1991; Brayton et al 1994; Adachi et al 2002; Trinklein et al 2004). "Head-to-head" gene 
organisations also occur in plants. Furthermore, the bidirectional gene pairs are more correlated in 
expression and are associated functionally, which confirms that this structure is prevalent in the 
plant genome (Wang et al 2009). However, neither individual examples of bidirectional gene 
pairs, nor genome-wide analyses for bidirectional genes of nematodes have been performed 
(Figure 4.1). Thus, the S. ratti HSP10 and HSP60 gene pair shows a probability of being 
coordinately regulated and functionally associated, which would be consistent with results in 
mammalians (Trinklein et al 2004). 
 
 
Discussion 
 
94 
 
 
 
Figure 4.1: Diagram of the genomic organisation of HSP10 and HSP60 genes of different species 
 
H. sapiens, C. elegans, S. ratti or O. volvulus Wolbachia HSP10 and HSP60 exons are printed in blue; the intergenic 
region is printed in yellow. The HSP10 and HSP60 transcription start sites are marked by arrows. With the exception 
of bacteria, all genes are arranged in a tandem head-to-head configuration, of which the H. sapiens bidirectional nature 
has been analysed and verified (Hansen et al 2003). 
4.4 Characterisation of SrHSP10 and SrHSP60 as binding partners 
In mammalian systems, HSP10 and HSP60 are known to be vital in the protein folding 
machinery (Fink 1999). Both HSP60 and HSP10 have essential functions in promoting the 
ATP-dependent folding of proteins, under normal growth conditions or under stress. Furthermore, 
the binding between HSP10 and HSP60 is essential for providing a folding compartment (Hartl 
1995). In bacteria, HSP60 also requires a co-chaperonin HSP10 for full function. The binding of 
HSP10 to HSP60 leads to substantial changes in the hydrophobic nature of the cavity. An 
unfolded substrate protein binds to the relatively hydrophobic cavity lining before HSP10, which 
is then required for productive polypeptide release (Fink 1999). To date, strong HSP10-HSP10 
and HSP10-HSP60 interactions were detected between the E. coli homologues GroES/GroES, and 
between the human HSP10 and HSP60, respectively, by yeast two-hybrid assays (Lee et al 2002). 
As approaches to investigate the interaction of SrHSP10-SrHSP60, mammalian and yeast 
two-hybrid assays were performed in this study. However, no binding was detected between 
SrHSP10 and SrHSP60 or between SrHSP60 and SrHSP60. Interestingly, HSP10 showed a 
dimerisation potential in the mammalian two-hybrid system, which was confirmed in the yeast 
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two-hybrid assays. A detailed analysis of HSP10 dimerisation revealed a potential HSP10 binding 
domain (AAEVKSKGGIYIPEKAQGPEKAQG). Many organisms share similar motifs in HSP10 
as conserved protein-protein interactions sites (Richardson et al 2001). Several SrHSP10 
fragments surrounding the potential SrHSP10 binding domain were examined. Here, the yeast 
two-hybrid analysis revealed that the N-terminus including the binding domain hybridised with 
the full length SrHSP10, whereas the C-terminus did not show any binding activity. This 
dimerisation of SrHSP10 may be a further indicator of additional, SrHSP60-independent 
functions. 
One explanation of the failure to detect SrHSP10-SrHSP60 interaction may be the lack of 
target proteins to be folded. To date, HSP10-HSP60 interactions in a yeast two-hybrid assay were 
only demonstrated during protein folding activities (Lee et al 2002).  
4.5 The immunological role of SrHSP10 
Since an immunological role of HSP10 protein has been demonstrated in other systems 
(Akyol et al 2006), and since HSP10 was detected in supernatants of worms and larvae, indicating 
its secretion as a factor putatively involved in parasite-host interaction, the immunological 
potential was investigated. To this end, HSP10 was recombinantly expressed in E. coli and used 
for immunisation studies. Rats were immunised with recombinant SrHSP10, and the serum 
analysed by ELISA and Western blot. A 12 kDa protein in S. ratti infective larvae extracts was 
recognised, representing the predicted molecular mass of the amino acid sequence. The high 
immunogenicity of SrHSP10 was demonstrated by a very strong reactivity of serum IgG with the 
recombinantly expressed SrHSP10 showing a titer >1:10,000 as compared to a very weak 
reactivity of the pre-immune serum. 
These results manifest the expression of HSP10 during an infection process when host and 
parasite interact. This suggests that S. ratti may also secrete SrHSP10 in the host, and confirms 
that SrHSP10 found in the S. ratti supernatant is no in vitro artefact. Furthermore, these findings 
suggest a role of SrHSP10 during parasite-host interaction. 
B. malayi infects humans and lives in the lymphatics, successfully evading host immune 
responses (Blaxter et al 1992; Behnke et al 1992). Many hypotheses have been put forward for 
the parasite's successful establishment and longevity in the mammalian host (Maizels et al 1993); 
among these are the production of parasite-encoded products that mimic host regulatory factors 
(Maizels et al 2001a; Maizels et al 2001b). In B. malayi, recombinant BmHSP12.6 bound to 
human IL10R in a dose-dependent fashion and inhibited the binding of human IL10 to human 
IL10R in vitro. SrHSP10 may also have the capacity to bind to human IL10R, blocking the 
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binding of human IL10R. To corroborate these assumptions, further immunological studies are 
needed to clarify a possible binding of the SrHSP10 to host immune cells and to elucidate 
subsequently how SrHSP10 might mediate its effect. In addition, immunofluorescence and 
electron microscopic localisation studies should be performed to obtain more detailed information 
of the SrHSP10 expression. 
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4.6 Outlook 
The data presented in this study provide a molecular basis for further studies on SrHSP10 
and SrHSP60, including immunological investigations. Furthermore, the high homology of 
SrHSP10 and SrHSP60 with S. stercoralis HSP10 and S. stercoralis HSP60, respectively, 
suggests that there is a potential for continued studies of both proteins, also in the human host. 
The fact that SrHSP10 and SrHSP60 may function not only as chaperones but also in immune 
modulation promotes them as potential targets for candidate vaccination approaches or 
chemotherapeutic approaches for nematode control.  
Moreover, there is substantial evidence from animal models of human diseases which 
support the hypothesis that infection with helminths can suppress the development of other 
maladies. The hygiene hypothesis suggests an inverse relationship between the incidence of 
parasitic infections and, for example, chronic inflammatory bowel diseases (IBD). It remains to be 
elucidated, whether SrHSP10, being highly immunogenic, and SrHSP60 may also have 
therapeutic potential.
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5 Summary 
S. stercoralis and S. ratti are intestinal parasitic nematodes infecting humans and rats. Both 
nematodes present extraordinary life cycles, comprising a free-living generation in addition to 
parasitic stages. To better understand the parasite-host relationship, the study of host 
defence-modulating molecules in parasitic systems may likely reveal new principles of their 
function. In search of such molecules, we performed mass spectrometry to identify 
excretory/secretory products of S. ratti. Among others, homologues of the heat shock proteins 
HSP10 and HSP60 (SrHSP10, SrHSP60) were detected. Intensive study of immune functions of 
HSP10 and HSP60 within the last years clearly demonstrated that they possess immune 
stimulatory potential and hence suggest additional roles to their protein folding function in 
parasite biology. To characterise SrHSP10 and SrHSP60, their full-length cDNA were cloned, the 
genomic organisation analysed, their presumptive role as interaction partners investigated, their 
tissue-specific transcription studied, and SrHSP10 was expressed for antibody production. Based 
up on these results, the protective potential of SrHSP10 was investigated by immunological 
studies. The SrHSP10 cDNA contains an open reading frame of 330 bp, encoding a polypeptide 
of 110 amino acids with an approximate molecular weight of 10 kDa. The resulting full length 
SrHSP60 cDNA is 1914 bp in size. The deduced amino acid sequence has a predicted molecular 
mass of 64 kDa. Both proteins exhibit high homology to that of the human pathogen 
S. stercoralis. The analysis of the genomic organisation of the SrHSP10 and SrHSP60 locus 
revealed that the genes are linked in a head-to-head configuration by a bidirectional promoter. 
Mammalian and yeast two-hybrid assays correspondingly showed dimerisation of SrHSP10. In 
situ hybridisation results demonstrated SrHSP10 transcription in the complete gut area. 
Immunisation experiments, finally, revealed a high immunogenicity of SrHSP10 and provided 
evidence for a strong protective effect in S. ratti-infected rats. 
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6 Appendix 
6.1 Mammalian and yeast two-hybrid SrHSP60 bait-constructs 
The cDNA sequences of the mammalian and yeast two-hybrid SrHSP60 are shown below, the base 
pair length is bracketed. Start and stop codons are printed in bold. 
 
6.1.1 SrHSP60 cDNA sequences of the mammalian two-hybrid bait-constructs 
pBindHSP60fl: SrHSP60 cDNA full length cDNA sequence (1695 bp) 
atgcttcgtcttgctgctcataatttttctaaatctattatcagatcatatgctaaagatcttaaatttggagctgatg
gaagaaaggccatgcttgttggagtagatcttttagctgacgctgtatctgttacaatgggaccaaaaggaagaaatgt
tattattgaacaaagttttggtggaccaaaaattacaaaagacggtgttaccgttgctaaggctattgatctcgaagat
aaatatcaaaatatgggtgcaaaattggttcaagatgttgcagataaggctaacgaacaagctggtgacggaacaactt
gcgctactgttcttgccagagctattgctaaagaaggatttgaaagtattagccgtggtgctaatccaattgaagttag
aaaaggtgtcatgtcatccgttgaagctattgttgaagagttaaagaagatgtcaaagcaagttacaactccagaagaa
attgctcaagttgctactatttctgctaatggagataaagatatcggaaaattgatatctgaagctatgaaaaaagttg
gaaataaaggtgtcattaccgttaaggatggaaaaactcttgacgatgaattagaaattattgaaggaatgaaatttga
ccgtggatatatttctccatatttcatgaatacttccaagggtggaaaatgtttctttgaaaaatgtttagtccttctt
tctgagaaaaaaatttcccaagttcaagatattgttccagctcttgaattagcaaataaatatcgtcaaccacttatta
ttattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaacagattaaaggttggtcttcaagtttgtgc
tgtaaaagctcctggttttggagacaaccgcaaaaacacattgaaagatattgccattgctacaggagctaaagtcttt
ggagatgaatctaatttacacaaacttgaagatattcaagcaggtgactttggtgaagttgctgaagttacagttacaa
aagatgatactcttatgcttaatggaaaaggtgatgctgaacaagttgagaagagaattcaacaaattgaatttgagat
tgaacaatctacttctgagtatgaaaaagaaaaacttaatgaacgtttagctaaattatcaaaaggtgttgctgtcctt
aaaattggaggtgcttctgaagttgaagttagtgaaaagagagatcgtgtcacagatgcgctctgtgcaacacgtgctg
ctgtagaagaaggaatcgtaccaggaggtggtgttgctcttcttcgtgctgtcaaagttcttgataacatcaaagtcgg
taattctgaccaagaattgggagttagaattgtccaaaaagccgttcgtcaaccaatttctaccattattaagaatgct
ggacttgaaccagctagtatcgttgaaaaagtttatgcaaatgaatcagtcagtttcggttacgatgctttgaatgata
agtttgttgatatgatccaaactggtattattgatccaaccaaagttgtccgtacatcacttcaagacgctgctggtgt
tgcttcacttttagccactactgaatgtgttgttacagaagttccaaaagaaactccagcacctccaatgggtggtatg
ggaggtatgggcggaatgggtggtggaatgttctaa 
 
pBindHSP60_1-6: SrHSP60 cDNA fragment (bp 1 to bp 873) 
atgcttcgtcttgctgctcataatttttctaaatctattatcagatcatatgctaaagatcttaaatttggagctgatg
gaagaaaggccatgcttgttggagtagatcttttagctgacgctgtatctgttacaatgggaccaaaaggaagaaatgt
tattattgaacaaagttttggtggaccaaaaattacaaaagacggtgttaccgttgctaaggctattgatctcgaagat
aaatatcaaaatatgggtgcaaaattggttcaagatgttgcagataaggctaacgaacaagctggtgacggaacaactt
gcgctactgttcttgccagagctattgctaaagaaggatttgaaagtattagccgtggtgctaatccaattgaagttag
aaaaggtgtcatgtcatccgttgaagctattgttgaagagttaaagaagatgtcaaagcaagttacaactccagaagaa
attgctcaagttgctactatttctgctaatggagataaagatatcggaaaattgatatctgaagctatgaaaaaagttg
gaaataaaggtgtcattaccgttaaggatggaaaaactcttgacgatgaattagaaattattgaaggaatgaaatttga
ccgtggatatatttctccatatttcatgaatacttccaagggtggaaaatgtttctttgaaaaatgtttagtccttctt
tctgagaaaaaaatttcccaagttcaagatattgttccagctcttgaattagcaaataaatatcgtcaaccacttatta
ttattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaacagattaaaggttggtcttcaagtttgtgc
tgta 
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pBindHSP60_4-6: SrHSP60 cDNA fragment (bp 625 to bp 873) 
gaaatttgaccgtggatatatttctccatatttcatgaatacttccaagggtggaaaatgtttctttgaaaaatgttta
gtccttctttctgagaaaaaaatttcccaagttcaagatattgttccagctcttgaattagcaaataaatatcgtcaac
cacttattattattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaacagattaaaggttggtcttca
agtttgtgctgta 
 
pBindHSP60_5-6: SrHSP60 cDNA fragment (bp 739 to bp 873) 
gatattgttccagctcttgaattagcaaataaatatcgtcaaccacttattattattgctgaagatgtcgatggtgaag
ctcttacaaccctcgttcttaacagattaaaggttggtcttcaagtttgtgctgta 
 
pBindHSP60_4-2: SrHSP60 cDNA fragment (bp 625 to bp 1683) 
gaaatttgaccgtggatatatttctccatatttcatgaatacttccaagggtggaaaatgtttctttgaaaaatgttta
gtccttctttctgagaaaaaaatttcccaagttcaagatattgttccagctcttgaattagcaaataaatatcgtcaac
cacttattattattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaacagattaaaggttggtcttca
agtttgtgctgtaaaagctcctggttttggagacaaccgcaaaaacacattgaaagatattgccattgctacaggagct
aaagtctttggagatgaatctaatttacacaaacttgaagatattcaagcaggtgactttggtgaagttgctgaagtta
cagttacaaaagatgatactcttatgcttaatggaaaaggtgatgctgaacaagttgagaagagaattcaacaaattga
atttgagattgaacaatctacttctgagtatgaaaaagaaaaacttaatgaacgtttagctaaattatcaaaaggtgtt
gctgtccttaaaattggaggtgcttctgaagttgaagttagtgaaaagagagatcgtgtcacagatgcgctctgtgcaa
cacgtgctgctgtagaagaaggaatcgtaccaggaggtggtgttgctcttcttcgtgctgtcaaagttcttgataacat
caaagtcggtaattctgaccaagaattgggagttagaattgtccaaaaagccgttcgtcaaccaatttctaccattatt
aagaatgctggacttgaaccagctagtatcgttgaaaaagtttatgcaaatgaatcagtcagtttcggttacgatgctt
tgaatgataagtttgttgatatgatccaaactggtattattgatccaaccaaagttgtccgtacatcacttcaagacgc
tgctggtgttgcttcacttttagccactactgaatgtgttgttacagaagttccaaaagaaactccagcacctccaatg
ggtggtatgggaggtatgggcggaatgggtggt 
 
6.1.2 SrHSP10 cDNA sequences of the mammalian two-hybrid prey-constructs 
pAct3SRHSP10fl: SrHSP10 full length cDNA sequence (bp 330) 
atgcttctttccgctgttcgtagatgttcatcagctcttaaaaatgttcaaccactttttgatcgtgttatgatcaaaa
aagctgctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaaggaaaggttcttgaaggtactgt
tgttgctgctggtccaggacttcgtactgaggatggtaaacttatacctttatcagttagtgttggagatcgtgttatg
ttgccagagtatggtggaaataaagttgttatggatgatacagaatatttcatctatcgtgagtcagatctcatcgcca
aactcactaactaa 
 
pAct3SRHSP10a: SrHSP10 cDNA fragment (bp 1 to bp 174) 
atgcttctttccgctgttcgtagatgttcatcagctcttaaaaatgttcaaccactttttgatcgtgttatgatcaaaa
aagctgctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaaggaaaggttcttgaaggtactgt
tgttgctgctggtcca 
 
pAct3SRHSP10b: SrHSP10 cDNA fragment (bp 85 to bp 138) 
gctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaagga 
 
pAct3SRHSP10c: SrHSP10 cDNA fragment (bp 169 to bp 330) 
tggtccaggacttcgtactgaggatggtaaacttatacctttatcagttagtgttggagatcgtgttatgttgccagag
tatggtggaaataaagttgttatggatgatacagaatatttcatctatcgtgagtcagatctcatcgccaaactcacta
actaa 
Appendix  
101 
 
6.1.3 SrHSP60 cDNA sequences of the yeast two-hybrid bait-constructs 
pBridgeHSP60fl: SrHSP60 full-length cDNA sequence (1695 bp) 
atgcttcgtcttgctgctcataatttttctaaatctattatcagatcatatgctaaagatcttaaatttggagctgatg
gaagaaaggccatgcttgttggagtagatcttttagctgacgctgtatctgttacaatgggaccaaaaggaagaaatgt
tattattgaacaaagttttggtggaccaaaaattacaaaagacggtgttaccgttgctaaggctattgatctcgaagat
aaatatcaaaatatgggtgcaaaattggttcaagatgttgcagataaggctaacgaacaagctggtgacggaacaactt
gcgctactgttcttgccagagctattgctaaagaaggatttgaaagtattagccgtggtgctaatccaattgaagttag
aaaaggtgtcatgtcatccgttgaagctattgttgaagagttaaagaagatgtcaaagcaagttacaactccagaagaa
attgctcaagttgctactatttctgctaatggagataaagatatcggaaaattgatatctgaagctatgaaaaaagttg
gaaataaaggtgtcattaccgttaaggatggaaaaactcttgacgatgaattagaaattattgaaggaatgaaatttga
ccgtggatatatttctccatatttcatgaatacttccaagggtggaaaatgtttctttgaaaaatgtttagtccttctt
tctgagaaaaaaatttcccaagttcaagatattgttccagctcttgaattagcaaataaatatcgtcaaccacttatta
ttattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaacagattaaaggttggtcttcaagtttgtgc
tgtaaaagctcctggttttggagacaaccgcaaaaacacattgaaagatattgccattgctacaggagctaaagtcttt
ggagatgaatctaatttacacaaacttgaagatattcaagcaggtgactttggtgaagttgctgaagttacagttacaa
aagatgatactcttatgcttaatggaaaaggtgatgctgaacaagttgagaagagaattcaacaaattgaatttgagat
tgaacaatctacttctgagtatgaaaaagaaaaacttaatgaacgtttagctaaattatcaaaaggtgttgctgtcctt
aaaattggaggtgcttctgaagttgaagttagtgaaaagagagatcgtgtcacagatgcgctctgtgcaacacgtgctg
ctgtagaagaaggaatcgtaccaggaggtggtgttgctcttcttcgtgctgtcaaagttcttgataacatcaaagtcgg
taattctgaccaagaattgggagttagaattgtccaaaaagccgttcgtcaaccaatttctaccattattaagaatgct
ggacttgaaccagctagtatcgttgaaaaagtttatgcaaatgaatcagtcagtttcggttacgatgctttgaatgata
agtttgttgatatgatccaaactggtattattgatccaaccaaagttgtccgtacatcacttcaagacgctgctggtgt
tgcttcacttttagccactactgaatgtgttgttacagaagttccaaaagaaactccagcacctccaatgggtggtatg
ggaggtatgggcggaatgggtggtggaatgttctaa 
 
6.1.4 SrHSP10 cDNA sequences of the yeast two-hybrid prey-constructs 
The SrHSP10 yeast two-hybrid prey-constructs are shown below. The in Richardson et al 2000 
described mobile loop sequence is printed in grey. Start and stop codons are printed in bold. The base pair 
position is bracketed. 
 
pAct2SRHSP10fl: SrHSP10 full length cDNA sequence (bp 1 to bp 330) 
atgcttctttccgctgttcgtagatgttcatcagctcttaaaaatgttcaaccactttttgatcgtgttatgatcaaaa
aagctgctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaaggaaaggttcttgaaggtactgt
tgttgctgctggtccaggacttcgtactgaggatggtaaacttatacctttatcagttagtgttggagatcgtgttatg
ttgccagagtatggtggaaataaagttgttatggatgatacagaatatttcatctatcgtgagtcagatctcatcgcca
aactcactaactaa 
 
pAct2SRHSP10a: SrHSP10 cDNA fragment (bp 1 to bp 174) 
atgcttctttccgctgttcgtagatgttcatcagctcttaaaaatgttcaaccactttttgatcgtgttatgatcaaaa
aagctgctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaaggaaaggttcttgaaggtactgt
tgttgctgctggtcca 
 
pAct2SRHSP10b: SrHSP10 cDNA fragment (bp 85 to bp 138) 
gctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaagga 
 
pAct2SRHSP10c: SrHSP10 cDNA fragment (bp 169 to bp 330) 
tggtccaggacttcgtactgaggatggtaaacttatacctttatcagttagtgttggagatcgtgttatgttgccagag
tatggtggaaataaagttgttatggatgatacagaatatttcatctatcgtgagtcagatctcatcgccaaactcacta
actaa 
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pAct2SRHSP10gen1: NcoI/xbaI digested SrHSP10 subfragment (origin: pCR2.1-pAct2_HSP10 plasmid) 
gccatggagatgcttctttccgctgttcgtagatgttcatcagctcttaaaaatgttcaaccactttttgatcgtgtta
tgatcaaaaaagcttaatctaga 
 
pAct2SRHSP10gen2: BamHI/XhoI digested SrHSP10 subfragment (origin: pCR2.1-pAct2_HSP10 
plasmid) 
gggatccgagttcaaccactttttgatcgtgttatgatcaaaaaagctgctgctgaagtaaaatctaaaggaggtattt
acattccagagaaagcccaaggataactcgag 
 
pAct2SRHSP10gen3: SmaI/SacI digested SrHSP10 subfragment (origin: pCR2.1-pAct2_HSP10 plasmid) 
gccccgggggctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaaggaaaggttcttgaaggta
ctgttgttgctgcttaagagctc 
 
6.2 SrHSP60 and SrHSP10 Southern blot probes 
6.2.1 SrHSP60 Southern blot probe cDNA sequences 
The SrHSP60 Southern blot probe cDNA sequences are shown below. The base pair position is 
bracketed. 
 
pBluescript_HSP60_Sonde1 (bp 52-bp 372) 
gctaaagatcttaaatttggagctgatggaagaaaggccatgcttgttggagtagatcttttagctgacgctgtatctg
ttacaatgggaccaaaaggaagaaatgttattattgaacaaagttttggtggaccaaaaattacaaaagacggtgttac
cgttgctaaggctattgatctcgaagataaatatcaaaatatgggtgcaaaattggttcaagatgttgcagataaggct
aacgaacaagctggtgacggaacaacttgcgctactgttcttgccagagctattgctaaagaaggatttgaaagtatta
gccgt 
 
pBluescript_HSP60_Sonde2 (bp 378-bp 708) 
taatccaattgaagttagaaaaggtgtcatgtcatccgttgaagctattgttgaagagttaaagaagatgtcaaagcaa
gttacaactccagaagaaattgctcaagttgctactatttctgctaatggagataaagatatcggaaaattgatatctg
aagctatgaaaaaagttggaaataaaggtgtcattaccgttaaggatggaaaaactcttgacgatgaattagaaattat
tgaaggaatgaaatttgaccgtggatatatttctccatatttcatgaatacttccaagggtggaaaatgtttctttgaa
aaatgtttagtcctt 
 
pBluescript_HSP60_Sonde3 (bp 936-bp 1235) 
agctaaagtctttggagatgaatctaatttacacaaacttgaagatattcaagcaggtgactttggtgaagttgctgaa
gttacagttacaaaagatgatactcttatgcttaatggaaaaggtgatgctgaacaagttgagaagagaattcaacaaa
ttgaatttgagattgaacaatctacttctgagtatgaaaaagaaaaacttaatgaacgtttagctaaattatcaaaagg
tgttgctgtccttaaaattggaggtgcttctgaagttgaagttagtgaaaagagagatcgtgt 
 
pBluescript_HSP60_Sonde4 (bp 1334-bp 1641) 
tcaaagtcggtaattctgaccaagaattgggagttagaattgtccaaaaagccgttcgtcaaccaatttctaccattat
taagaatgctggacttgaaccagctagtatcgttgaaaaagtttatgcaaatgaatcagtcagtttcggttacgatgct
ttgaatgataagtttgttgatatgatccaaactggtattattgatccaaccaaagttgtccgtacatcacttcaagacg
ctgctggtgttgcttcacttttagccactactgaatgtgttgttacagaagttccaaaagaaactccagca 
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6.2.2 SrHSP10 Southern blot probe cDNA sequence 
The SrHSP10 Southern blot probe cDNA sequences are shown below. The base pair position is 
bracketed. 
 
pBluescript_HSP10_Sonde (bp 14-bp 323) 
atgcttctttccgctgttcgtagatgttcatcagctcttaaaaatgttcaaccactttttgatcgtgttatgatcaaaa
aagctgctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaaggaaaggttcttgaaggtactgt
tgttgctgctggtccaggacttcgtactgaggatggtaaacttatacctttatcagttagtgttggagatcgtgttatg
ttgccagagtatggtggaaataaagttgttatggatgatacagaatatttcatctatcgtgagtcagatctcatcgcca
aactcactaacta 
 
6.3 SrHSP60 subfragment cDNA sequence for E. coli expression excluding the 
mitochondrial leading sequence 
The SrHSP60 subfragment cDNA sequences for E. coli expression excluding the mitochondrial 
leading sequence are shown below. The base pair position is bracketed 
 
pJC45_HSP60-52 (bp 51-bp 1695) 
gctaaagatcttaaatttggagctgatggaagaaaggccatgcttgttggagtagatcttttagctgacgctgtatctg
ttacaatgggaccaaaaggaagaaatgttattattgaacaaagttttggtggaccaaaaattacaaaagacggtgttac
cgttgctaaggctattgatctcgaagataaatatcaaaatatgggtgcaaaattggttcaagatgttgcagataaggct
aacgaacaagctggtgacggaacaacttgcgctactgttcttgccagagctattgctaaagaaggatttgaaagtatta
gccgtggtgctaatccaattgaagttagaaaaggtgtcatgtcatccgttgaagctattgttgaagagttaaagaagat
gtcaaagcaagttacaactccagaagaaattgctcaagttgctactatttctgctaatggagataaagatatcggaaaa
ttgatatctgaagctatgaaaaaagttggaaataaaggtgtcattaccgttaaggatggaaaaactcttgacgatgaat
tagaaattattgaaggaatgaaatttgaccgtggatatatttctccatatttcatgaatacttccaagggtggaaaatg
tttctttgaaaaatgtttagtccttctttctgagaaaaaaatttcccaagttcaagatattgttccagctcttgaatta
gcaaataaatatcgtcaaccacttattattattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaaca
gattaaaggttggtcttcaagtttgtgctgtaaaagctcctggttttggagacaaccgcaaaaacacattgaaagatat
tgccattgctacaggagctaaagtctttggagatgaatctaatttacacaaacttgaagatattcaagcaggtgacttt
ggtgaagttgctgaagttacagttacaaaagatgatactcttatgcttaatggaaaaggtgatgctgaacaagttgaga
agagaattcaacaaattgaatttgagattgaacaatctacttctgagtatgaaaaagaaaaacttaatgaacgtttagc
taaattatcaaaaggtgttgctgtccttaaaattggaggtgcttctgaagttgaagttagtgaaaagagagatcgtgtc
acagatgcgctctgtgcaacacgtgctgctgtagaagaaggaatcgtaccaggaggtggtgttgctcttcttcgtgctg
tcaaagttcttgataacatcaaagtcggtaattctgaccaagaattgggagttagaattgtccaaaaagccgttcgtca
accaatttctaccattattaagaatgctggacttgaaccagctagtatcgttgaaaaagtttatgcaaatgaatcagtc
agtttcggttacgatgctttgaatgataagtttgttgatatgatccaaactggtattattgatccaaccaaagttgtcc
gtacatcacttcaagacgctgctggtgttgcttcacttttagccactactgaatgtgttgttacagaagttccaaaaga
aactccagcacctccaatgggtggtatgggaggtatgggcggaatgggtggtggaatgttctaa 
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6.4 SrHSP60 cDNA and amino acid sequences including the 5’ and 3’ UTR 
The SrHSP60 full length cDNA sequences and the deduced amino acid sequence are shown below. 
Start and stop codons are printed in bold. Spliced leader sequence is shadowed grey. 
 
ttggtttaattacccaagtttgaggaatatattaacagtacaactttaaaaaatgcttcgt 
  W  F  N  Y  P  S  L  R  N  I  L  T  V  Q  L  -  K  M  L  R  
cttgctgctcataatttttctaaatctattatcagatcatatgctaaagatcttaaattt 
 L  A  A  H  N  F  S  K  S  I  I  R  S  Y  A  K  D  L  K  F  
ggagctgatggaagaaaggccatgcttgttggagtagatcttttagctgacgctgtatct 
 G  A  D  G  R  K  A  M  L  V  G  V  D  L  L  A  D  A  V  S  
gttacaatgggaccaaaaggaagaaatgttattattgaacaaagttttggtggaccaaaa 
 V  T  M  G  P  K  G  R  N  V  I  I  E  Q  S  F  G  G  P  K  
attacaaaagacggtgttaccgttgctaaggctattgatctcgaagataaatatcaaaat 
 I  T  K  D  G  V  T  V  A  K  A  I  D  L  E  D  K  Y  Q  N  
atgggtgcaaaattggttcaagatgttgcagataaggctaacgaacaagctggtgacgga 
 M  G  A  K  L  V  Q  D  V  A  D  K  A  N  E  Q  A  G  D  G  
acaacttgcgctactgttcttgccagagctattgctaaagaaggatttgaaagtattagc 
 T  T  C  A  T  V  L  A  R  A  I  A  K  E  G  F  E  S  I  S  
cgtggtgctaatccaattgaagttagaaaaggtgtcatgtcatccgttgaagctattgtt 
 R  G  A  N  P  I  E  V  R  K  G  V  M  S  S  V  E  A  I  V  
gaagagttaaagaagatgtcaaagcaagttacaactccagaagaaattgctcaagttgct 
 E  E  L  K  K  M  S  K  Q  V  T  T  P  E  E  I  A  Q  V  A  
actatttctgctaatggagataaagatatcggaaaattgatatctgaagctatgaaaaaa 
 T  I  S  A  N  G  D  K  D  I  G  K  L  I  S  E  A  M  K  K  
gttggaaataaaggtgtcattaccgttaaggatggaaaaactcttgacgatgaattagaa 
 V  G  N  K  G  V  I  T  V  K  D  G  K  T  L  D  D  E  L  E  
attattgaaggaatgaaatttgaccgtggatatatttctccatatttcatgaatacttcc 
 I  I  E  G  M  K  F  D  R  G  Y  I  S  P  Y  F  M  N  T  S  
aagggtggaaaatgtttctttgaaaaatgtttagtccttctttctgagaaaaaaatttcc 
 K  G  G  K  C  F  F  E  K  C  L  V  L  L  S  E  K  K  I  S  
caagttcaagatattgttccagctcttgaattagcaaataaatatcgtcaaccacttatt 
 Q  V  Q  D  I  V  P  A  L  E  L  A  N  K  Y  R  Q  P  L  I  
attattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaacagattaaag 
 I  I  A  E  D  V  D  G  E  A  L  T  T  L  V  L  N  R  L  K  
gttggtcttcaagtttgtgctgtaaaagctcctggttttggagacaaccgcaaaaacaca 
 V  G  L  Q  V  C  A  V  K  A  P  G  F  G  D  N  R  K  N  T  
ttgaaagatattgccattgctacaggagctaaagtctttggagatgaatctaatttacac 
 L  K  D  I  A  I  A  T  G  A  K  V  F  G  D  E  S  N  L  H  
aaacttgaagatattcaagcaggtgactttggtgaagttgctgaagttacagttacaaaa 
 K  L  E  D  I  Q  A  G  D  F  G  E  V  A  E  V  T  V  T  K  
gatgatactcttatgcttaatggaaaaggtgatgctgaacaagttgagaagagaattcaa 
 D  D  T  L  M  L  N  G  K  G  D  A  E  Q  V  E  K  R  I  Q  
caaattgaatttgagattgaacaatctacttctgagtatgaaaaagaaaaacttaatgaa 
 Q  I  E  F  E  I  E  Q  S  T  S  E  Y  E  K  E  K  L  N  E  
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cgtttagctaaattatcaaaaggtgttgctgtccttaaaattggaggtgcttctgaagtt 
 R  L  A  K  L  S  K  G  V  A  V  L  K  I  G  G  A  S  E  V  
gaagttagtgaaaagagagatcgtgtcacagatgcgctctgtgcaacacgtgctgctgta 
 E  V  S  E  K  R  D  R  V  T  D  A  L  C  A  T  R  A  A  V  
gaagaaggaatcgtaccaggaggtggtgttgctcttcttcgtgctgtcaaagttcttgat 
 E  E  G  I  V  P  G  G  G  V  A  L  L  R  A  V  K  V  L  D  
aacatcaaagtcggtaattctgaccaagaattgggagttagaattgtccaaaaagccgtt 
 N  I  K  V  G  N  S  D  Q  E  L  G  V  R  I  V  Q  K  A  V  
cgtcaaccaatttctaccattattaagaatgctggacttgaaccagctagtatcgttgaa 
 R  Q  P  I  S  T  I  I  K  N  A  G  L  E  P  A  S  I  V  E  
aaagtttatgcaaatgaatcagtcagtttcggttacgatgctttgaatgataagtttgtt 
 K  V  Y  A  N  E  S  V  S  F  G  Y  D  A  L  N  D  K  F  V  
gatatgatccaaactggtattattgatccaaccaaagttgtccgtacatcacttcaagac 
 D  M  I  Q  T  G  I  I  D  P  T  K  V  V  R  T  S  L  Q  D  
gctgctggtgttgcttcacttttagccactactgaatgtgttgttacagaagttccaaaa 
 A  A  G  V  A  S  L  L  A  T  T  E  C  V  V  T  E  V  P  K  
gaaactccagcacctccaatgggtggtatgggaggtatgggcggaatgggtggtggaatg 
 E  T  P  A  P  P  M  G  G  M  G  G  M  G  G  M  G  G  G  M  
ttctaaatcactagtcatttttttaccttctgcttccaatctttccttatttttaagatc 
 F  -  I  T  S  H  F  F  T  F  C  F  Q  S  F  L  I  F  K  I  
aataattataatgtatttaaagtatcaaactagattattgttttagggttgttacatttt 
 N  N  Y  N  V  F  K  V  S  N  -  I  I  V  L  G  L  L  H  F  
tgttttggttttcaacaaataaataaaatataanccaaaaaaaaaaaaaaaaaaaaaaaa 
 C  F  G  F  Q  Q  I  N  K  I  -  X  K  K  K  K  K  K  K  K  
 
6.5 SrHSP10 cDNA and amino acid sequences including the 5’ and 3’ UTR 
The SrHSP10 full length cDNA sequence and the deduced amino acid sequence are shown below. 
Start and stop codons are printed in bold. Spliced leader sequence is shadowed grey. 
 
ggtttaattacccaagtttgaggttcttgtaattttggtaaatatgcttctttccgctgtt 
  V  -  L  P  K  F  E  V  L  V  I  L  V  N  M  L  L  S  A  V  
cgtagatgttcatcagctcttaaaaatgttcaaccactttttgatcgtgttatgatcaaa 
 R  R  C  S  S  A  L  K  N  V  Q  P  L  F  D  R  V  M  I  K  
aaagctgctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaagga 
 K  A  A  A  E  V  K  S  K  G  G  I  Y  I  P  E  K  A  Q  G  
aaggttcttgaaggtactgttgttgctgctggtccaggacttcgtactgaggatggtaaa 
 K  V  L  E  G  T  V  V  A  A  G  P  G  L  R  T  E  D  G  K  
cttatacctttatcagttagtgttggagatcgtgttatgttgccagagtatggtggaaat 
 L  I  P  L  S  V  S  V  G  D  R  V  M  L  P  E  Y  G  G  N  
aaagttgttatggatgatacagaatatttcatctatcgtgagtcagatctcatcgccaaa 
 K  V  V  M  D  D  T  E  Y  F  I  Y  R  E  S  D  L  I  A  K  
ctcactaactaaggaatacattaaagtgtaatttttatatattattttgttgttttttgc 
 L  T  N  -  G  I  H  -  S  V  I  F  I  Y  Y  F  V  V  F  C  
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atagttgatattgtagtttgtattcttgttggttggttaaagactataaaaaattttaca 
 I  V  D  I  V  V  C  I  L  V  G  W  L  K  T  I  K  N  F  T  
caaaaaaaaaaaaaaaaaaaaaaaaa 
 Q  K  K  K  K  K  K  K   
 
6.6 SrHSP60 and SrHSP10 parasitic female cDNA sequences 
6.6.1 SrHSP60 parasitic female cDNA sequence 
The SrHSP60 full length parasitic female cDNA sequences and the alignment with the SrHSP60 full 
length iL3 cDNA sequences are shown below. Start and stop codons are printed in bold. 
 
il3   atgcttcgtcttgctgctcataatttttctaaatctattatcagatcatatgctaaagat 60 
    :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf   atgcttcgtcttgctgctcataatttttctaaatctattatcagatcatatgctaaagat 60 
 
il3 cttaaatttggagctgatggaagaaaggccatgcttgttggagtagatcttttagctgac  120 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf cttaaatttggagctgatggaagaaaggccatgcttgttggagtagatcttttagctgac  120 
 
il3 gctgtatctgttacaatgggaccaaaaggaagaaatgttattattgaacaaagttttggt  180 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf gctgtatctgttacaatgggaccaaaaggaagaaatgttattattgaacaaagttttggt  180 
 
il3 ggaccaaaaattacaaaagacggtgttaccgttgctaaggctattgatctcgaagataaa  240 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf ggaccaaaaattacaaaagacggtgttaccgttgctaaggctattgatctcgaagataaa  240 
 
il3 tatcaaaatatgggtgcaaaattggttcaagatgttgcagataaggctaacgaacaagct  300 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf tatcaaaatatgggtgcaaaattggttcaagatgttgcagataaggctaacgaacaagct  300 
 
il3 ggtgacggaacaacttgcgctactgttcttgccagagctattgctaaagaaggatttgaa  360 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf ggtgacggaacaacttgcgctactgttcttgccagagctattgctaaagaaggatttgaa  360 
 
il3 agtattagccgtggtgctaatccaattgaagttagaaaaggtgtcatgtcatccgttgaa  420 
  ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf aatattagccgtggtgctaatccaattgaagttagaaaaggtgtcatgtcatccgttgaa  420 
 
il3 gctattgttgaagagttaaagaagatgtcaaagcaagttacaactccagaagaaattgct  480 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf gctattgttgaagagttaaagaagatgtcaaagcaagttacaactccagaagaaattgct  480 
 
il3 caagttgctactatttctgctaatggagataaagatatcggaaaattgatatctgaagct  540 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf caagttgctactatttctgctaatggagataaagatatcggaaaattgatatctgaagct  540 
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il3 atgaaaaaagttggaaataaaggtgtcattaccgttaaggatggaaaaactcttgacgat  600 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf atgaaaaaagttggaaataaaggtgtcattaccgttaaggatggaaaaactcttgacgat  600 
 
il3 gaattagaaattattgaaggaatgaaatttgaccgtggatatatttctccatatttcatg  660 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf gaattagaaattattgaaggaatgaaatttgaccgtggatatatttctccatatttcatg  660 
 
il3 aatacttccaagggtggaaaatgtttctttgaaaaatgtttagtccttctttctgagaaa  720 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf aatacttccaagggtggaaaatgtttctttgaaaaatgtttagtccttctttctgagaaa  720 
 
il3 aaaatttcccaagttcaagatattgttccagctcttgaattagcaaataaatatcgtcaa  780 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf aaaatttcccaagttcaagatattgttccagctcttgaattagcaaataaatatcgtcaa  780 
 
il3 ccacttattattattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaac  840 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf ccacttattattattgctgaagatgtcgatggtgaagctcttacaaccctcgttcttaac  840 
 
il3 agattaaaggttggtcttcaagtttgtgctgtaaaagctcctggttttggagacaaccgc  900 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf agattaaaggttggtcttcaagtttgtgctgtaaaagctcctggttttggagacaaccgc  900 
 
il3 aaaaacacattgaaagatattgccattgctacaggagctaaagtctttggagatgaatct  960 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf aaaaacacattgaaagatattgccattgctacaggagctaaagtctttggagatgaatct  960 
 
il3 aatttacacaaacttgaagatattcaagcaggtgactttggtgaagttgctgaagttaca 1020 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf aatttacacaaacttgaagatattcaagcaggtgactttggtgaagttgctgaagttaca 1020 
 
il3 gttacaaaagatgatactcttatgcttaatggaaaaggtgatgctgaacaagttgagaag 1080 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf gttacaaaagatgatactcttatgcttaatggaaaaggtgatgctgaacaagttgagaag 1080 
 
il3 agaattcaacaaattgaatttgagattgaacaatctacttctgagtatgaaaaagaaaaa 1140 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf agaattcaacaaattgaatttgagattgaacaatctacttctgagtatgaaaaagaaaaa 1140 
 
il3 cttaatgaacgtttagctaaattatcaaaaggtgttgctgtccttaaaattggaggtgct 1200 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf cttaatgaacgtttagctaaattatcaaaaggtgttgctgtccttaaaattggaggtgct 1200 
 
il3 tctgaagttgaagttagtgaaaagagagatcgtgtcacagatgcgctctgtgcaacacgt 1260 
  ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf tctgaagttgaagttagtgaaaagagagatcgtgtcacagatgcactctgtgcaacacgt 1260 
 
il3 gctgctgtagaagaaggaatcgtaccaggaggtggtgttgctcttcttcgtgctgtcaaa 1320 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf gctgctgtagaagaaggaatcgtaccaggaggtggtgttgctcttcttcgtgctgtcaaa 1320 
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il3 gttcttgataacatcaaagtcggtaattctgaccaagaattgggagttagaattgtccaa 1380 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf gttcttgataacatcaaagtcggtaattctgaccaagaattgggagttagaattgtccaa 1380 
 
il3 aaagccgttcgtcaaccaatttctaccattattaagaatgctggacttgaaccagctagt 1440 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf aaagccgttcgtcaaccaatttctaccattattaagaatgctggacttgaaccagctagt 1440 
 
il3 atcgttgaaaaagtttatgcaaatgaatcagtcagtttcggttacgatgctttgaatgat 1500 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf atcgttgaaaaagtttatgcaaatgaatcagtcagtttcggttacgatgctttgaatgat 1500 
 
il3 aagtttgttgatatgatccaaactggtattattgatccaaccaaagttgtccgtacatca 1560 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf aagtttgttgatatgatccaaactggtattattgatccaaccaaagttgtccgtacatca 1560 
  
il3 cttcaagacgctgctggtgttgcttcacttttagccactactgaatgtgttgttacagaa 1620 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf cttcaagacgctgctggtgttgcttcacttttagccactactgaatgtgttgttacagaa 1620 
 
il3 gttccaaaagaaactccagcacctccaatgggtggtatgggaggtatgggcggaatgggt 1680 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf gttccaaaagaaactccagcacctccaatgggtggtatgggaggtatgggcggaatgggt 1680 
 
il3 ggtggaatgttctaa  1695 
  ::::::::::::::: 
pf ggtggaatgttctaa  1695 
 
6.6.2 SrHSP10 parasitic female cDNA sequence  
The SrHSP10 full length parasitic female cDNA sequences and the alignment with the SrHSP10 full 
length iL3 cDNA sequences are shown below. Start and stop codons are printed in bold. 
 
iL3 atgcttctttccgctgttcgtagatgttcatcagctcttaaaaatgttcaaccacttttt 60 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf atgcttctttccgctgttcgtagatgttcatcagctcttaaaaatgttcaaccacttttt 60 
 
il3 gatcgtgttatgatcaaaaaagctgctgctgaagtaaaatctaaaggaggtatttacatt 120 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf gatcgtgttatgatcaaaaaagctgctgctgaagtaaaatctaaaggaggtatttacatt 120 
 
il3 ccagagaaagcccaaggaaaggttcttgaaggtactgttgttgctgctggtccaggactt 180 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf ccagagaaagcccaaggaaaggttcttgaaggtactgttgttgctgctggtccaggactt 180 
 
il3 cgtactgaggatggtaaacttatacctttatcagttagtgttggagatcgtgttatgttg 240 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf cgtactgaggatggtaaacttatacctttatcagttagtgttggagatcgtgttatgttg 240 
 
il3 ccagagtatggtggaaataaagttgttatggatgatacagaatatttcatctatcgtgag 300 
  :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
pf ccagagtatggtggaaataaagttgttatggatgatacagaatatttcatctatcgtgag 300 
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il3 tcagatctcatcgccaaactcactaactaa  330 
  :::::::::::::::::::::::::::::: 
pf tcagatctcatcgccaaactcactaactaa  330 
 
6.7 SrHSP60 and SrHSP10 gDNA sequences 
The SrHSP60 and SrHSP10 full length gDNA sequences including the intergenic sequence are 
shown below. Stop codons are printed in bold. The SrHSP60 start codon is shadowed grey. The SrHSP10 
start codon is shadowed black. The intergenic region is printed in grey. 
 
ttagaacattccaccacccattccgcccatacctcccataccacccattggaggtgctggagtttcttttggaact
tctgtaacaacacattcagtagtggctaaaagtgaagcaacaccagcagcgtcttgaagtgatgtacggacaactttgg
ttggatcaataataccagtttggatcatatcaacaaacttatcattcaaagcatcgtaaccgaaactgactgattcatt
tgcataaactttttcaacgatactagctggttcaagtccagcattcttaataatggtagaaattggttgacgaacggct
ttttggacaattctaactcccaattcttggtcagaattaccgactttgatgttatcaagaactttgacagcacgaagaa
gagcaacaccacctcctggtacgattccttcttctacagcagcacgtgttgcacagagcgcatctgtgacacgatctct
cttttcactaacttcaacttcagaagcacctccaattttaaggacagcaacaccttttgataatttagctaaacgttca
ttaagtttttctttttcatactcagaagtagattgttcaatctcaaattcaatttgttgaattctcttctcaacttgtt
cagcatcaccttttccattaagcataagagtatcatcttttgtaactgtaacttcagcaacttcaccaaagtcacctgc
ttgaatatcttcaagtttgtgtaaattagattcatctccaaagactttagctcctgtagcaatggcaatatctttcaat
gtgtttttgcggttgtctccaaaaccaggagcttttacagcacaaacttgaagaccaacctttaatctgttaagaacga
gggttgtaagagcttcaccatcgacatcttcagcaataataataagtggttgacgatatttatttgctaattcaagagc
tggaacaatatcttgaacttgggaaatttttttctcagaaagaaggactaaacatttttcaaagaaacattttccaccc
ttggaagtattcatgaaatatggagaaatatatccacggtcaaatttcattccttcaataatttctaattcatcgtcaa
gagtttttccatccttaacggtaatgacacctttatttccaacttttttcatagcttcagatatcaattttccgatatc
tttatctccattagcagaaatagtagcaacttgagcaatttcttctggagttgtaacttgctttgacatcttctttaac
tcttcaacaatagcttcaacggatgacatgacaccttttctaacttcaattggattagcaccacggctaatactttcaa
atccttctttagcaatagctctggcaagaacagtagcgcaagttgttccgtcaccagcttgttcgttagccttatctgc
aacatcttgaaccaattttgcacccatattttgatatttatcttcgagatcaatagccttagcaacggtaacaccgtct
tttgtaatttttggtccaccaaaactttgttcaataataacatttcttccttttggtcccattgtaacagatacagcgt
cagctaaaagatctactccaacaagcatggcctttcttccatcagctccaaatttaagatctttagcatatgatctgat
aatagatttagaaaaattatgagcagcaagacgaagcattttttaaagttgtactgttaatatattcctaaaaatttaa
atattaaacaaacttttaattgaaaaaattttcaaaaaaattataatttttaaaaactgaaaactaatttttataacga
aagtattaaagatatactttaaattaaaataaattggaatagaataaacatttcttgctgcactattgcgaaatattaa
tataggaattttcgcgaaatttctttaaaaaaaatctacaaattaataaattgctcctacaacgatagtagagacgatc
ttgttgcagaatgttctagaatgacttttaagttatgatggtaatctgcggctcgtccatataacttagagattatttt
aattttaaattattttttaactaattgcaggttcttgtaattttggtaaatatgcttctttccgctgttcgtagatgtg
taggttattttatttctatataaaattatatttctttttagtcatcagctcttaaaaatgttcaaccactttttgatcg
tgttatgatcaaaaaagctgctgctgaagtaaaatctaaaggaggtatttacattccagagaaagcccaaggaaaggtt
cttgaaggtactgttgttgctgctggtccaggacttcgtactgaggatggtaaacttatacctttatcagttagtgttg
gagatcgtgttatgttgccagagtatggtggaaataaagttgttatggatgatacagaatatttcatctatcgtgagtc
agatctcatcgccaaactcactaactaa 
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8 Abbreviations and Units  
8.1 Abbreviations 
A adenine HSP Heat shock protein 
APS  ammoniumperoxodisulfate IPTG  isopropyl-beta-d-thiogalactopyranoside 
aa  amino acid iL3s infectious third stage larvae 
BD  binding domain LacZ  general structure of beta galactosidase 
BSA  bovine serum albumine  LB  luria broth  
conc.  concentrated  MCS  multiple cloning site  
d  coat thickness  MOPS  3-n(morpholino) propane sulfonic acid 
DEPC  diethylpyrocarbonate NCBI  National Centre for Biotechnology 
Information  
dH2O  deionised water  NCS  newborn calf serum  
DMSO  dimethyl sulfoxide ONPG  o-nitrophenyl-ß. -d-galactopyranoside 
DNA  deoxyribonucleic acid ORF  open reading frame  
cDNA  complementary DNA  PAGE  polyacrylamide gel electrophoresis 
DNase  deoxyribonuclease PBS  phosphate buffered saline  
dNTP  deoxyribonucleotide triphosphate PCR  polymerase chain reaction  
DTT  dithiothreitol  PEG  polyethylenglycole  
E  extinction  RNA  ribonucleic acid  
EDTA  ethylenediaminetetraacetic acid mRNA  messenger RNA  
et al.  et alii  rRNA  ribosomal RNA  
EtBr  ethidium bromide RNase  ribonuclease  
EtOH  ethanol  RT  room temperature 
G  guanine RT  reverse transcription 
GFP  green fluorescent protein  RT-PCR  reverse transcription-PCR 
HCl  hydrochloric acid  SDS  sodium dodecyl sulfate  
HEPES  4-2-hydroxyethyl)piperazine-1-ethanesulfon
i cacid 
T  thymidine  
Taq  thermophilus aquatus  TWEEN  poloxyethylenglykolsorbitol-monooleat  
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TEMED  tetramethylethylenediamine WHO  World Health Organisation  
TK  tyrosine kinase  X-Gal  5-bromo-4-chloro-3-indoyl- ß-d-galacto-
pyranosid  
Tris  tris(hydroxymethyl)amino- methane  λ wavelength  
 
 
 
 
8.2 Units 
aa  amino acid  kb  kilo base pair tm  temperature melting point 
 
bp  base pair min  minute  u  unit  
 
c  concentration  ml  millilitre  v  volt  
 
°C  Celsius  mM  millimolar  (v/v)  volume per volume  
 
cm  centimetre  ng  nanogram w  watt  
 
d  day nm  nanometre  (w/v)  weight per volume  
 
da  dalton  od  optical density  µg  microgram  
 
g  gram ph  h+-concentration  µl  microlitre 
 
g  acceleration of gravidity rpm  rotations per minute  µmol  micromol  
 
h  hours sec  seconds µm  micromolar  
 
hz  hertz t  time   % percentage 
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8.3 Amino acids 
A  Ala  alanine M  Met  methionine  
B  Asx  asparagine, asparagine acid N  Asn  asparagine  
C  Cys  cysteine  P  Pro  proline  
D  Asp  asparagine acid Q  Gln  glutamine 
E  Glu  glutamine acid R  Arg  arginine  
F  Phe  phenylalanine  S  Ser  serine  
G  Gly  glycine  T  Thr  threonine  
H  His  histidine V  Val  valine  
I  Ile  isoleucine  W  Trp  tryptophane  
K  Lys  lysine  Y  Tyr  tyrosine  
L  Leu  leucine  Z  Glx  glutamine, glutamine acid 
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